ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000311.1|Balhimycin_1 # 1 # 741 # -1 # ID=1_1;partial=10;start_type=ATG;rbs_motif=GGA;rbs_spacer=13bp;gc_cont=0.696	BGC0000311.1|Balhimycin_1 	1	741	-	Loose	650	267.7	vanS gene in vanO cluster	65.13	3002941	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	ATGAGCGTCCGCCTCAAACTCACCCTCAGCTACGCCTGCTTCCTCGTGCTCGCCGGTGTACTGCTGCTCGCTTCCGTGTGGCTGTTCCTGCTGCGTGATGTCCCCGACGTGCTGGCCAAACCGCCCCCCGGCGGGGTGCTGGAGCGGTCCGTCCTGGTGCGCAACTTCCTGCCGGCCGCGGGCTCAGTGCTGTTCTTCCTGCTGCTGTTCGGCCTGCTGGGCGGCTGGATCCTCGCCGGCCGCATGCTCGCCCCGCTGACCCGGATCACCGACGCCGCGCGCATGGCCGCGAACGGGTCGCTCTCCCACCGGATCCGGCTGGAAGGCACCGAAGACGAGTTCCGCGAACTCGCCGATGCCTTCGACGCCATGCTCGCCCGGCTCGAAGCCCACGTCGCCGCGCAGCGGAGGTTCGCCGCGAACGCCTCGCACGAGCTGCGCACCCCGCTGGCGATCACGCAGGCGCTTCTCGAAGTGGCCCGCAACGATCCGGCGAAAGACCCGCTGCTGGTCTTCGACCGCCTCCACGCGGTGAACGCCCGGGCGATCGACCTCACCGAGGCGCTGCTGGTGCTCAGCCGCGCCGATCAGCGCGCGTTCACCCGGGAACCGGTCGACCTGTCCCTGCTTGTGGAAGAGGCCATCGAAACGCTGCTCCCGATCGCCGAGAAACGCCGTGTCGTCATCATCGCCTCCGGTCACATCAGCCGGGTGGTGGGGTCGGCGACGCTGCTGCTGCAG	MSVRLKLTLSYACFLVLAGVLLLASVWLFLLRDVPDVLAKPPPGGVLERSVLVRNFLPAAGSVLFFLLLFGLLGGWILAGRMLAPLTRITDAARMAANGSLSHRIRLEGTEDEFRELADAFDAMLARLEAHVAAQRRFAANASHELRTPLAITQALLEVARNDPAKDPLLVFDRLHAVNARAIDLTEALLVLSRADQRAFTREPVDLSLLVEEAIETLLPIAEKRRVVIIASGHISRVVGSATLLLQ	MLAGVLLLAAVWVFLLRGRSTNFQFPALADFARVFDPSNFGPVVFVPAAILALGFLLVFGLVGGWILAGRMLAPLARITRAAREAGSGSLSYRIELEGRNDEFRELADAFDAMLARLEARDAAQQRFAANASHELRTPLAITQTLLDVARNDPNRDGGELDERLRAVNARAIELTEALLLLSRTDQRSFSREDVDLSLIAEEAAETLLPFAEKHGVSIETSGDIAPVIGSHALLLQLTTNLLHNAIVHNVPEHGSVQISTAIGSESVMLTVENTGDKLSPQLVSTLTEPFQRGTARTRGDDARVGLGLAIVKSITQAHDGSLTLSPRAAGGLSVAVRLPAAQRRP	71.59	gnl|BL_ORD_ID|4732|hsp_num:0	465			0	690	vancomycin
BGC0000311.1|Balhimycin_2 # 770 # 1486 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.678	BGC0000311.1|Balhimycin_2 	770	1486	-	Loose	400	349.747	vanR gene in vanO cluster	84.3	3002930	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGCCGACGATATGTAGTGGCCTCTCGTACCATCGGGGCATGCGCGTGCTGATCGTCGAGGACGAGCCCTATCTGGCCGAAGCCATCCGCGACGGCCTGCGTTTGGAAGCGATCGCGGCGGACACCGCGGGCAACGGCGACACCGCTCTCGAACTGCTGAGCCTCAACACCTACGACATCGCCGTCCTCGACCGGGATATTCCCGGACCCAGCGGGGACGAGATCGCCAAACGGATCGTCGCTTCCGGCAGCGGCCTGCCGATCCTCATGCTCACCGCCGCCGACCGGCTCGACGACAAGATCACCGGGTTCGAGCTCGGTGCCGACGACTACCTCACGAAGCCGTTCGAACTGCGGGAGCTCGTGCTCAGGCTGCGGGCGCTCGATCGCCGGCGTGCCCACAACCGGCCGCCGGTACTGGAAATCGCCGGCCTGCGGCTGAACCCGTTCCGCCGCGAGGTCTACCGCGACGACCGCTACATCGCGCTGACCAGGAAGCAGTTCGCCGTGCTCGAAGTCCTCGTTTCCGCCGACGGCGGTGTCGTCAGCGCCGAAGAGCTGCTGGAACGGGCCTGGGACAAGAACGCCGACCCGTTCACCAACGCTGTGCGCATCACGGTTTCGGCTCTGCGCAAGCGGCTCGGCGAGCCCTGGATCATCACCACGGTGGCCGGCGTCGGGTACCGCATCGGCGCGGCGCCCGGCGCCGGGCGCTAG	MPTICSGLSYHRGMRVLIVEDEPYLAEAIRDGLRLEAIAADTAGNGDTALELLSLNTYDIAVLDRDIPGPSGDEIAKRIVASGSGLPILMLTAADRLDDKITGFELGADDYLTKPFELRELVLRLRALDRRRAHNRPPVLEIAGLRLNPFRREVYRDDRYIALTRKQFAVLEVLVSADGGVVSAEELLERAWDKNADPFTNAVRITVSALRKRLGEPWIITTVAGVGYRIGAAPGAGR	MASMRVLVVEDERFMAEAIRDGLRLEAIAADIAGDGDTALDLLGVNAYDIAVLDRDIPGPSGDEIAQRIVASGGGIPILMLTAADRMDDKASGFELGADDYLTKPFELQELVLRLRALDRRRAHSRPPVREIAGLQLDPFRREVYRDGRYVALTRKQFAVLEVLVAAEGGVISAEELLERAWDENADPFTNAVRITVSTLRKRLGEPWLIATVPGVGYRIDTEPDARGGGDGG	102.15	gnl|BL_ORD_ID|4742|hsp_num:0	1689			9	678	vancomycin
BGC0000311.1|Balhimycin_3 # 1537 # 2157 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.736	BGC0000311.1|Balhimycin_3	1537	2157	+	Strict	50	59.6918	vanY gene in vanB cluster	32.87	3002956	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanY; glycopeptide resistance gene cluster	ATGACCTACCGCGAGTCGGCCCGGACGACGACCCGCCGGATTCCCGGCGCCGTCGTGCCGGTGGCCCGCCGGATTCGCGGGGTCCTTCTCGCCGGCCTGCGCGCCGTCGGCACGAGGATTGCCCGGTCGCCCGGTCGCCCGGTCCGCCCCCAGGACCGTGCCGGCCTCGGCAAGACCCACGGTGCCGTCCCCGCCGGGGTGACGGTCTTCGACGACGACGTCCCGGCTGTGACTCGCCTCGACCCGGCGCTTCTGAGTGCACTGCGCCGGGCCGCGACCGCGGCCGCCGACGGCGGGGTCGAACTGTGCGTGAACAGCGGCTGGCGGTCTCCGGAATACCAGAGCCGGCTTCTTCGCGAGGCGGTGGCGAAATACGGGTCGGCGGCGGCGGCCGCCCGGTGGGTGGCCACCCCGGAGACGTCGATCCACGTGGCGGGGAAGGCGGTCGACATCGGGCCACCCGCGTCCGCGTCGTGGTTGTCCGAGCACGGCGCCGATTACGGGTTGTGCCGCGTCTACCGCAACGAACCCTGGCACTTCGAATTGCGTCCCGAAGCGATCGAGCACGGCTGCCCGCCCCTGTATGCCGACCCGAGTCACGACCCGCGGCTGCGCCGGTGA	MTYRESARTTTRRIPGAVVPVARRIRGVLLAGLRAVGTRIARSPGRPVRPQDRAGLGKTHGAVPAGVTVFDDDVPAVTRLDPALLSALRRAATAAADGGVELCVNSGWRSPEYQSRLLREAVAKYGSAAAAARWVATPETSIHVAGKAVDIGPPASASWLSEHGADYGLCRVYRNEPWHFELRPEAIEHGCPPLYADPSHDPRLRR	MEKSNYHSNVNHHKRHMKQSGEKRAFLWAFIISFTVCTLFLGWRLVSVLEATQLPPIPATHTGSGTGVAENPEENTLATAKEQGDEQEWSLILVNRQNPIPAQYDVELEQLSNGERIDIRISPYLQDLFDAARADGVYPIVASGYRTTEKQQEIMDEKVAEYKAKGYTSAQAKAEAETWVAVPGTSEHQLGLAVDINADGIHSTGNEVYRWLDENSYRFGFIRRYPPDKTEITGVSNEPWHYRYVGIEAATKIYHQGLCLEEYLNTEK	76.87	gnl|BL_ORD_ID|602|hsp_num:0	556			297	726	vancomycin
BGC0000311.1|Balhimycin_4 # 3179 # 3976 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.709	BGC0000311.1|Balhimycin_4 	3179	3976	+	Loose	500	25.409	OXA-18	37.7	3001413	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGCAGGTGCTCGACGGCCTGCACCGGTTGAAGGTGGCGCGAGTCCGGGGTGACACGAAAATCCTGGCCAGACTGGTCGACGCCACCGAATCGGATGCGTTCGTCCTGGCGGTCGAGGCGAACATCCGGCACGGTCTGCCGCTGTCCCTCGCCGATCGCAAGCGTGCGGCCGTCCAGATCATCGGGACGCATCCGCAGTGGTCCGATCGGCGGGTGGCCTCGGCGACCGGGATCTCCGCGGGCACGGTGGCCGACCTGCGCAGGCGCGCGGGAGAGGACGGGACCGAGGCCCGGATCGGGCGGGACGGGCGTGTCCGCCCGTCCGACGGTTCGGAGCGGAGAAGACTCGCCGCCGAGCTCATCCGCAGCGATCCGGGTCTGTCTCTGCGGCAGGTCGCCAAGCAGGTCGGCATCTCCCCGGAGACGGTGCGTGACGTGCGGGGCCGGCTGGAGCGCGGGGAGAGCCCGACTCCGGACGGGACAAGGAGATTGCCGGCCAAGCCGCACCCGCTGCGGTTGTCGGAGCCCGACTTCGGCCGTGCCGTGGACCAGGATCGGCTCGCGCTGCTGGAAAGGCTCAAGAGCGACCCGGCACTGCGGCTGAACGAGGTCGGCCGGATCCTGCTGCGCATGCTCACCATGCACTCCATGGACGGGCAGGAGTGGGAACGGATCCTGCAGGGTGTTCCACCACACCTGCACGGCGTGATCGCCGGGTTCGCCCGGGACCACGCCCGGGTCTGGGCGGAGTTCGCCGACCACCTGGAGAGCCGGGCGACCGAGCTGGCCGCGGGATGA	MQVLDGLHRLKVARVRGDTKILARLVDATESDAFVLAVEANIRHGLPLSLADRKRAAVQIIGTHPQWSDRRVASATGISAGTVADLRRRAGEDGTEARIGRDGRVRPSDGSERRRLAAELIRSDPGLSLRQVAKQVGISPETVRDVRGRLERGESPTPDGTRRLPAKPHPLRLSEPDFGRAVDQDRLALLERLKSDPALRLNEVGRILLRMLTMHSMDGQEWERILQGVPPHLHGVIAGFARDHARVWAEFADHLESRATELAAG	MQRSLSMSGKRHFIFAVSFVISTVCLTFSPANAAQKLSCTLVIDEASGDLLHREGSCDKAFAPMSTFKLPLAIMGYDADILLDATTPRWDYKPEFNGYKSQQKPTDPTIWLKDSIVWYSQELTRRLGESRFSDYVQRFDYGNKDVSGDPGKHNGLTHAWLASSLKISPEEQVRFLRRFLRGELPVSEDALEMTKAVVPHFEAGDWDVQGKTGTGSLSDAKGGKAPIGWFIGWATRDDRRVVFARLTVGARKGEQPAGPAARDEFLNTLPALSENF	96.36	gnl|BL_ORD_ID|927|hsp_num:0	1003			372	552	cloxacillin; oxacillin; cefalotin
BGC0000311.1|Balhimycin_5 # 4106 # 4981 # 1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.749	BGC0000311.1|Balhimycin_5 	4106	4981	+	Loose	750	28.8758	tet(54)	27.91	3004590	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	GTGACCATCGAGAAAGCGCTTGTCGTCGGTACCGGGCTGATCGGCACCTCGGTGGCGCTGGCCCTCCGGGAGAAGGGCGTCGCGGTCTTCCTCTCCGACGTCGACACCGAGGCCGCCCGGCTGGCGCAGGTACTCGGCGCCGGGCGGGAGTGGGCGGGAGAAGGTGTGGATCTGGCGGTGATCGCCGTGCCGCCGCACCTGGTGGGGGACCGGCTGGCCGACCTGCAGAAGCAAGGTGCGGCCCGGGTGTACACCGACGTGGCCAGTGTGAAGGCCGATCCGATCGCCGACGCGGAGCGGCTCGGGTGTGACCTGGCCTCCTATGTGCCGGGCCACCCGCTTGCCGGCCGGGAACGCTCGGGCCCGGCCGCCGCCCGCGCCGAGCTGTTCTCGGGCCGGCCGTGGGCACTGTGCCCCGGCCCCGAGACGGACGCGGAAGCCCTGCGACGGGTGCGGGAGCTGGTGTCCCTGTGCGGGGCGACGGCCGTCGTCGTGGGTGCGGGCGAGCACGACTCGGCCGTGGCGCTGGTGTCGCACGCCCCGCACGTGGTGGCGTCGGCGGTGGCGGCCAGCCTGGCGAGCGGCGACGACGTCGCGCTGGGCCTGGCGGGGCAGGGACTCCGTGATGTGACGCGCATCGCAGCCGGGGATCCCTTGCTGTGGCGGAGGATTCTCTCCGGGAACACCCGGCCGGTGGCCGGGGTGCTCGAACGGATCGCGGCCGACCTCGCCGCGGCGGCCTCGGCGTTGCGGTCCGGCGACCTGGACGAGGTGACGGATCTGCTGCGGCGCGGCGTGGACGGTCACGGCCGGATCCCTGGTCAGCGCGGCGGATCCCTTCCCGGCCGCAACCCGGCGGGTTCCCCGGGGCGTTAG	MTIEKALVVGTGLIGTSVALALREKGVAVFLSDVDTEAARLAQVLGAGREWAGEGVDLAVIAVPPHLVGDRLADLQKQGAARVYTDVASVKADPIADAERLGCDLASYVPGHPLAGRERSGPAAARAELFSGRPWALCPGPETDAEALRRVRELVSLCGATAVVVGAGEHDSAVALVSHAPHVVASAVAASLASGDDVALGLAGQGLRDVTRIAAGDPLLWRRILSGNTRPVAGVLERIAADLAAAASALRSGDLDEVTDLLRRGVDGHGRIPGQRGGSLPGRNPAGSPGR	MSTIKKILVIGAGIAGTAVCYWLRRFGFYPVLIEKSACIRKGGQGLDIRGVAIDIVKKMVIYEQICKMRTQVECGRYVDVVGKTLHEEKGEKFAFRQDEDVEILRGDLIEILMKTIDDVPCHFNQSIDSIEQNDDDVIVYFKDARVEHYDLIIGADGIHSSIRRMVFDKDEYRLVNLAEAYFSIFSIPNYLNLSHTEVQCETNEKLVSITSDKDPKTAQVAFMFRSQHVWNNLRDEHEQMQFLRDIFHDFGWEAQKILELMPNSHDFYFDSVTQVKMRSWTKGQVALVGDASYSASPLSGQGNNLALVGAYILAGELKAAEGNYRLAFNRYNELLHPFVEANQQLGAWVSESFLVPDAVSKEVAEERSNRILQKVQIISNAIKLPEYE	75.00	gnl|BL_ORD_ID|2726|hsp_num:0	3292			6	240	tetracycline; oxytetracycline
BGC0000311.1|Balhimycin_6 # 5186 # 7135 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=5bp;gc_cont=0.681	BGC0000311.1|Balhimycin_6 	5186	7135	+	Loose	1190	385.956	novA	38.72	3002522	protein homolog model	n/a	n/a	aminocoumarin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGTGTTGCGTTTCGAGGGGGTGGACAAGAGCCCTGACGACCCCGACCCCTGGGTGACCAAGGTCCGCAAGGGGACGCTGCGCCGCGTGCTCGCCTACTTCCGCCCGCACGTCGGGAAGGTGGCGCTCTTCTGTCTCGTCGCCGTGCTGGAGTCGCTCATCGTCGTGGCAACTCCGTTGCTGTTGAAGGAACTCATCGACAACGGCATCGTCAAGAACGATCTCGGGGTCGTGATCCTGATGGCCGGCCTCACCGCGGTGCTCGCCGTGCTGGGCGCCGGGCTGACGATGGTGTCCGGCTACATCTCCGGGCGGATCGGGGAGGGGATCACCTACGATCTCCGGGTCCAGGCGCTCGGCCACGTCCGGCGGCTGCCGATCGCGTTCTTCACCCGTACCCAGACGGGGGTGCTGGTCGGCAGGCTGCACACGGAACTGATCATGGCGCAGCAGCATTTCACCGGCTTGCTCATGGCGGCCACCAGCGTGGTCATGGTCGTGGTGGTGCTGGCCGAGCTGATCTACCTTTCGTGGATCGTCGCCATCGTCTCGCTGGTGCTGATTCCGATATTCCTCGTGCCCTGGATTCGCGTGGGGCGGGCGATCCAGCGGCGCAGTATCCGGCTCATGGACGCGAATACCGGCCTCGGCGGGCTTCTCCAGGAGCGGTTCAACGTCCAGGGGGCCATGCTCTCCAAGCTCTTCGGCCGTCCCGCCGAGGAAATGGCCGAGTACGAGGAGCGTGCCGGGGAGATCCGCAAGATCGGCGTGAGCCTTTCCGTGTGGGGCCGGATGGCCTTCGTCATGATGGCGCTGATGGCCTCGCTCGCCACGGCCCTCGTCTACGGGATCGGGGGCGGGCTCGTGCTCGCCGGTGCGTTCGAGCTCGGCACGCTGGTCGCCATCGCCACCCTGCTCCAGCGGCTGTTCGGGCCGATCACCCAGCTGTCCGGGATGCAGGAGCTCGCGCAGACGGTCGTGGTGAGCTTTTCCCGGGTCTTCGAGCTGCTCGACCTCAAGCCACTGATCCAGGAACGCCCCGACGCGATCGCGCTGAAGAAGAAGGTGGTGCCGGACGTCGAGTTCGAGCACGTGTCGTTCCGCTACCCCACCGCGGACGAGGTCTCGCTGGCGTCGCTGGAGCACCTGCGGGCCGAGCGGGAGCGCAGCGAAGTGACGCCGGATGTCCTGCGCGACGTGAGCTTCCACGCGCAGGCCGGAACCCTCACCGCGCTCGTCGGCCCGTCCGGCGCGGGGAAGAGCACCATCACCCACCTGGTCTCCCGGCTGTACGACCCGAACGGCGGGACCGTCCGCCTCGGCGGCCACGATCTGCGCGATCTCACCTTCGAATCGCTCCGCGAAGCGGTCGGGGTGGTCAGCCAGGACGCCTACCTCTTCCACGACACGATCCGGGAGAACCTCCTCTACGCCCGCCCGACCGCCACCGAGGACGAGCTGATGGAGGCGTGCAAGGGGGCCCAGATCCGGGACCTGATCGACTCCCTCCCGCTCGGGCTGGACACCGTCACGGGCGATCGCGGCTACCGCATGTCGGGCGGGGAGAAGCAACGACTGGCCATCGCCCGGCTGCTGCTGAAGGAGCCGTCGATCGTCGTCCTCGACGAAGCCACCGCCCACCTGGACTCCGAGTCGGAGGCCGCCGTCCAGCGGGCGCTCAAGACGGCCCTGCACGGCCGGACCTCGCTGGTGATCGCCCACCGGTTGTCCACGATCCGCGAGGCCGACCAGATCCTCGTGATCGACGGCGGCAGGGTGCGGGAGCGCGGGACACACGACGAGCTGCTGGCCCAGGGCGGCCTGTACGCGGAGCTCTACCACACGCAGTTCGCCAACCCGGCCGCCAACGACCCCAAGCCGGAGATCGAGGACGAGCTCGACGACATCGAGCCCGAGCCGGTGATCCAACACATGGGCTACGGAGGATGA	MVLRFEGVDKSPDDPDPWVTKVRKGTLRRVLAYFRPHVGKVALFCLVAVLESLIVVATPLLLKELIDNGIVKNDLGVVILMAGLTAVLAVLGAGLTMVSGYISGRIGEGITYDLRVQALGHVRRLPIAFFTRTQTGVLVGRLHTELIMAQQHFTGLLMAATSVVMVVVVLAELIYLSWIVAIVSLVLIPIFLVPWIRVGRAIQRRSIRLMDANTGLGGLLQERFNVQGAMLSKLFGRPAEEMAEYEERAGEIRKIGVSLSVWGRMAFVMMALMASLATALVYGIGGGLVLAGAFELGTLVAIATLLQRLFGPITQLSGMQELAQTVVVSFSRVFELLDLKPLIQERPDAIALKKKVVPDVEFEHVSFRYPTADEVSLASLEHLRAERERSEVTPDVLRDVSFHAQAGTLTALVGPSGAGKSTITHLVSRLYDPNGGTVRLGGHDLRDLTFESLREAVGVVSQDAYLFHDTIRENLLYARPTATEDELMEACKGAQIRDLIDSLPLGLDTVTGDRGYRMSGGEKQRLAIARLLLKEPSIVVLDEATAHLDSESEAAVQRALKTALHGRTSLVIAHRLSTIREADQILVIDGGRVRERGTHDELLAQGGLYAELYHTQFANPAANDPKPEIEDELDDIEPEPVIQHMGYGG	MKSALSTWKPSDRPPDPTLPEPPAQLRRIFRLFRPYRGRLAVVGLLVGASSLVAVASPFMLREILDTAIPQGRTGLLSLLALGMILTAVLSSVFGVVQTLISTTVGQRVMHDLRTAVYAQLQRMPLAFFTRTRTGEVQSRIANDIGGMQATVTSTATSLVSNLTAVIATVVAMLALDWRLTVVSLLLLPVFVWISRRVGRERKRITLQRQKQMATMAATVTESLSVSGILLGRTMGRADSLTRSFAEESERLVDLEVRSNMAGRWRMSVIGIVMAAMPAVIYWAAGFVLQSGGTVVSIGTLVAFVSLQQGLFRPAVSLLATGVQMQTSLALFQRIFEYLDLPVDITEPERPVALDKVRGEVRFDGVDFSYEEKDGNTLHGLDLTVPAGGSLAVVGPTGSGKSTLSYLVPRLYDVTGGRVLLDGVDVRDLAFDTLARAVGVVSQETYLFHASVADNLRFAKPDATDEEIEKAARAAQIHEHIVTLPDGYDTLVGERGYRFSGGEKQRLAIARTILRDPPVLVLDEATSALDTRTEHAVQQAIDSLSEGRTTITIAHRLSTVRDADQIVVLDAGRIAERGTHEELIDRDGRYAALVRRDGAPAPAPVPARDERVGAA	105.53	gnl|BL_ORD_ID|1112|hsp_num:0	1210			75	1779	novobiocin
BGC0000311.1|Balhimycin_7 # 7168 # 16635 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=11bp;gc_cont=0.732	BGC0000311.1|Balhimycin_7 	7168	16635	+	Loose	1000	107.842	almE	31.59	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGCTGGATCTGTTCGCTTCGCACGTGGACCGGACACCTGACGCGGTGGCCGTGGCCGGCGGTGACGGGGTTCTGACGTACCGGCAGCTCGACGAGCGCGCGGGCCGGTTGGCGGGGCGGCTGGCGAGTCGCGGCATTCGCCGTGGCGACCGCGTCGCGGTGGTGATGGACCGTTCGGCGGACCTGGTGGTGGCGCTGCTCGCCGTGTGGAAGGCGGGGGCGGCGTACGTGCCGGTGGACGCCGGCTACCCCGCGCCGCGAGTGGCCTTCATGGTGGCGGACTCGGCGGCCAAGCTCGTGGTGTGCTCGGCCGCGTCGCGCGGCGCCGTACCGGCCGGGGTCGAGTCGCTCGAGCCGGCCGCCGCCGCCGAGGAGGGCGCGTCCGACGCGCCGGCGGCCACGGTGCGACCGGGGGATCCGGCGTACGTGATGTACACGTCCGGCTCGACGGGCACACCGAAGGGCGTGACCATTTCGCAGGGCTGCGTCGCGGAGCTGACGATGGACGCCGGGTGGGCGATGGAGCCCGGCGAGGCGGTGCTCATGCATTCGCCGCACGCCTTCGACGCGTCACTGTTCGAACTCTGGATGCCGCTGGCGTCGGGGGTCCGGGTGGTGCTCGCCGAACCGGGTTCGGTGGACGCCCGGCGGCTGCGGGAAGCGGCCGCGGCCGGGGTGACGAGGGTGTACCTCACCGCGGGGAGCCTGCGCGCGGTGGCGGAGGAGGCGCCGGAATCGTTCGCGGAGTTCCGTGAGGTGCTGACCGGCGGTGACGTGGTACCCGCGCACGCGGTGGAGCGGGTGCGGACGGCCGCACCCCGGGCGCGGTTCCGGAACATGTACGGCCCGACGGAAGCGACGATGTGCGCGACGTGGCACCTGCTGCAGCCGGGTGACGTGGTGGGCCCGGTCGTGCCGATCGGCCGTCCGCTGACCGGCCGCCGGGTGCAGGTGCTCGACGCGTCGCTGCGGCCCGTGGGGCCGGGTGTGGTCGGCGACCTGTACCTCTCCGGGGCGCTGGCGGAGGGCTACTTCAACCGGGCGGCGCTGACGGCGGAGCGGTTCGTGGCGGATCCGTCCGCACCGGGGCAGCGGATGTACTGGACCGGGGACCTCGCCCAGTGGACCGCGGACGGTGAGCTGGTGTTCGCGGGCCGGGCCGACGACCAGGTGAAGATCCGCGGGTTCCGGATCGAGCCCGGCGAGATCGAGGCCGCGCTGATCGCTCAGCCGGACGTGCACGACGCCGTCGTGGCGGCGGTCGACGGACGGCTGATCGGGTATGTGGTGACCGAGGGGGACGCCGATCCCCGGGTCATCCGCGAACGCCTCGGTGCGGTGCTGCCGGAGCACCTGGTCCCGGCCGCCGTGCTCGCACTGGACGCACTGCCGCTGACCGGCAACGGCAAGGTGGACCGGTCCGCGCTGCCGGCGCCCGAGTTCGCGGCGAGTGCCGCCGGGCGGGCACCGAGCACCGATGCGGAACGTGTCCTCTGTGGACTCTTCGCCGAGGTGCTCGGCGTGGCACGAGCCGGCGTCGACGACGGTTTCTTCGAGCTGGGCGGGGATTCGATCGGCGCGATGCGGCTGGCGGCCCGGGCCGCCAAGGCGGGCCTGCTGGTGACGCCCGCCCAGATCTTCGAGGAGCCGACCCCCGCCCGGCTGGCCGCCGTGGCGCGGCCGGTCCCGGCCGGCGGGCCCGTCGACGGCCCCCTGCTCACCCTGACCGCGGCCGAGGAGGCGGAGCTGGCGCTCGCCGCTCCGGGCGCCGAGGAGATCTGGCCGCTGGCCCCGTTGCAGGAGGGGCTGCTCTTCGAATCGATCCTCGACGACCAGGGCTCCGACATCTACCAGGTGCAGGTGATCCTGGAGCTGAACGGGCCGGTGGACGCGCCCCGGCTGCGGGCCGCGTGGGACGCGGTCGTCCGGCGGCACCCCGAGCTCCGGCTGAGCTTCCACCGCCTCGCCTCGGGCAAGACGGTGCAGGCCGTCCACGGGGACGTCACCCCGCCGTGGCGGGTGGTGGACCTGACGGGTGCCGGCGACGTCGACGCGGCCGTCGCGGCCCTCGTCGCCGAGGAACAGCAGCAGCGGTTCGAACTCGCCACGGCGCCGCTGGTCCGGCTGGTGCTGGTCCGGATCGCGGCGGACCGGTACCGCCTGCTGTTCGTCATCCACCACATCCTCGTCGACGGCTGGTCGGTGGCGGTCATCCTCAACGACGTCTCCGAGGCGTACGAAGCCGGCGAGCCGGTGCCGGAACAGCGGGGCGGCGCCACCTTCCGGGACTACCTGGCCTGGCTGGACCGGCAGGACGACGACGCGGCCCGGGCGGCCTGGCGGGCGGAGCTGGCCGGTCTCGACGAGCCCGCGCTGATCGCGACTTCGGGCGTCGAGACGGAGTACGACTACCGCGCCACGCACCTGACGCCGGCCCTGCACACCAGGCTGCTGGGGTTCGCCCGCGAGCACGGGCTGACGCCGAGCACGGTGGTGCACGCCGCCTGGGCGATGGTGCTGGCGCGGCTCACGCGGCGGACCGACGTCGTGTTCGGCACCATGGTCGCGACCCGTCCCCCGGAACTGGCGGGGATCGAGTCGATGCCGGGCCTGCTGATGACCGCGGTGCCGGTCCGGGTGCCGCTGGACGGCGGGCAATCGGTCCTGGACATGCTCACCGACCTGCACAGCAGGCAGACGGCCCTCAAACGACACCAGTACCTGGGGCTGCCGGAGATCCAGAAGGCGGCGGGACCGGGCGCGACGTTCGACACGATGCTGGTGGTCGAGAACTACCCGCGGGAGTACGCCCGCCGGTACACGCATCTGCGCACGATCGAGGGGACCCACTACCCGGTGACCCTGGGCATCACCCCGGGCGACCGGTTCAAGATCCAGCTCGGCTACTGGCCGGGCCAGGTCCCGGACACCGTCGCCGAGTCGCTGCTGGAGTGGTTCGTCGGCGCCATCGGCGCGCTGGTCGCCGATCCCGCCGGCCTGGTGGGGCGGATCGGGATGGGCGCGGCCGACGTGCGCCGCTGGGACCCGCCGCTGCAGGCGGGGGAGCCGCTGCCGGCCCTGGTGGGGCGGATGGCGGCGCGGCCGCCGGACAACGTGGCGGTCGTGGACGGCGACGGTGCGCTGTCCTATGCGGACTTGTGGGAGCGGTCGCTGAAGTTCGCGGCCGTCCTGCGGGCCCACGGAGTCCGGTCCGAGGACCGGGTCGGCCTGGTGGTGGGGCGCTCGGCCTGGTGGACGGTCGGCATGCTGGGCGTCCTGCTGGCGGGCGGCACGTTCGTGCCGGTGGACCCGGCCTATCCGGCCGAGCGCAAGGAATGGATCTTCCGGAGCGCGAACCCGATGCTGGTGGTGTGCGCGGGCGCGACACGGGGGGCGGTGCCCGCGGAGTTCGCGGACCGGCTGGTGGTGATCGACGAGGTCGATCCGGCCGCGGGCTCGGCGGGGGACCTGCCGCGGGTGGATCCGCGCAGTGCCGCGTACGTGATCTACACGTCGGGGTCGACGGGAACCCCGAAGGGGGTCGTCGTCACCCATGCCGGGCTGGGAAACCTGGCGCTGGCGCACATCGACCGGTTCGGGGTGTCCCCGTCGTCACGGGTGCTGCAGTTCGCGGCGCTCGGGTTCGACACCATCGTCTCCGAGGTGATGATGGCGTTGCTCTCGGGAGCGACGCTGGTGGTGCCGCCGGAGCGGGACCTGCCGCCGCGGGCGTCGTTCACCGACGCCCTGGAACGGTGGGACATCACGCACGTGAAGGCGCCGCCGTCGGTGCTGGGCACGGCCGACGTGTTGCCGTCGACGGTGGAGACGGTGGTGGCGGCGGGCGAGCTCTGCCCGCCGGGCCTGGTGGACCGGCTGTCCGCGGACCGGCGGATGATCAACGCCTACGGGCCGACCGAAACCACGATCTGCGCGACGATGAGCATGCCGTTGTCGCCCGGCCAGCACCCGATCCCGTTCGGCAAGCCGGTGCCGGGGGTGCGCGGATATCTGCTGGACTCGTTCCTGCGCCCGTTGCCGCCCGGGGTCACCGGTGAGCTCTACCTGGCCGGGATCGGCGTGGCCCGCGGCTACCTCGGCCGTTCGGCGCTGACGGCCGAGCGGTTCGTCGCCGATCCGTTCGTGCCCGGTGAGCGGATGTACCGGACCGGGGACCTGGCGTACTGGACCGAACAGGGCGAGCTGGTGTCCGCCGGGCGCGCCGACGACCAGGTCAAGATCCGCGGCTTCCGTGTCGAACCCCGCGAGATCGAGTTCGCCTTGTCCGGCTACCCCCGGGTCACCCAGGCCGCGGTCGCCGTCCGCGACGACCGCCTGGTCGCCTACGTGACACCAGGCGACATCGACACGCAGGCGGTGCGGGCGCACCTCGCGTCCCGGATGCCCCAGTACATGGTCCCCGCGGCGGTGGTGGCGCTGGACGCCCTGCCGCTGACGGCGCACGGGAAGATCGATCGGCGCGCACTGCCCGACCCCGACTTCACCGCCGGGAAGCAGGCCAGGGAGCCGGCCACCGAGACCGAGCGGGTGCTGTGCGAGTTGTTCGCCGGCGTGCTCGGCCTGGCGCGGGTCGGGGTGGACGACAGCTTCTTCGAGCTCGGCGGGGACTCCATCCTCTCGATGCAGCTGGCGGCGCGGGCGCGGCGGTCGGGGCTGACGTTCACCGCGGCGGACGTCTTCGACGGGAAGACGCCCGAGCGGATCGCGCAGCTGGCGGCGGAGTCGTCGGTGCCGGAGCCCGGTCGTTCCCCGAAACCCGATGGCGTCGGTGACGTCGCGTGGACGCCGGTGATGTGGATGCTGGGAGACGGCGTCGCGGGACCGGCGTTCGCGCAGTGGATGGTGGTCGGGACGCCTTCGGACCTGACGGAGAAGGCGCTGGCGGCGGGCTTTGCGGCCGTGGTGGATACGCACGACATGCTGCGGGCGCGGGTCGTCGCCGACGAGGGCGGCCGGCGCCTGGTGGTGGGTGAGCGTGGGTCGGTGGATGTCGCCGGGGCGGTCACCCGCATCCGCGCCGATGGCCGCTCGCTGGACGAAGCCGTGGCGGACGCGGCGCGCGCGGCCGTGACCCGGTTGGACCCGTCGGCGGGCGTGATGGCCCAGGCGGTGTGGGTCGACGCCGGACCGGACCAGGTGGGGCGGCTGGTGGTGGTGGCGCACCACCTGTCGGTCGATGGCGTGTCGTGGCGGATTCTGCTGTCGGATCTGCAGGCGGCCTGCGAAGCCGCGGTCGCGGGGCGGGAGCCGGTGCTGGAGCCGGTCGGTGCGTCGTTCAAGCGGTGGGCGGGCTTGCTGGCCGAGTGGGCGGTTTCCGCGGAGCGGGCCGGTGAGCTGGCCGCGTGGAAGGCGATTCTCGGACCGGGGGACCGGCCGGCCGGTGCGCAGGCCACGAGCCGGGCCGCGGAAGGTGCCGTGCGCTCGCGGTCGTGGGTCGTGCCGAAGGTGGAGACGGCGGCGTTGGCAGGCCGGGCTCCGGTGGCGTTCCACTGCGGGGTGAACGAGGTCCTGCTCGCCGGGCTGGCGGGCGCGGTCGCGCGGTGGCGCGGCGGGGACGCCGTGCTGGTGGACGTGGAAAGCCATGGCCGCCACCCGGTGGACGGGACGGACCTGTCCCGGACGGTGGGCTGGTTCACCAGCGCACATCCGGTACGGCTGGACGTGGCCGGCACCGATCTGGCGGACGTGCTCGCCGGCGGTCCGGCGGCCGGGCGTTTGCTGAAGGCCGTCAAGGAGCAGTCACGGGCCGTGCCCGGCGACGGGCTCGGATACGGCTTGCTGCGGTACCTCAACGGCACGACGGGGCCGGTGCTGGCGGACCTGCCGTCGCCGCAGATCGGGTTCAACTACATGGGCCGGTTCGCCGCCGGCGAGAAGAGCGGGGTGCGGGCGTGGCAGCCGGTCGGTGACATCGGCAGTTCGCTGGAACCCGGTATGGGCCTGCCGCACGCGCTCGAGGTCAACGCGATCGTCCAGGACCTGCCGGACGGTCCCGAGCTGACGCTCATGCTGGAATGGCAGGACGGCCTGCTCGGCGAGGACGAGATCGACCGGCTGGGCCGGGCCTGGCTGGACATGCTGTCCGGGGTGGCCCGCCAGGCGGCTGATCCCGCCGCGGGCGGGCACACCGCGTCCGACTTCGACCTCGTCACCCTGGACCAGGCGGAGATCGAGGCCCTCGAGGCCGAATTCGCGGCCGCCGGCGGACTGGCCGAGGTGCTGCCGCTGTCGCCGCTGCAGCACGGGCTGGCCTTCCACGCCGGTTACGCCGGCGACGGCGTCGACGTCTACACCGCGCAGGCGGTGCTGGAGCTGGCCGGCCCGCTGGACGTGCCGCTGCTGCGGAAGTCGGTGCGCGCGCTGCTGGACAGGCACGCGAATCTGCGTGCCGGCTTCCGGCACGGCGCCGACGGGACCGCCTACCAGGTGGTCCCCGGCGCCGTGGCGGTGCCGGTGACCCTGGTGGACGTGACGGAATCGGCGGATCCGGCGGCCGAGGCGGCGGCGGTGGCCGCGGCCGAACGGGCGCGGCCGTTCGAGCTGGCCCGGCCCCCGCTGCTGCGGGTCATGGTGGTGGTGCTCGGCCCGGACCGGCACCGGCTGGTGCTGACCAACCACCACATCCTGCTCGACGGCTGGTCGACGCCGCTGCTGCTGGACGAACTGCTCACGCTTTACCGCAACGGAGCCGCTCCGGCCGCGCTGGCGCCGGTCACCCCGTATCGGGACTACCTGGCCTGGGTGCGCGAAACCGACCGGGAGGCGGCTACCGAAGCCTGGCGCGACGCCCTGGCCGGCTTGCCCGAGCCGACCCTGGTGGCGGCGGACCGGCCGGTCCCGGTCGAGGTGCCCGAGCAGATCTGGACCACCCTGGACGAGACGTTCGCCCAGGCGCTGGGGGCGCGGGCACGCGAGTGCGGTGTCACGGTCAGCACCGTGCTGCAGGCGGTGTGGGGCATGGTGCTGGCGGCGCTCACCGGACGCGACGACGTGGTGTTCGGGTCGGTGGTGTCCGGGCGCCCGGCCGAGCTGCCGGGGATCGAGACCATGGTCGGGTTGTTCATCAACACCGTCCCGGTCCGGGTCCGGATGCGGCCGCAGGACACCTTCGCCGAACTGGTGCGGGGACTGCAGAACGAGCAGGTGGCGCTGCTGGCCCACCACCACGTGGGTCTCACCGACATCCAGCAGGCCGCGGGGCTGGGGCGGCTGTTCGACACCATCATCGTCTACGAGAACTACCCGAGACCGGCCGAGATCGGCGACGAATCCGCCGATGCCGATCGGGTCCGGGTGCAGGGACTGACCGCCGCCGATGCCACCCACTACCCGCTGGCGCTGGCGGTCGTGCCGGGCACCGACCTGCGGCTGCGGCTGGAGCACCAGCCCGCGCTGTTCACCGCCGAGCAGGCCGGCGCCGTGCTCGAGCGGTTCACGCTGGTGCTCGAAGCCGTCGTCGCCGATCCGCGGCTGCCGCTCGCGGTGGTGCCGATCCTGTCCGATGCCGAACGGCGACAGCTGCAGGCGGGCAACGACACCGCGCTGCCGGTGCCGGACCGGACGTTGCCGGAGCTGTTCGCCGCGCAGGCCGCCGCCACCCCGGAGGCGACCGCGGTGGTCTTCGAGGACCGGTCGCTGACCTACGCCGAGCTCGACGCGCGCGCCAACCAGCTGGCGCGCTGGCTCATCGACCAGGGTGCCGGGCCGGAAGGCCTGGTCGCGGTGCTGCTGCCCCGGTCGCTGGAACTGGTCGTCGCGTTGCTGGCGGTCACCAAGACCGGCGGCGCGTGGCTGCCGATCGATCCGGGCTATCCGGCCGACCGCATCGCCTTCATGCTCGACGACGCCGGACCGGCGCTGGTGATCACCACCGCGGTGCTGTCGGCATCGCCGATCGGTGACGTGCTGGCCGCCCGCTCGAGGACGGTGGTGCTCGACGAGCCCGCGGCCGCGGGCCAGCTGGCGGGGCGGGACCGCGCGCCGGTCACCGACACCGACCGCGCTCGAGCGCTGGATCCGCGCCACCCGGCGTACCTCATCTACACCTCGGGCTCCACCGGTCGCCCCAAGGCCGTGGTCGTCACCCATCGGAACCTGACGAACTACCTGCTCCACTGTGGACGGATGTACCCGGGTCTGCGGGGGCGGTCGGTGCTGCATTCGTCGATCGCCTTCGATCTGACGGTCACCGCGACGTTCACCCCGCTCATCGTGGGGGGAGAGATTCACGTCGGTGCCCTGGAAGACCTGATCGGGGTGGTGGAGGCCGCACCGTCGATCTTCCTCAAGGCCACGCCGAGCCATCTGCTGACCTTGGACACCGCTTCCCGGGGCAGTGCCGGTTCGGGTGACCTCCTGCTCGGCGGCGAACAATTGCCGGCCGACACGGTCGTCCAATGGCGCCGGAAGTATCCGAACATCGTGGTGGTCAATGAATACGGGCCGACCGAGGCGACCGTCGGGTGCGTCGAATACCGGCTCGAACCGGGGCAGGAATGCCCGCCGGGCGGTGTGGTGCCGATCGGCACCCCGCTGGCGAACATGCGGGCGTTCGTGCTGGATTCGTGGCTGCGGCTGGTGCCGCCGGGTGCGGTGGGCGAGTTGTACGTGGCCGGTGCGGGCCTGGCGCGGGGATACCTGGGCCGGGCAGGGCTGACGGCGACGCGGTTCGTGGCCGATCCGTTCGGCTCCGGCGAGCGGATGTACCGGACCGGGGACCTGGTGCAGTGGAACCCGGACGGACAGCTGGTGTTCGCCGGCCGGGTCGACGACCAGGTGAAGGTGCGGGGCTTCCGGATCGAGCCCGGTGAGATCGAGGCCGCCCTGGTGGCGCAGGAGTCAGTGGGCCAGGCGGTGGTGGTGGCCCGTGACAGCGAGATCGGCACCCGGCTGATCGGGTACGTGACCGCCGCGGGGGAGTCCGGTGTGGACGAAGCCGCGGTGCGCGAGGGAGTGGCGGCCCGGTTGCCGCAGTACATGGTGCCGGCGGCGCTGGTGGTACTCGGCGCGCTGCCGTTGACGGCGAACGGAAAGGTGGACCGGGCGGCGCTGCCGGATCCCGACTTCGGCGCCCGTGCCGGGGGCCGGGAGCCGGTCACGGAGGCCGAGCGGCTGCTGTGTGCGCTCTTCGCCGAGGTGCTCGGCCTGGAGCGCGCCGGTGCGGACGACAGTTTCTTCGAGCTGGGTGGGGATTCCATCCTTTCGATGCGGCTGGCGGCCCGGGCCCACCGCGAGGGAATGTCCTTCGGTGCGCGCGAGGTGTTCGAGCAGCGCACGCCCGCGGGGATCGCGGCGATCGTGGAACGGGTTGCGGGCGATCGTCCTGTCGCGGCGGTACACGCCGTGTCCGATGTCGCCCTTCTCGACCTGGACCAAGGCGAGCTCGACGAATTCAAGGCTGAGTTCGACGACGATTCCCAGCCCTTTGCTGATCCAGGGAGATATTGA	MLDLFASHVDRTPDAVAVAGGDGVLTYRQLDERAGRLAGRLASRGIRRGDRVAVVMDRSADLVVALLAVWKAGAAYVPVDAGYPAPRVAFMVADSAAKLVVCSAASRGAVPAGVESLEPAAAAEEGASDAPAATVRPGDPAYVMYTSGSTGTPKGVTISQGCVAELTMDAGWAMEPGEAVLMHSPHAFDASLFELWMPLASGVRVVLAEPGSVDARRLREAAAAGVTRVYLTAGSLRAVAEEAPESFAEFREVLTGGDVVPAHAVERVRTAAPRARFRNMYGPTEATMCATWHLLQPGDVVGPVVPIGRPLTGRRVQVLDASLRPVGPGVVGDLYLSGALAEGYFNRAALTAERFVADPSAPGQRMYWTGDLAQWTADGELVFAGRADDQVKIRGFRIEPGEIEAALIAQPDVHDAVVAAVDGRLIGYVVTEGDADPRVIRERLGAVLPEHLVPAAVLALDALPLTGNGKVDRSALPAPEFAASAAGRAPSTDAERVLCGLFAEVLGVARAGVDDGFFELGGDSIGAMRLAARAAKAGLLVTPAQIFEEPTPARLAAVARPVPAGGPVDGPLLTLTAAEEAELALAAPGAEEIWPLAPLQEGLLFESILDDQGSDIYQVQVILELNGPVDAPRLRAAWDAVVRRHPELRLSFHRLASGKTVQAVHGDVTPPWRVVDLTGAGDVDAAVAALVAEEQQQRFELATAPLVRLVLVRIAADRYRLLFVIHHILVDGWSVAVILNDVSEAYEAGEPVPEQRGGATFRDYLAWLDRQDDDAARAAWRAELAGLDEPALIATSGVETEYDYRATHLTPALHTRLLGFAREHGLTPSTVVHAAWAMVLARLTRRTDVVFGTMVATRPPELAGIESMPGLLMTAVPVRVPLDGGQSVLDMLTDLHSRQTALKRHQYLGLPEIQKAAGPGATFDTMLVVENYPREYARRYTHLRTIEGTHYPVTLGITPGDRFKIQLGYWPGQVPDTVAESLLEWFVGAIGALVADPAGLVGRIGMGAADVRRWDPPLQAGEPLPALVGRMAARPPDNVAVVDGDGALSYADLWERSLKFAAVLRAHGVRSEDRVGLVVGRSAWWTVGMLGVLLAGGTFVPVDPAYPAERKEWIFRSANPMLVVCAGATRGAVPAEFADRLVVIDEVDPAAGSAGDLPRVDPRSAAYVIYTSGSTGTPKGVVVTHAGLGNLALAHIDRFGVSPSSRVLQFAALGFDTIVSEVMMALLSGATLVVPPERDLPPRASFTDALERWDITHVKAPPSVLGTADVLPSTVETVVAAGELCPPGLVDRLSADRRMINAYGPTETTICATMSMPLSPGQHPIPFGKPVPGVRGYLLDSFLRPLPPGVTGELYLAGIGVARGYLGRSALTAERFVADPFVPGERMYRTGDLAYWTEQGELVSAGRADDQVKIRGFRVEPREIEFALSGYPRVTQAAVAVRDDRLVAYVTPGDIDTQAVRAHLASRMPQYMVPAAVVALDALPLTAHGKIDRRALPDPDFTAGKQAREPATETERVLCELFAGVLGLARVGVDDSFFELGGDSILSMQLAARARRSGLTFTAADVFDGKTPERIAQLAAESSVPEPGRSPKPDGVGDVAWTPVMWMLGDGVAGPAFAQWMVVGTPSDLTEKALAAGFAAVVDTHDMLRARVVADEGGRRLVVGERGSVDVAGAVTRIRADGRSLDEAVADAARAAVTRLDPSAGVMAQAVWVDAGPDQVGRLVVVAHHLSVDGVSWRILLSDLQAACEAAVAGREPVLEPVGASFKRWAGLLAEWAVSAERAGELAAWKAILGPGDRPAGAQATSRAAEGAVRSRSWVVPKVETAALAGRAPVAFHCGVNEVLLAGLAGAVARWRGGDAVLVDVESHGRHPVDGTDLSRTVGWFTSAHPVRLDVAGTDLADVLAGGPAAGRLLKAVKEQSRAVPGDGLGYGLLRYLNGTTGPVLADLPSPQIGFNYMGRFAAGEKSGVRAWQPVGDIGSSLEPGMGLPHALEVNAIVQDLPDGPELTLMLEWQDGLLGEDEIDRLGRAWLDMLSGVARQAADPAAGGHTASDFDLVTLDQAEIEALEAEFAAAGGLAEVLPLSPLQHGLAFHAGYAGDGVDVYTAQAVLELAGPLDVPLLRKSVRALLDRHANLRAGFRHGADGTAYQVVPGAVAVPVTLVDVTESADPAAEAAAVAAAERARPFELARPPLLRVMVVVLGPDRHRLVLTNHHILLDGWSTPLLLDELLTLYRNGAAPAALAPVTPYRDYLAWVRETDREAATEAWRDALAGLPEPTLVAADRPVPVEVPEQIWTTLDETFAQALGARARECGVTVSTVLQAVWGMVLAALTGRDDVVFGSVVSGRPAELPGIETMVGLFINTVPVRVRMRPQDTFAELVRGLQNEQVALLAHHHVGLTDIQQAAGLGRLFDTIIVYENYPRPAEIGDESADADRVRVQGLTAADATHYPLALAVVPGTDLRLRLEHQPALFTAEQAGAVLERFTLVLEAVVADPRLPLAVVPILSDAERRQLQAGNDTALPVPDRTLPELFAAQAAATPEATAVVFEDRSLTYAELDARANQLARWLIDQGAGPEGLVAVLLPRSLELVVALLAVTKTGGAWLPIDPGYPADRIAFMLDDAGPALVITTAVLSASPIGDVLAARSRTVVLDEPAAAGQLAGRDRAPVTDTDRARALDPRHPAYLIYTSGSTGRPKAVVVTHRNLTNYLLHCGRMYPGLRGRSVLHSSIAFDLTVTATFTPLIVGGEIHVGALEDLIGVVEAAPSIFLKATPSHLLTLDTASRGSAGSGDLLLGGEQLPADTVVQWRRKYPNIVVVNEYGPTEATVGCVEYRLEPGQECPPGGVVPIGTPLANMRAFVLDSWLRLVPPGAVGELYVAGAGLARGYLGRAGLTATRFVADPFGSGERMYRTGDLVQWNPDGQLVFAGRVDDQVKVRGFRIEPGEIEAALVAQESVGQAVVVARDSEIGTRLIGYVTAAGESGVDEAAVREGVAARLPQYMVPAALVVLGALPLTANGKVDRAALPDPDFGARAGGREPVTEAERLLCALFAEVLGLERAGADDSFFELGGDSILSMRLAARAHREGMSFGAREVFEQRTPAGIAAIVERVAGDRPVAAVHAVSDVALLDLDQGELDEFKAEFDDDSQPFADPGRY	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	567.45	gnl|BL_ORD_ID|4935|hsp_num:0	5928			588	1629	colistin A; colistin B
BGC0000311.1|Balhimycin_8 # 16635 # 28868 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.736	BGC0000311.1|Balhimycin_8 	16635	28868	+	Loose	1000	116.701	almE	30.29	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGAGCCAGTCGCGGATCGAGGAAATCTGGCCGCTGTCGCCACTGCAGGCCGGTTTGCTCTTCCACGCGGTTTACGACGGCGAAGGGCCCGACGTCTACATCGGTCACTGGATTCTCGACCTGGCCGGACCGGTGGACGCGGCCGGGCTGCGTGCGGCGTGGGAGACGCTGCTGGCCCGGCACGCCCCGCTCCGGGCGTGTTTCCGGCAGCGCAAGTCGGGCGAGACGGTGCAGATCATCGCCAGGCAGGTGGAACTGCCGTGGCGGGAGGTCGACCTTTCCCACCTCGACGACCCCGAGGAGGCCGTTCGCGAGCTGGCCGAGCAGGACCGGACGACGAGGTTCGACCTCGCGCAGGCGCCGTTGCTGCGGCTGACCCTGATCCGGCTCGGCGCCGACGCGCACCGCCTGGTGGTGACCTGCCACCACACGATCATGGACGGCTGGTCGCTGCCCATCGTGATCGACGAGCTGTCGGTGCTGTACCCGGCGGGCGGTGACGCGTCGGCGCTGCCGGACGTGCCGTCCTACCGGGAATACCTCGCGTGGCTGAGCCGGCAGGACAAGGAACGCGCGCTGTCGGCGTGGACCGCGGAGCTCAGCGGCGCCGAGGAACCGACGCTGGTGGTGCCCGCCGATCCGGGGCGGGCACCCGCCGAGCCGGAGAGCGTCGAGGCCCACCTGCCGGAGCACCTCACGCGCTCGCTGGCCGAGCTGGCCCGTCGCCACGGGTTGACGTTGAACACCGTGGTGCAGGGCGCCTGGGCGCTGGTGCTGGCGCAGCTGGCCGGCCGGCCGGACGTGGTGTTCGGGGCGGCGGTGTCGGCGCGCCCGCCGGACCTGCCCGGTGTGGAGGGGATGGTGGGGCTGTTCCTCAACACCGTTCCCGTGCGCGTGCGGTTGCGCGGCTCGACGCCGGTCGTCGAGCTGCTGGCGGAGTTGCAGAAACGGCAGTCGGCGCTCATTCCCGACCAGTTCGTCGGGCTGGCGGACATCCAGCAGGCGGCGGGTCCCGCCGCGGTTTTCGACACGCTGCTCGTCTTCGAGAAGTTCCACCACGGGCCCGCCGGATCGGACTCCGCGGGAACCTTCCGCATTCACGTGAACCAGGGCCGGGTGGCGGCCCACTACCCGCTGACGCTGGTCGCCGTCCCCGGCGAGTCGATGTACCTCAAGCTCGACTACCTGACGGAGCTCTTCGACCGGGAAACCGCGTTCGCCATCCTCGAGCGGTTCACCGGGGTGCTGCGGCAGCTGACCGGCGCGGGCGAGCTCACGGTGGCCGGCGTCGAGGTGACGACCGCGGCCGAGCGGGCCCTGGTGGCCGGGGAATGGGGTGCCTCGACCTCGGCGCCGCCGAGCCTGCCGGCGCTGGATCTGTTCGGGCACCAGGTGGCGCACCGCCGCGACGAGCCGGCGGTCGTCGACGGCGATCGGACGGTGTCGTACGGAGAACTCGCCGAGCGCGCTGAGCGGCTCGCCGGCTACCTGAACGGCCGGGGAGTCCGGCGCGGAGACCGGGTGGCCGTGGTGCTCGACCGGTCACCCGACCTGATCGCGACGCTGCTCGCGGTGTGGAAGGCGGGCGCGGCGTACGTTCCGGTGGACCCCGCCTACCCGGTGGAACGCAGGAAGTTCATGCTGGCGGACTCCGGGCCCGCGGCGGTGGTGTGCGCGGAAGCGTACCGGGCCGCCGTGCCGGACACCTGCCCCGAGCCGATCGTCCTGGACGATCCCCGGACGCGGCAGGCGGTGGCGGAGAGCCCTCGCCTGTCGGCAGGCACGAGCGCCGACGACCTCGCCTACGTGATGTACACGTCCGGATCGACCGGGACGCCGAAGGGCGTCGCGGTGTCGCACGGCAACGTCGCGGCGCTGGCCGGGGAGCCGGGCTGGCGGGTGGGCCCCGGTGACGCCGTGCTGCTGCACGCCTCGCACGCCTTCGACATCTCGTTGTTCGAAATGTGGGTGCCGCTGCTGTCGGGTGCCCGGGTGGTGCTGGCCGGACCGGGCGCGGTGGACGGCGCGGCGCTGGCGGCCTACGTGGCCGGTGGCGTCACGGCCGCCCACCTGACCGCGGGGGCCTTCCGGGTGCTGGCCGACGAGTCGCCGGAGGCGGTCGCCGGGCTGCGCGAGGTGCTGACCGGTGGGGACGCGGTGCCGCTGGCGGCGGTCGAGCGGGTGCGCGGACGTGTCCGGAACGTGCGGGTGCGGCACCTCTACGGCCCGACCGAGGCCACGCTGTGCGCGACGTGGTGGCTGCTCGAACCCGGCGACGAGACGGGATCGGTGCTGCCGATCGGACGTCCGCTCGCCGGGCGGCGCGTCCACGTCCTCGACGCGTTCCTGCGGCCCGTGCCGCCGGGCGTGGCGGGCGAGCTGTATGTCGCCGGAGCCGGTGTGGCGCAGGGCTATTCGAGCCGCCCGGCGCTGACGGCCGAGCGGTTCGTCGCCGATCCCTCCGGTTCCGGTGCGCGGATGTACCGCACCGGGGACCTGGCGTACTGGACGGAGCAGGGTGCGCTGGCGTTCGCCGGGCGGGCCGACGACCAGGTGAAGATCCGCGGGTACCGCGTGGAGCCCGGCGAGATCGAGGTGGTCCTCGCCGGCCTGCCCGGCGTCGGCCAGGCCGTGGTGACCCCGCGGGGTGAGCACCTGATCGGCTATGTGGTCGCCGAAGCGGGCCACGACGCCGACCCGGTGCGGCTGCGCGAGCAGCTCGCCGGGACGCTGCCCGAGTTCATGGTGCCGGCCGCGGTGCTGGTGCTGGACGAGTTGCCGTTGACGGTCAACGGGAAGGTGGACCGGCGGGCACTGCCCGAACCGGACTTCGCGGCGAAGTCGGCGGGCCGGGAGCCGGTCACCGAGGCCGAACGAGTCCTTTGTGGAGTGTTTGCCGACGTCCTCGGCCTCGACCACGTCGGCGTCGACGACAGCTTCTTCGAGCTGGGCGGCGACTCGATCTCGTCGATGCAGGTCGCCGCGCGTGCGCGTCGCGAAGGGATCTCGCTGACCCCGCGGCTGGTGTTCGAGCACCGGACGCCGGAACGCCTCGCGGCACTGGCGCAGGAGGCAGGCGCGACGCCACGCGCCGAGGTCGTCACGGGCGTGGGCGAGATCCCGTGGACGCCGGTGATGCGTGCCCTCGGGGACGACGCGATGCGCCCCGGCTTCGCGCAGGTGAGAGTCGTCGTCACCCCGGCGGGGGTGAACCCGGACGCGCTCGTGAGCGCCCTGCAGGCGGTGCTGGACGCGCACGACCTGCTGCGGGCCCGGGTGGAGCCGGACGGACGGCTGATCGTGCCCGAGCGCGGCGCGGTGGCCGCGGCCGGCCTGCTCACGCGGGTGGCCGCCGGGACCGGCGGCCTCGACGAGATCGCCGAGCGCGAGGTCAGGACGGCGACGGGCACGCTGGACCCGTCGGCGGGAATCATGGCGCGGGTCGTGTGGATCGACGCCGGGGACGCCGAGCCGGGCCGGTTGGCCTTCGTGGCGCACCACCTCTCGGTCGACGCGGTCTCCTGGGGGATCCTGCTGCCGGATCTGCGAGCGGCCTACGACGAGGTGATCTCCGGCGGGACCCCGGCCCTCGAACCCCCGGTGACGTCGTATCGGCAGTGGGCGCGCCGGCTGACCGCGCGGGCGCTCAGCGAAAGCACCGTGGCCGAACTCGAAAAATGGGCTGCCGTCGTGGAAGGCGCGGAACCGGCACTGCCCCAGGACACCGGGCAGCACACCGGGCAGTCGCACTCGTGGTCCACGAGCCTGTCCGGCACCGAGGTGCGAGACCTGGTCACTGTCTTGCCGGGCGCGTTCCACTGCGGGATCCAGGACGTTCTGCTGGCGGGGCTCGCGGGTGCGGTGGCGCGTGTGCGCGGTTCCGGCGCCGCGCTGCTGGTCGACGTGGAAGGGCACGGTCGCGAAGCCGCCGACGGCGAGGACCTGTTGCGCACCGTCGGCTGGTTCACCAGCGTTCACCCGGTCCGTCTCGAACTGTCCGATGTGGACCTCGCGGGCGCGGCGGACGGCGAGCGGCCTGCCGGGCAGTTGCTGAAGGCCGTGAAGGAGCAGATCCGGGCCGTGCCCGGCGACGGATCCGGCTACGGGCTGCTGCGCCACCTCAACCCGGGCACCGGGGCGAGGCTGGCCGAGTTGCCGTCCGCGCAGATCGGCTTCAACTACCTCGGCCGGACTGTCCTCGCTCCCGAGGACACCGCGTGGCAGCCCAACGGCGGAGGGCCGCTCGGCGGCGGTCCGGACATGGTCCTCGCGCACGCCGTGGAGGTCAGCGCGGAACTCCAGGACACGCCGGCCGGCCCCCGGCTCGGGCTGGCCATCGACACGCGGGATTTCGACCTCGCCACGGTGGAGCGGCTCGGCGAGGCCTGGCTGGAGATGCTGACCGGTCTCGCGGCGGTGGCCCGCGGATCCGGCGCGGGCGGGCACACGCCCGCCGACTTCGCTCTGGTCGACCTGACGCAGCGGGACGTGGCGGAGCTGGAGGCCGCGGCGCCCGGGCTGACGGACATCTGGCCGTTGTCGCCGCTGCAGGAAGGCATGCTCTTCGAACGGGCCTTCGACGAGGACGGCGTCGACGTCTACCAGACGCAGCGGATCCTGGACCTCGACGGGCCGCTCGACGAACCCCGGCTGCGCGCGGCCTGGAACCAGGTCCTCGCCCGGCACGCCTCGCTGCGGACCGGCTTCCACCAGCTGGGGTCCGGCGCCACGGTGCAGGTCGTCGTGCGCGAGGCCGACATCCCGTGGCGGGTGGCGGATCTGTCGCACCTCGATGCGGCGGAGGCGGCCGCGGAGGTCGAGCGGCTGCTCGCCGAGGACCAGGGCCGGCGGTTCGACGTGACCCGGCCGCCGCTGCTGCGGCTGCTGCTGATCCGGCTCGGTGCGGACGAGCACCGACTCGTCGTGACCTCGCACCACGTACTCCTCGACGGCTGGTCGACCCCGCTCGTCGTGGGGGAGATGTCGGACGGCTACGCGGGCGGCCGCAGCTCCTCGAAGCCGCCGTCCTACCAGGACTACCTGGCGTGGCTGAGCCGTCAGGACGCGGAGGCGACCCGATCGGCGTGGCGGGCCGAGCTCGCCGGCGCGGACGAACCGACCTTGGTCGACGCCGACGCGGGCAAGACGCTCGTGATGCCGGACGAGCACGCCGAATGGCTGCCCGAGCCGGCGACGCGGGCACTCGCCGGCTTCGCCCGTGGCCACGGGCTGACGGTGAGCACGATCGTGCTGGGCGCGTGGGCGCTGGTGCTGGCGCGGCTGGCCGGCCGGACCGACGTGGTGTTCGGCTCGGTGGTGTCGGGGCGTCCGGCGGACGTGCCGGATGTCGAGCGCATGGTGGGCATGTTCATCAACACCGTCCCGGCCCGGGTGCGGCTCGACGGCCGCCGGCCGTTGCTGGAGATGCTCGAAGACCTGCAGGCGCGCCAGGCGGCGTTGACCGAGCACCAGTACCTGGGGCTGCCGGAGATCCAGAAGGTGGCGGGGACCGGCGCGATCTTCGACACGATCGTGATGGTCGAGAACTACCCGCACGACGCCGCCGGTCTCGGCGGCGACGGCGGGGTGGCGATCAGCTCGGTCGTCACCCGGACCGGCACCAGCTATCCGCTGACCATGAACGTCAGCCTCGGGGACCGCCTGCGCATCACCGTGTCCTACCGGCCCGACCGGATCGACGACGCGACGGCCGCCGAGGTCGCCAGGCAGGTCGTGCGGGTCCTGGAACGGGTGGTGGCCGAGCCTTCGCTGCCGGTGGGCCGCCTCGGCGTGACGAGCGAACCGACGCGCGCGGCGGTGGTGGAACGCTGGAACTCGACGGGCGAAGCGGCCGCCGAGACGTCCGTGCTGGAGCTGTTCCGGCGGCAGGCAGGTGCCTCGCCGGACGCGGTGGCGGTCGTGGCGGGGGAACGCACCCTGTCCTACGCCGACCTCGACCGCGAGTCCGACCGGCTGGCCGGGCACCTGGCCGGGATCGGCGTGGGGCGTGGTGACCGCGTCGGCGTGGTGATGACACGCGGCGCGGACCTGTTCGTCGCCCTGCTCGGGGTCTGGAAGGCAGGCGCCGCGCAGGTACCGGTGAACGTGGACTACCCCGCGGAACGGATCGAGCGGATGCTGGCCGACGTCGGCGCGTCGGTCGCGGTCTGCGTGGAAGCGACCCGCAAGGCGGTGCCGGACGGGGTCGAGCCGGTGGTCGTGGACCTGCCGGTGATCGGCGGAGTACGGCCCGAGGCGCCACCGGTCACGGTCGGAGCGCACGACGTGGCCTACGTGATGTACACGTCCGGCTCGACCGGCGTGCCGAAGGCCGTCGCGGTGCCGCACGGGAGCGTGGCGGCGCTGGCGAGCGACCCGGGCTGGTCGCAGGGCCCCGGCGATTGCGTGCTGCTGCACGCGTCGCACGCGTTCGACGCGTCGCTGGTCGAGATCTGGGTGCCGCTGGTCAGCGGAGCCCGCGTGCTGGTTGCGGAACCGGGCACGGTCGACGCGGAACGGCTGCGCGAAGCGGTCTCCCGCGGCGTGACCACCGTCCACCTGACGGCCGGTGCCTTCCGTGCGGTGGCCGAGGAATCGCCGGACTCCTTCATCGGGCTGCGCGAGATCCTGACCGGTGGGGACGCGGTGCCGCTCGCGTCCGTCGTGCGGATGCGCCAGGCCTGCCCGGACGTCCGGGTCCGGCAGCTGTACGGCCCCACCGAGATCACCCTCTGCGCCACCTGGCTCGTCCTCGAGCCGGGGGCCGCGACGGGCGACGTCCTGCCGATCGGCAGGCCGCTGGCCGGCCGGCAGGCCTACGTGCTCGACGCGTTCCTGCAGCCCGTGGCGCCGAACGTGACCGGCGAGCTCTACCTCGCCGGCGCTGGCCTGGCGCACGGTTACCTGGGCAACACCGCGGCGACCTCGGAGCGGTTCGTCGCCAACCCGTTCTCCGGCGGCGGCCGGATGTACCGCACCGGCGACCTGGCTCGCTGGACCGACCAGGGCGAGCTGGTGTTCGCCGGCCGCGCCGACTCCCAGGTGAAGATCCGCGGCTACCGCGTCGAGCCGGGTGAGGTCGAGGTGGCGCTGACCGAGGTGCCCCACGTCGCGCAGGCGGTCGTGGTGGCGCGGGAAGGCCAGCCCGGCGAGAAGCGCCTGATCGCGTACGTGACCGCGGAAGCGGGATCGGCACTGGAATCCGCCGCGGTCCGCGCGCACCTCGCGACGCGGCTGCCGGAGTTCATGGTGCCGTCGGTGGTGGTGGTGCTGGAGAGCTTCCCGTTGACGCTCAACGGGAAGATCGACCGCGCGGCCCTGCCCGCCCCCGAGTTCGCCGGGAAGGCGGCCGGGCGCGAACCGCGCACGGAGGCCGAGCGGGTGCTGTGCGGCCTGTTCGCCGAGATCCTCGGGCTGGAGCGGGTCGGCGCCGACGACGGCTTCTTCGAGCTGGGCGGCGACTCGATCCTCTCGATGCGGCTGGCCGCCCGCGCGCGTCGCGAGAACTTCGTCTTCGGCGCGAAGCAGGTCTTCGAGCAGAAGACGCCCGCGGGGATCGCGGCGGTCGCCGAGCGTGGCGGGCAGAGCCGCCCGGCCGGCGTCGCCGACGGCGTCGGCGAGGTTCCGTGGACGCCGGTGGTGCGGGCACTGCTCGAACGCGATCCCGCCGGGCTGACCCGCGGTGCCATGGCGCAGTGGGTCAGCGTGGCAGCGCCCCGCGACCTTTCGGTGACCGCGCTGGTCGCCGGGCTGGGCGCGGTGATCGACACGCACGACATGCTGCGGAGCCGGATCGTCGAGAGCGAGGGCGTGGAACCCCGGCTGGTCGTGGCCGGGCGGGGCACGGTGGACGCGGCGGCGCTGGTCGAACGGGTCGAGGCCGGCGACGGTGATCTCGCCGAGATCGCGGACCGGTGCGCCCACGACACGGCCGCACGCCTGGATCCCGTGGCCGGCGTGCTGGTCCGGGCCGTCTGGGTGGACGCCGGACCGGGCCGCGCCGGACGGCTCGTGGTGGCCGCGCACCACCTCGTGGTCGACGTCGTGTCGTGGCGAACCCTCCTGCCGGACCTGCAGGCGGCCTGTGAAGCCGTGGTCGCGGGCGGGCAGCCGGCGCTCGATCCGCCGGACGTCTCGTTCCGGCGCTGGTCGCGGACGCTGGACGGCGAGGCGGCGATCCGGACCGGCGAACTGGCGGTGTGGACGGAGATCCTCGACGGGGCGCAGTCCCGGCTGGGCGAGCTCGATCCGCGGCGCGACACCGTGTCCACCGCGGGACGCCGGTCCTGGACCGTGCCCCGGGAACACGCGGGCGTGCTCGTGGAACAGGTCACCTCGGCCTTCCACTGTGGTGTCCACGAGGTGCTGCTGGCCACCCTGGCGGGCGCCGTGGCGGGCTGGCGCGGCGGCACGGCCGTCGTGGTGGACGTCGAAGGCCACGGCCGTCAGCCCCTCGGGGAACTGGACCTGTCGCGGACACTCGGCTGGTTCACCGACGTCCACCCGCTCCGGCTGGACGTCACCGGGGTCGACCCGGCCGAGGCGGTCGCCGGCGGCGACGCGGCGGGCCGGTTGCTGAAGCAGGTCAAGGAGAACGTGCGAGCCGTGCCCGACGGCGGGCTCGGCTACGGGATGCTGCGGTACCTCAACGCCGAGACGGGGCCGGTCCTCGCCGCGCTGCCGAAGGCGGAGATCGGGTTCAACTACCTCGGCCGCTTCTCGGCGGGGTCCGGCGGCGAGGCACAACCCTGGCAGATCACGGGAATCGTCGGCGGTGCGGCGGAGCAGGACACGCCCTTGCGGCACGTCGTGGAGATCGACGCCGTCGTGGTGGACGGCCCGGACGGACCCGAATTCACCCTGACCGTGACCTGGGCCGGGCGGATGCTCGGCGACGCCGAGGCGGAGTCGCTCGCGCAGGCGTGGCTGGACATGCTGGCCGGCCTGGCCGCCCACGTGGCCGCCGGTGGCCCCGGGGGGCACACGCCGTCCGACTTCCCGCTCACCGCGCTGACGCAGCGGGAGGTGGCGGAGTTCGAGGCCGCCGTGCCGGGCCTGCTCGACATCTGGCCGCTTTCCCCGCTGCAGGAAGGCCTGTTGTTCCACGCCGCCGACGACCGCGGCCCGGACGTCTACGCGAGCATGCGCACCCTCGCCATCGACGGCCCGCTGGACGTCGCCCGGTTCCGGGCGTCCTGGACGGTCCTGCTCGACCGGCATCCCGCCCTGCGGGCGAGTTTCCACCAGCTGGAATCCGGCGAGGCCGTGCAGGTGATCGCCCGGGACGTGCCGCCGGACTGGCGGGAGACCGACCTGTCCGGGCTGCCCGAGAGCGAAGCGCTCGCGGAGTTCGACCGCCTCGCGGCGCGGATGCACGCCGAGCGGTTCGACCTGACCAAGGCTCCGCAGCTGCGCCTGCACCTGGTGCGCCTCGGTGACCGCAGGTACCGGCTGATCTTCACGTCGCACCACATCGTGGCCGACGGCTGGTCCCTGCCGCTCATCCTGGTCGACGTGCTGACGGCGTACGAGGCAGGCGGTGACGGCCGGACGCTGCCGGCCGCGACGTCGTACCGTGACTTCCTCGCCTGGGTCGACCGCCAGGACAAGGGGGCGGCCGGGCAGGCGTGGCGGACCGAGCTCGCGGGGCTCGACGAGGCGACCCACGTCGTGCCGCCGGGCTCGATCATCACGCCCCTGGAGCCCGAACGCGTCGCGTTCGAACTCGACGACGAGACGAGCAAGCGGCTGGTCGAGTTCACCCGGCGGCACGGCGTCACGGCGAACACGCTCTTCCAGGGGGTCTGGGCACTGCACCTGGCCCGGCTGGCCGGGCGGAACGACGTGGTCTTCGGTGCCGCGGTCGCGGGGCGCCCGCCGGAGATCCCCGGCGTCGAGTCCGCGGTCGGCCTGTTCATGAACATGCTGCCGGTCCGGGCGCGCCTCACCGGTGCCGAGCCGGTCGTCGACATGCTGAAGGACCTGCAGGAGCGGCAGGTCGCGATGATGGCGCACCAGCACATCGGGCTGCCCGAGATCAAGCAGCTCACCGGGCCGGGGGCGGCGTTCGACACGATCGTGGTGTTCGAGAACTACCCGCCCGCGCCGCCGAGGTCCGACGACCCCGACGCGCTCGTCATCCGCCCGGTGGGGATCCCGAACGACACCGGGCACTACCCGCTGTCCATGCGCGCGTCCGTGGCGGCGGGCCCCGTCCGCGGTGAGTTCATCTACCGGCCGGACGTGGTCGACCGGACCGAGGCCGGGGAGATGGTCGCGGCGATCCTCCGCGCGCTCGAGCAGGTGGTGGCCGAGCCGTGGACGCCGGTGGGCCAGGTCGGCCTGATCGGCCCGGAGCAGCGCCGTCTGGTCGTGGACGAGTGGAACCGGACCGACGTGCCGCTGGCGGCGGAGACGCTGCCGGTGTTGTTCCGCAGGCAGGCGGAGCGGTCACCGGATGCGGTGGCCGTCGAGGACGGGGCGCGGAGCCTGACGTTCGGTGGGCTGCTCGGCGAGGTGGAAGCGCTGGCCCGGCTGCTCGTGGGGGCGGGCGTGCGGCGCGAGCACCGGGTGGGCGTCCTGGTCGAGCGCTCGGCCGAGCTGGCGGTGACCATGATGGCCGTGTCGTTCGCCGGCGGGGTGTTCGTGCCGGTCGACCCCGACTATCCCCGTGAGCGCGTCGAGTTCATGCTGGCGAACTCGGCACCCGGGGTCATGGTGTGCACGAAGACGACCCGGGCGGCCGTGCCCGCGGAGTTCGCGGGCACCGTGCTGGTGCTGGACGAGCTGCCCGCCGCGGACCCGGACGTCGAGCTGCCGCCGGTGGCACCGGAAGACGCGGCGTACGTGATCTACACGTCCGGGTCGACGGGGGTGCCCAAGGGCGTCCTGGTGACCCACTCCGGGCTCGCCAATCTGGGGTACGCGCACATCGAGCGGATGGCGGTGACGTCGTCCTCGCGGGTCCTGCAGTTGTCCGCGACCGGCTTCGACGCCATCGTGTCCGAGCTCTACATGGCCTTGCTGGCCGGCGCGACCCTGGTGCTGCCGGACGCGGCGAGCATGCCGCCCCGGGTGACGCTGGGCGAGGCGATCCGGCGGGCGGGCATCACGCACCTGACCGTGTCGCCGAGTGTGCTGGCGAGCGAGGACGACCTGCCGGACACGCTGCGGACCGTGCTGACGGGCGGCGAGGCACTGCCGCCCGCGCTGGTGGACCGCTGGTCACCGGGCCGCCGGGTGATCCAGGCCTACGGGCCGACCGAGACGACCATCTGCTCGACGATGAGTGCCCCGCTGTCCCCGGGGCACGACCAGGTCCCGCTCGGCGGCCCGATCCACAACGTGCGGCACTACGTGCTCGACGCGTTCCTGCAGCCGGTGCCGCCCGGCGTGGTCGGCGAGCTCTACATCACGGGTGTCGGGCTGGCGCGCGGCTACCTCGGGCGTCCCGGCCTGACCGCGGAACGGTTCGTGGCCAGCCCGTTCGCCCCCGGCGAGCGGATGTACCGCTCGGGCGACCTGTTCCGCTGGACCCGGGAAGGCCAGCTGCTCTTCGCGGGCCGTGTCGACGCGCAGGTCAAGGTGCGGGGGTACCGGGTCGAGCCCGCCGAGATCGAGGCCGTGCTCGCGGAGCACCCGTGGGTCGGCCAGGTGGCGGTGTCCGTCCGCCGGGACGGCCCGGGCGACAAGCAGCTGGTGGCTTACGTCGTGCCGTCGGCCGACGCGGCCGCCGAGAACGGCACGCTGGCCTCGGCACTGCGCGAGCTGGCGGCCGAACGCCTGCCGGAGTACATGATGCCCGCGGCGTTCGTGTCGCTGGAGCAGATGCCGCTCACCCCGAACGGCAAGCTCGACCACCGGGCGCTGCAAGCCCCCGACTTCGCCGGGATGTCCTCGAAGCGGGCCCCCCGCACGCCCATGGAGGCGAGGCTGTGCGCGCTCTTCGCGGACGTGCTCGGCCTTGACCAGGTGGGGCCCGACGACAGCTTCTTCGAACTCGGCGGCGACTCGATCACCTCGATGCAGCTGTCGGCCCGGGCTCGGCCGACGGGGCTGGAACTGACCCCGTGGCAGGTGTTCGACGAGAAGACGCCGGAACGGCTGGCGGTGATCGTCCAGGAACTCGCGGCCGAGGGCGGGACCACCCCGGCGCCGGAGCCCGGCGAGGGCACGCTCGTCGCTCTCTCACCTGACCAGATGGACCTACTCGAGGCCGGGCTGGCCGGCGAATGA	MSQSRIEEIWPLSPLQAGLLFHAVYDGEGPDVYIGHWILDLAGPVDAAGLRAAWETLLARHAPLRACFRQRKSGETVQIIARQVELPWREVDLSHLDDPEEAVRELAEQDRTTRFDLAQAPLLRLTLIRLGADAHRLVVTCHHTIMDGWSLPIVIDELSVLYPAGGDASALPDVPSYREYLAWLSRQDKERALSAWTAELSGAEEPTLVVPADPGRAPAEPESVEAHLPEHLTRSLAELARRHGLTLNTVVQGAWALVLAQLAGRPDVVFGAAVSARPPDLPGVEGMVGLFLNTVPVRVRLRGSTPVVELLAELQKRQSALIPDQFVGLADIQQAAGPAAVFDTLLVFEKFHHGPAGSDSAGTFRIHVNQGRVAAHYPLTLVAVPGESMYLKLDYLTELFDRETAFAILERFTGVLRQLTGAGELTVAGVEVTTAAERALVAGEWGASTSAPPSLPALDLFGHQVAHRRDEPAVVDGDRTVSYGELAERAERLAGYLNGRGVRRGDRVAVVLDRSPDLIATLLAVWKAGAAYVPVDPAYPVERRKFMLADSGPAAVVCAEAYRAAVPDTCPEPIVLDDPRTRQAVAESPRLSAGTSADDLAYVMYTSGSTGTPKGVAVSHGNVAALAGEPGWRVGPGDAVLLHASHAFDISLFEMWVPLLSGARVVLAGPGAVDGAALAAYVAGGVTAAHLTAGAFRVLADESPEAVAGLREVLTGGDAVPLAAVERVRGRVRNVRVRHLYGPTEATLCATWWLLEPGDETGSVLPIGRPLAGRRVHVLDAFLRPVPPGVAGELYVAGAGVAQGYSSRPALTAERFVADPSGSGARMYRTGDLAYWTEQGALAFAGRADDQVKIRGYRVEPGEIEVVLAGLPGVGQAVVTPRGEHLIGYVVAEAGHDADPVRLREQLAGTLPEFMVPAAVLVLDELPLTVNGKVDRRALPEPDFAAKSAGREPVTEAERVLCGVFADVLGLDHVGVDDSFFELGGDSISSMQVAARARREGISLTPRLVFEHRTPERLAALAQEAGATPRAEVVTGVGEIPWTPVMRALGDDAMRPGFAQVRVVVTPAGVNPDALVSALQAVLDAHDLLRARVEPDGRLIVPERGAVAAAGLLTRVAAGTGGLDEIAEREVRTATGTLDPSAGIMARVVWIDAGDAEPGRLAFVAHHLSVDAVSWGILLPDLRAAYDEVISGGTPALEPPVTSYRQWARRLTARALSESTVAELEKWAAVVEGAEPALPQDTGQHTGQSHSWSTSLSGTEVRDLVTVLPGAFHCGIQDVLLAGLAGAVARVRGSGAALLVDVEGHGREAADGEDLLRTVGWFTSVHPVRLELSDVDLAGAADGERPAGQLLKAVKEQIRAVPGDGSGYGLLRHLNPGTGARLAELPSAQIGFNYLGRTVLAPEDTAWQPNGGGPLGGGPDMVLAHAVEVSAELQDTPAGPRLGLAIDTRDFDLATVERLGEAWLEMLTGLAAVARGSGAGGHTPADFALVDLTQRDVAELEAAAPGLTDIWPLSPLQEGMLFERAFDEDGVDVYQTQRILDLDGPLDEPRLRAAWNQVLARHASLRTGFHQLGSGATVQVVVREADIPWRVADLSHLDAAEAAAEVERLLAEDQGRRFDVTRPPLLRLLLIRLGADEHRLVVTSHHVLLDGWSTPLVVGEMSDGYAGGRSSSKPPSYQDYLAWLSRQDAEATRSAWRAELAGADEPTLVDADAGKTLVMPDEHAEWLPEPATRALAGFARGHGLTVSTIVLGAWALVLARLAGRTDVVFGSVVSGRPADVPDVERMVGMFINTVPARVRLDGRRPLLEMLEDLQARQAALTEHQYLGLPEIQKVAGTGAIFDTIVMVENYPHDAAGLGGDGGVAISSVVTRTGTSYPLTMNVSLGDRLRITVSYRPDRIDDATAAEVARQVVRVLERVVAEPSLPVGRLGVTSEPTRAAVVERWNSTGEAAAETSVLELFRRQAGASPDAVAVVAGERTLSYADLDRESDRLAGHLAGIGVGRGDRVGVVMTRGADLFVALLGVWKAGAAQVPVNVDYPAERIERMLADVGASVAVCVEATRKAVPDGVEPVVVDLPVIGGVRPEAPPVTVGAHDVAYVMYTSGSTGVPKAVAVPHGSVAALASDPGWSQGPGDCVLLHASHAFDASLVEIWVPLVSGARVLVAEPGTVDAERLREAVSRGVTTVHLTAGAFRAVAEESPDSFIGLREILTGGDAVPLASVVRMRQACPDVRVRQLYGPTEITLCATWLVLEPGAATGDVLPIGRPLAGRQAYVLDAFLQPVAPNVTGELYLAGAGLAHGYLGNTAATSERFVANPFSGGGRMYRTGDLARWTDQGELVFAGRADSQVKIRGYRVEPGEVEVALTEVPHVAQAVVVAREGQPGEKRLIAYVTAEAGSALESAAVRAHLATRLPEFMVPSVVVVLESFPLTLNGKIDRAALPAPEFAGKAAGREPRTEAERVLCGLFAEILGLERVGADDGFFELGGDSILSMRLAARARRENFVFGAKQVFEQKTPAGIAAVAERGGQSRPAGVADGVGEVPWTPVVRALLERDPAGLTRGAMAQWVSVAAPRDLSVTALVAGLGAVIDTHDMLRSRIVESEGVEPRLVVAGRGTVDAAALVERVEAGDGDLAEIADRCAHDTAARLDPVAGVLVRAVWVDAGPGRAGRLVVAAHHLVVDVVSWRTLLPDLQAACEAVVAGGQPALDPPDVSFRRWSRTLDGEAAIRTGELAVWTEILDGAQSRLGELDPRRDTVSTAGRRSWTVPREHAGVLVEQVTSAFHCGVHEVLLATLAGAVAGWRGGTAVVVDVEGHGRQPLGELDLSRTLGWFTDVHPLRLDVTGVDPAEAVAGGDAAGRLLKQVKENVRAVPDGGLGYGMLRYLNAETGPVLAALPKAEIGFNYLGRFSAGSGGEAQPWQITGIVGGAAEQDTPLRHVVEIDAVVVDGPDGPEFTLTVTWAGRMLGDAEAESLAQAWLDMLAGLAAHVAAGGPGGHTPSDFPLTALTQREVAEFEAAVPGLLDIWPLSPLQEGLLFHAADDRGPDVYASMRTLAIDGPLDVARFRASWTVLLDRHPALRASFHQLESGEAVQVIARDVPPDWRETDLSGLPESEALAEFDRLAARMHAERFDLTKAPQLRLHLVRLGDRRYRLIFTSHHIVADGWSLPLILVDVLTAYEAGGDGRTLPAATSYRDFLAWVDRQDKGAAGQAWRTELAGLDEATHVVPPGSIITPLEPERVAFELDDETSKRLVEFTRRHGVTANTLFQGVWALHLARLAGRNDVVFGAAVAGRPPEIPGVESAVGLFMNMLPVRARLTGAEPVVDMLKDLQERQVAMMAHQHIGLPEIKQLTGPGAAFDTIVVFENYPPAPPRSDDPDALVIRPVGIPNDTGHYPLSMRASVAAGPVRGEFIYRPDVVDRTEAGEMVAAILRALEQVVAEPWTPVGQVGLIGPEQRRLVVDEWNRTDVPLAAETLPVLFRRQAERSPDAVAVEDGARSLTFGGLLGEVEALARLLVGAGVRREHRVGVLVERSAELAVTMMAVSFAGGVFVPVDPDYPRERVEFMLANSAPGVMVCTKTTRAAVPAEFAGTVLVLDELPAADPDVELPPVAPEDAAYVIYTSGSTGVPKGVLVTHSGLANLGYAHIERMAVTSSSRVLQLSATGFDAIVSELYMALLAGATLVLPDAASMPPRVTLGEAIRRAGITHLTVSPSVLASEDDLPDTLRTVLTGGEALPPALVDRWSPGRRVIQAYGPTETTICSTMSAPLSPGHDQVPLGGPIHNVRHYVLDAFLQPVPPGVVGELYITGVGLARGYLGRPGLTAERFVASPFAPGERMYRSGDLFRWTREGQLLFAGRVDAQVKVRGYRVEPAEIEAVLAEHPWVGQVAVSVRRDGPGDKQLVAYVVPSADAAAENGTLASALRELAAERLPEYMMPAAFVSLEQMPLTPNGKLDHRALQAPDFAGMSSKRAPRTPMEARLCALFADVLGLDQVGPDDSFFELGGDSITSMQLSARARPTGLELTPWQVFDEKTPERLAVIVQELAAEGGTTPAPEPGEGTLVALSPDQMDLLEAGLAGE	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	733.27	gnl|BL_ORD_ID|4935|hsp_num:0	5928			588	1632	colistin A; colistin B
BGC0000311.1|Balhimycin_9 # 28888 # 34464 # 1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.734	BGC0000311.1|Balhimycin_9 	28888	34464	+	Loose	1000	88.9669	almE	26.37	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGACCGTTGACGACACTCGCGCGAAGCGCCGCTCCAGCGTCGAGGACGTCTGGCCTCTTTCGCCGCTGCAGGAGGGAATGCTCTATCACACCGCCCTCGACGACGACGGGCCGGACACCTACACGGTGCAGACCGTCTACGGCATCGACGGCCCGCTGGACCCGGGGCTCTTGCGGGCGTCGTGGCAGGCGCTCGTGGACCGGCACGCCGCGCTGCGGGCCTGTTTCCGGTACGTCTCCGGGGCGCAGATGGTGCAGGTCATCGCGCGGGAGGCCGAGGTTCCCTGGCGCGAGACGGACCTTTCCGGGCTGCCGGACGACATCGCCGAGGGCGAGGTTGACCGGCTGGCGGCGGACGAGGTGGCCGAGCGGCTGCGCATCGAGGCCGCGCCGCTGATGAAGCTGCACCTGATCCGGCTCGGCCCGGACCGCCACCGGCTCGTGCACACGCTGCACCACGTGCTGGTGGACGGCTGGTCGATGCCGATCCTGCACCGGGAGCTCGCCGCGATCTACGCGGCGGGCGGGGACGCGTCCGGCCTCCCGCCCACCGTCTCCTACCGGGACTACCTCGCCTGGCTGGGCCGGCAGGACAAGGAGGTGGCGCGGGCGGCCTGGCGGGCCGAGCTCGCCGGGCTGGACACGCCGACCACGGTCGCCGCGCCCGATCCGGCCCGCGTCCCGGACATCCACACGGCGGTGGTCGAGCTGCCGGCGGAGCTGACGGACGGCTTGGCGCAGTTCGCGCGTGGCCACGACCTCACGCTGAACACCGTCGTGCAGGGCGCGTGGGCCGTCGTGCTGGCCCAGCTCGCGGGCCGCGACGACGTCGTGTTCGGCGCGACCGCCTCCGGGCGGCCCGCGGACCTGCCCGGGGTGGAGGCGATGGTCGGCCAGCTGCTCAACACCCTGCCGGTGCGGGTCCGGCTCGACGGCGGGCGCCGCGCGGCCGAGCTGTTCGCCCGGCTGCAGCGCGACCAGTCGGCACTCATGGCCCACCAGCACCTCGGCCTGCAGGACGTGCAGGCCGTCGTCGGACCCGGAGCGGTCTTCGACACGCTCGTCATCTACGAGAACTTCCCCCGCAAGGGACTCGGCCGGGCACCGGGCGGTGGCCTGAGCCTGGTCCCGGTGAAGCGCGGGCGGAACTCCTCGCACTACCCGTTCACGCTGATCACCGGACCCGGCGAGCGGATGCCGCTGATCCTCGACTACGACCGGGGCCTGTTCGACCCCGCGGCCGCCGAATCGGTCGTCGGCGCGCTGGCCAGGGTGCTGGAGCGGCTGGTCGCCGAGCCCGACGTCCTCGTCGGCAGGCTGACGCTCGCGAGCGAGGCCGAACGCGCGCTGGTGGTGGAGGGCTTCAACGCCACCGCGGGCCCGGTGCCGGGGGAGTCCGTCCTCGAGCTGTTCGCCCGGCGGGTGGCCGCCGCGCCGGACGCGGTGGCGATCACCGGCGCCGCCGGCGCGAACCTGACCTACGCCGAGGTCGACCAGGCGTCGAACCGGCTGGCGGGCTACCTCGCCGTCCGGGGCGTGGGCCGTGGCGACCGCGTCGGGGTGGCCATGGAACGGTCGCCGGATCTGCTGATCGCGTTCCTGGCGATCTGGAAGGCGGGTGCCGCCTACGTTCCGGTGGACGTCGAGTACCCGGCCGAGCGGATCTCGTTCGTCTTCGACGACTCCGGCGTCTCGACCGTCCTGTGCACCCTGGCCACCAGCGCGGTCGCGCCGGGCAACGCGATCGTGCTCGACGCGCCCGAAACACGCGTGGCCGTGCGGGACTGCGCCGCGCCGGAAATCCGGCCGCACGCGGACGACCTGGCGTACGTCATGTACACCTCCGGCTCCACCGGCCTGCCGAAGGGCGTGGCCATCCCGCACGGGGCCGTGGCCGGCCTGGCGGGCGACGCGGGCTGGCAGATCGGTCCCGGCGACGGCGTGCTGATGCACGCGACGCACGTCTTCGACCCTTCGCTCTACGCGATGTGGGTGCCGCTCGTCTCGGGCGCCCGGGTCCTGCTCACCGAGCCGGGGGTGCTGGACGCGGCCGGGGTACGGCAGGCCGTGCACCGGGGCGCGACCTTCGTCCACCTCACCGCCGGCACCTTCCGCGCGCTGGCGGAGACGGCACCGGAGTGCTTCGAAGGCCTGGTCGAGATCGGGACCGGCGGCGACGTGGTTCCGCTGCAGTCGGTGGAGAACCTGCGGCGGGCCCAGCCCGGCCTGCGGGTGCGCAACACCTACGGGCCGACCGAGACCACCCTGTGCGCGACGTGGCTGCCGATCGAGCCCGGTGAGGTGCTCGGCCGGGAGCTGCCGATCGGCCATCCGATGACCAACCGCCGGATCTACCTCCTCGACGCCTTCCTGCGCCCGGTTCCGCCGGGCGTGGCCGGCGAGCTGTACATCGCGGGCACGGGCCTGGCCCACGGGTACCTGAAGAGCCCCGGCCTGACGGCCGGCCGGTTCGTGGCCTGCCCGTTCGCCGCCGGTGAACGCATGTACCGCACCGGCGACCGGGCGCGCTGGACCCGCGACGGCGAGGTGGTGTTCCTCGGCCGCGCCGACGACCAGGTGAAGATCCGCGGCTACCGGGTCGAGCTCGGCGAAGTGGAGGCTGCGCTGGCGGCCCAGCCGGGCGTGGTCGAGGCCGTCGTCACGGCGCGGGAGGACCAGCCCGGCGAGAAGCGCCTGGTCGGCTACTTCGTCTCCGACGGCGGCGACGCGGGGCCGGTGGAGATCCGGCGGCAGCTGGCCCTGGTGCTGCCCGACTACCTGGTCCCCATCGCCGTGGTCGCCCTGCCCGGCCTGCCCGTCACCCCCAACGGCAAGGTCGATCGCCGGGCCCTGCCCGCCCCGGATCTCGCGGGACACTCGCCGGAGAAGGCACCCGAGAACGAGACCGAGAAGGTGCTGTGCGCGCTGTTCGCCGAGATCCTCAGCATCGACCAGGTGGGGGTCGACGACACCTTCCACGACCTCGGCGGCAGTTCGGCGCTGGCCATGCGGCTCGTCGCGCGGATCCGTGAGGAGCTCGGCGCGGACCTGCCCATCCGGCAGCTGTTCTCCTCGCCGACCCCCGCGGGCCTGGCCAGGGCGCTGGCCGCGAAGTCACGCCCCGCGCTGGAAGCCGCCCAGCGGCCGGACCGGGTGCCCGTCACCGCCCGGCAGCTGCGTGCCTGGCTGCTGGCCGATCCCGGCGGGGAGACGGCCGGCCTGCACACCTCCGTCGCCCTGCGCCTGCACGGCCGGGTGGACGTGCCCGCGCTGGCGGCGGCGCTCGGCGACGTCGCGGCCCGGCACGAGATCCTCCGCACGACCTTCCCGGGTGACGCGCAGAGCGTTCACCAGCACGTCCACGACGCCTTGGCGGTCGAGCTGACTCCGGTCGGAGTCACCGAGGAAGACCTCCCGGGGCTGCTCGCCGAGCGGCGTGACCTGCTCTTCGACCTCACCAGGGACGTGCCGTGGCGGTGTGACCTCTTCGCGCTCTCGGACAACGAGCACGTGCTGCACCTGCAGGTCCACCGGATCCTCGCCGACGACGACTCGCTCGACGTGTTCTTCCGCGACCTGGCGGCCGCCTATGGTGCGCGCCGCGAAGGCCGGGTCCCGGAGCGCGCGCCCCTGGCGTTGCAGTTCGCCGACTACGCGCTCTGGGAGCAGCGCCTGCTCACGGACGAGAACGAGCCGGGCAGCCTGATCAACGAGCAGGTGGCCTTCTGGCGGGACAACCTGGCCGGCCTCGACGGGGAGACGGTGCTGCCGTTCGACCGCCCGCGCCCGGCCGTCCCGTCGCGGCGCGCCGGAACGGTCGCGCTGCGGCTGGAGGCCGGCCCGCACGCCCGGTTGACGGAGGCGGCGGAGCCGCCGGGCGCGGACACGCTCGAGATGGTGCACGCCGCGCTCGCGATGCTGCTGGCCAAGCTCGGAGCGGGCCACGACGTGGTGATCGGCACGGCGCTGCCGCGGGACGAGGAGCTCTTCGACCTCGAGCCGATGATCGGGCCGTTCACCCGGGCGCTCGCCCTGCGCACCGACGTCTCGGGCGATCCGACCTTCCTCGAGGTCGTCGCCAGGGTGCAGGAGGCGGGCCAAGCCACGGGCGAGCACCTGGACCTGCCCTTCGAACGGATCGTCGAGCTGCTCGATCTGCCGGCCTCGCTCGCCCGCCACCCCGTGTTCCAGGTGGGACTTCAGGTGGACGAGGAGGACATCGACGGATGGGCCGCGGCGGAACTGCCCGCCCTGCGCACCGCCGTCGAACCCGGCGGGACCGCGGCCATGGAGCTGGACCTCGCGGTCAAGCTCACCGAGCGCTTCGACGACGACGACAACGCCGGCGGCCTCGAGGGCGCGCTGCACTACGCCACCGACCTGTTCGACGAGGCCACGGCGGAGTCGGTGGCCCGGCGGCTGGTCCGCGTCCTCGAGCAGGTGGCGGAGGATCCCGGGCGGCGGATCAGCGACCTGGATGTCTTCCTGGACGACTTCGAACGCGGCCGTCCGCCCATCGCTCCGGCGCGGTGGGCCGGGGCCGTGCCCCCGGTGGTCGCCGAACTGGCCGGGGACGGCCCGCTCGGCGCGCTCCTGCTCGACGAGCAGCTGCGCCCGGTCGCTCCCGGAGCCGTCGGCGATCTGTACGTCACCGGCCCGGCCGTGGACGCGGGAACGGCCACCCTGGCGACCGTGCCCTGCCCGTTCGGGGACGAGGGGCACCGGATGCTGCACACGGGCCTGCTCGCCCGCAAAACGCCCGCCAAGACCCTGGTCGTCGTGGGCGAGCGGAGGCGGTCGAGCGCTTCGGTGAAGACGGGTGACTTCGAGATCCTGCTGCCGCTGCGCGCCGGCGGTGACCGCCCGCCCCTGTTCTGCGTCCACGCGAGCGGTGGCCTGAGCTGGAACTACGAGCCGTTGCTGCGGTACCTCCCGCCGAACCAGCCGGTCTACGGCGTGCAGGCTCGCGGCCTGGCCCGGACCGAACCGCTGCCGGGCAGCGTCGAGGAGATGGCGGCCGACTACCTCGAGCAGATCCGTGCCGTGCAGCCGGCCGGGCCGTACCACCTCCTCGGCTGGTCCCTCGGCGGCCGGATCGCGCAGGCGATGGCCAGGTTGCTCGAGGCGGACGGGGAGCGGCTCGGCCTGCTCGCCCTGCTCGACGCCTATCCCGTCTACATGGGACGCAAGACGACCGGCGCCGCGAGCGAAGAAGCGGCTCTCGAACAGCGGAACCAGCAGGATCTGGACCTCGCGGGGCAACTGGTCAAGGGTGTGGCCGCCCGGTCGCGCCTCGAGGCGGTCATGCGCAACCTCTGGAAGGTCGGGCCACGGCACACACGTTCGCCCTTCGCCGGCGACGTCCTGCTTTTCGTGGCCACTGTGGACCGTCCCGCGCATTTGCCCGTCCCAGTGGCGAAGGCCAGCTGGAAGGAATTCACCAGTGGGGCGGTAGAGGCCCACGAAATCCCGTCCAACCACTACGACATGGTGCAATCCGCGGCGCTGGGCCAGATTGGTGCCATCGTCGCCGAGAAACTCCGGTCCCGGCCGGAGGGTGAAAGGACACAACGATGA	MTVDDTRAKRRSSVEDVWPLSPLQEGMLYHTALDDDGPDTYTVQTVYGIDGPLDPGLLRASWQALVDRHAALRACFRYVSGAQMVQVIAREAEVPWRETDLSGLPDDIAEGEVDRLAADEVAERLRIEAAPLMKLHLIRLGPDRHRLVHTLHHVLVDGWSMPILHRELAAIYAAGGDASGLPPTVSYRDYLAWLGRQDKEVARAAWRAELAGLDTPTTVAAPDPARVPDIHTAVVELPAELTDGLAQFARGHDLTLNTVVQGAWAVVLAQLAGRDDVVFGATASGRPADLPGVEAMVGQLLNTLPVRVRLDGGRRAAELFARLQRDQSALMAHQHLGLQDVQAVVGPGAVFDTLVIYENFPRKGLGRAPGGGLSLVPVKRGRNSSHYPFTLITGPGERMPLILDYDRGLFDPAAAESVVGALARVLERLVAEPDVLVGRLTLASEAERALVVEGFNATAGPVPGESVLELFARRVAAAPDAVAITGAAGANLTYAEVDQASNRLAGYLAVRGVGRGDRVGVAMERSPDLLIAFLAIWKAGAAYVPVDVEYPAERISFVFDDSGVSTVLCTLATSAVAPGNAIVLDAPETRVAVRDCAAPEIRPHADDLAYVMYTSGSTGLPKGVAIPHGAVAGLAGDAGWQIGPGDGVLMHATHVFDPSLYAMWVPLVSGARVLLTEPGVLDAAGVRQAVHRGATFVHLTAGTFRALAETAPECFEGLVEIGTGGDVVPLQSVENLRRAQPGLRVRNTYGPTETTLCATWLPIEPGEVLGRELPIGHPMTNRRIYLLDAFLRPVPPGVAGELYIAGTGLAHGYLKSPGLTAGRFVACPFAAGERMYRTGDRARWTRDGEVVFLGRADDQVKIRGYRVELGEVEAALAAQPGVVEAVVTAREDQPGEKRLVGYFVSDGGDAGPVEIRRQLALVLPDYLVPIAVVALPGLPVTPNGKVDRRALPAPDLAGHSPEKAPENETEKVLCALFAEILSIDQVGVDDTFHDLGGSSALAMRLVARIREELGADLPIRQLFSSPTPAGLARALAAKSRPALEAAQRPDRVPVTARQLRAWLLADPGGETAGLHTSVALRLHGRVDVPALAAALGDVAARHEILRTTFPGDAQSVHQHVHDALAVELTPVGVTEEDLPGLLAERRDLLFDLTRDVPWRCDLFALSDNEHVLHLQVHRILADDDSLDVFFRDLAAAYGARREGRVPERAPLALQFADYALWEQRLLTDENEPGSLINEQVAFWRDNLAGLDGETVLPFDRPRPAVPSRRAGTVALRLEAGPHARLTEAAEPPGADTLEMVHAALAMLLAKLGAGHDVVIGTALPRDEELFDLEPMIGPFTRALALRTDVSGDPTFLEVVARVQEAGQATGEHLDLPFERIVELLDLPASLARHPVFQVGLQVDEEDIDGWAAAELPALRTAVEPGGTAAMELDLAVKLTERFDDDDNAGGLEGALHYATDLFDEATAESVARRLVRVLEQVAEDPGRRISDLDVFLDDFERGRPPIAPARWAGAVPPVVAELAGDGPLGALLLDEQLRPVAPGAVGDLYVTGPAVDAGTATLATVPCPFGDEGHRMLHTGLLARKTPAKTLVVVGERRRSSASVKTGDFEILLPLRAGGDRPPLFCVHASGGLSWNYEPLLRYLPPNQPVYGVQARGLARTEPLPGSVEEMAADYLEQIRAVQPAGPYHLLGWSLGGRIAQAMARLLEADGERLGLLALLDAYPVYMGRKTTGAASEEAALEQRNQQDLDLAGQLVKGVAARSRLEAVMRNLWKVGPRHTRSPFAGDVLLFVATVDRPAHLPVPVAKASWKEFTSGAVEAHEIPSNHYDMVQSAALGQIGAIVAEKLRSRPEGERTQR	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	334.17	gnl|BL_ORD_ID|4935|hsp_num:0	5928			168	1629	colistin A; colistin B
BGC0000311.1|Balhimycin_10 # 34461 # 34670 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.667	BGC0000311.1|Balhimycin_10 	34461	34670	+	Loose	850	21.557	OprM	35.71	3000379	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; aminoglycoside antibiotic; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; peptide antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; sulfonamide antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGCAATCCGTTCGACAACGAAGACGGCTCCTTTTTCGTGCTGGTCAACGACGAGGGCCAGCACTCCCTCTGGCCGACCTTCGCGGAGGTGCCCGCCGGCTGGACCCGCGTGCACGGCGAAGCGGGCCGTCAGGAGTGCCTCGCCTACGTCGAGGAGAACTGGACGGACCTCCGGCCGAAGAGCCTCATCCGGGAAGCGAGCGCCTGA	MSNPFDNEDGSFFVLVNDEGQHSLWPTFAEVPAGWTRVHGEAGRQECLAYVEENWTDLRPKSLIREASA	MKRSFLSLAVAAVVLSGCSLIPDYQRPEAPVAAAYPQGQAYGQNTGAAAVPAADIGWREFFRDPQLQQLIGVALENNRDLRVAALNVEAFRAQYRIQRADLFPRIGVDGSGTRQRLPGDLSTTGSPAISSQYGVTLGTTAWELDLFGRLRSLRDQALEQYLATEQAQRSAQTTLVASVATAYLTLKADQAQLQLTKDTLGTYQKSFDLTQRSYDVGVASALDLRQAQTAVEGARATLAQYTRLVAQDQNALVLLLGSGIPANLPQGLGLDQTLLTEVPAGLPSDLLQRRPDILEAEHQLMAANASIGAARAAFFPSISLTANAGTMSRQLSGLFDAGSGSWLFQPSINLPIFTAGSLRASLDYAKIQKDINVAQYEKAIQTAFQEVADGLAARGTFTEQLQAQRDLVKASDEYYQLADKRYRTGVDNYLTLLDAQRSLFTAQQQLITDRLNQLTSEVNLYKALGGGWNQQTVTQQQTAKKEDPQA	14.23	gnl|BL_ORD_ID|2355|hsp_num:0	1305			141	267	erythromycin; amikacin; gentamicin C; ciprofloxacin; acriflavine; tetracycline; tobramycin; ceftazidime; ceftriaxone; meropenem; novobiocin; azithromycin; trimethoprim; sulfamethoxazole; chloramphenicol; thiamphenicol; aztreonam; colistin A; colistin B; ampicillin; nalidixic acid; norfloxacin; ofloxacin; panipenem; ticarcillin; trimethoprim-sulfamethoxazole; gentamicin
BGC0000311.1|Balhimycin_11 # 34866 # 35957 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=13bp;gc_cont=0.709	BGC0000311.1|Balhimycin_11 	34866	35957	+	Loose	800	29.261	PDC-285	30.16	3005287	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin	antibiotic inactivation	PDC beta-lactamase	ATGGGCGAGGGCACCATGTCCATCCTGCAGCCCCCGGATTCCCCCGGCGGGCGGACCGGGTGGCTGGCCACCGGGCACGACGAGGTCCGGCAGGTCCTCGGCTCGGACAAGTTCAGCGCCAAGCTGCTCTACGGCGGGACCGTGGCCGGCCGCATCTGGCCGGGCTTCCTCAACCAGTACGACCCCCCGGAGCACACGCGCCTGCGCCGGATGGTGACGTCGGCGTTCACCGTCCGGCGGATGCAGGACTTCCGGCCGCGGATCGAGCAGATCGTCCAGGCGAGCCTGGACGCCATCGAGGCCGCCGGTGGCCCGGTGGACTTCGTCCCCCGGTTCGCCTGGTCCGTGGCGACGACGGTGACGTGCGACTTCCTCGGCATCCCGCGTGACGATCAGGCGGACTTGTCGCGCGCCCTGCACGCCAGCCGGTCCGAACGGTCGGGCAAGCGGCGGGTGGCGGCGGGGAACAAGTACTGGACGTACATGACCGAGATCGCGGCCCGCGCGCGCCGCGATCCCGGTGACGACATGTTCGGCGCGGTGGTGCGCGACCACGGCGACGCGATCACCGACGCGGAACTGCTGGGCGTGGCCGCGTTCGTCATGGGCGCGGGCGGGGACCAGGTGGCCCGGTTTCTCGCGGCGGGCGCGTGGCTGATGGTCGAGCACCCCGATCAGTTCGCGCTGCTGCGGGAAAAGCCGGACACCGTCCCGGACTGGCTGAACGAGGTGGAGCGGTACCTCACCAGCGACGAGAAGACCACTCCGCGCATCGCGCAGGAGGACGTGCGCATCGGTGATCAGCTCGTCAAGGCCGGCGATGCCGTCACCTGCTCGCTGCTGGCGGCGAACCGCAGGAAGTTCCCCGCCCCGGAGGACGAGTTCGACATCACCCGGGAACGGCCGGTGCACGTCACGTTCGGCCACGGCATCCACCACTGCCTCGGCAGGCCACTGGCCGAGATGGTGTTCCGGGCGGCGATTCCGGCGCTGGCACAACGCTTTCCCAAGCTGAGGCTGGCCGAGCCGGACCGCGAGATCAAGCTGGGGCCGCCGCCGTTCGACGTGGAAGCCCTGCTGCTGGAGTGGTGA	MGEGTMSILQPPDSPGGRTGWLATGHDEVRQVLGSDKFSAKLLYGGTVAGRIWPGFLNQYDPPEHTRLRRMVTSAFTVRRMQDFRPRIEQIVQASLDAIEAAGGPVDFVPRFAWSVATTVTCDFLGIPRDDQADLSRALHASRSERSGKRRVAAGNKYWTYMTEIAARARRDPGDDMFGAVVRDHGDAITDAELLGVAAFVMGAGGDQVARFLAAGAWLMVEHPDQFALLREKPDTVPDWLNEVERYLTSDEKTTPRIAQEDVRIGDQLVKAGDAVTCSLLAANRRKFPAPEDEFDITRERPVHVTFGHGIHHCLGRPLAEMVFRAAIPALAQRFPKLRLAEPDREIKLGPPPFDVEALLLEW	MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAAHSLGQPFKRLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR	91.44	gnl|BL_ORD_ID|2991|hsp_num:0	4019			552	741	
BGC0000311.1|Balhimycin_12 # 36007 # 37203 # 1 # ID=1_12;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.707	BGC0000311.1|Balhimycin_12 	36007	37203	+	Loose	650	25.409	MexH	35.62	3000807	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TTGAATGATGACGACCCGCGGCCGCTGCACATTCGCCGGCAGGGCCTGGACCCGGCGGACGAGCTGCTCGCCGCCGGATCGCTGACGAGGGTCACCATCGGATCCGGAGCGGATGCCGAGACCCATTGGATGGCCACCGCGCACGCCCTCGTCCGGCAGGTGATGGGCGACCACCAGCGGTTCAGCACCCGGCGCCGCTGGGACCCGCGGGACGAGATCGGCGGGACGGGCACCTTCCGGCCGCGTGAACTGGTCGGCAACCTGATGGACTACGACCCGCCCGAGCACACGCGGCTGCGCCAGAAGCTGACCCCCGGGTTCACGCTGCGCAAGATGCAGCGGCTGCAGCCGTACATCGAACAGATCGTCAACGAGCGACTCGACGAGATGGCGCGGGCGGGATCGCCCGCGGATCTGGTCGCGTTCGTCGCCGACAAGGTGCCCGGCGCCGTGCTGTGCGAGCTGATCGGCGTGCCGAGGGACGACCGGGCCACGTTCATGCAGCTGTGCCACGCGCATCTCGACGCCTCGCGAAGCCAGAAACGGCGGGCGGCGGCGGGAGAGGCGTTCTCCCGCTACCTGCTGGCGATGATCGCCAGGGAACGCAAGGACCCGGGCGAGGGGCTCATCGGAGCGGTCGTCGCCGAATACGGCGACGAAGCCACGGACGAGGAGCTGCGCGGCTTCTGCGTGCAGGTGATGCTGGCTGGCGACGACAACATCTCCGGCATGATCGGGCTCGGCGTGCTGGCGCTGCTGCGGCACCCCGAGCAGATCGACGCGTTGCGCGGCGGCGAACAGCCGGCGCAACGAGCCGTCGACGAGCTGATCCGGTACCTGACCGTGCCCTACGGCCCGACACCCCGCATCGCGAAGCAGGACGTCACCGTCGGGGACCAGGTGATCAAGGCGGGCGAGAGCGTCATCTGCTCGCTCCCGGCGGCCAACCGCGACCCCGCCCTCGTGCCGGACGCGGACCGGCTCGATGTCACGCGCGACCCCGTCCCGCACGTCGCGTTCGGGCACGGGATCCACCACTGCCTGGGAGCCGCACTGGCCCGCCTCGAACTGCGCACGGTCTTCACCGCGCTGTGGCGGCGGTTTCCCGACCTGCGGCTCGCGGATCCCGCCCAGGAGACCAAGTTCCGCCTCACCACCCCCGCTTACGGGCTGACCGAGCTGATGGTCGCCTGGTGA	MNDDDPRPLHIRRQGLDPADELLAAGSLTRVTIGSGADAETHWMATAHALVRQVMGDHQRFSTRRRWDPRDEIGGTGTFRPRELVGNLMDYDPPEHTRLRQKLTPGFTLRKMQRLQPYIEQIVNERLDEMARAGSPADLVAFVADKVPGAVLCELIGVPRDDRATFMQLCHAHLDASRSQKRRAAAGEAFSRYLLAMIARERKDPGEGLIGAVVAEYGDEATDEELRGFCVQVMLAGDDNISGMIGLGVLALLRHPEQIDALRGGEQPAQRAVDELIRYLTVPYGPTPRIAKQDVTVGDQVIKAGESVICSLPAANRDPALVPDADRLDVTRDPVPHVAFGHGIHHCLGAALARLELRTVFTALWRRFPDLRLADPAQETKFRLTTPAYGLTELMVAW	MQKPVLIASAALICAAVIGIAVYATGSAKKDAGGFAGYPPVKVALASVERRVVPRVFDGVGELEAGRQVQVAAEAAGRITRIAFESGQQVQQGQLLVQLNDAVEQAELIRLKAQLRNAEILHARARKLVERNVASQEQLDNAVAARDMALGAVRQTQALIDQKAIRAPFSGQLGIRRVHLGQYLGVAEPVASLVDARTLKSNFSLDESTSPELKLGQPLEVLVDAYPGRSFPARISAIDPLIGKSRTVQVQALLDNPEGLLAAGMFASIRVSRKADAPSLSVPETAVTYTAYGDTVFVAHQDGDRPLSAKRVSVRIGERWDGRVEILQGLAEGDRVVTSGQINLSDGMAVEPVKEDTLSSAAPPVPVAGR	107.57	gnl|BL_ORD_ID|1350|hsp_num:0	1344			759	978	acriflavine; tetracycline; norfloxacin
BGC0000311.1|Balhimycin_14 # 38634 # 40109 # 1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.675	BGC0000311.1|Balhimycin_14 	38634	40109	+	Loose	600	54.299	Streptomyces venezuelae rox	27.33	3007209	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	ATGTCGGTCGAAGACTTCGACGTGGTGGTGGCGGGCGGCGGGCCGGGTGGTTCGACGGTGGCCACGCTGGTGGCCATGCAGGGACACCGGGTGCTGCTGCTGGAGAAAGAGGTTTTCCCGCGGTATCAGATCGGTGAGTCGCTGCTGCCCGCCACGGTGCACGGCGTGTGCCGGATGCTCGGCATCTCCGACGAGCTGGCCAATGCCGGGTTCCCGATCAAGCGCGGCGGCACGTTCCGCTGGGGCGCCCGGCCGGAGCCGTGGACGTTCCACTTCGGCATCTCGGCCAAGATGGCCGGCTCGACGTCGCACGCCTACCAGGTCGAGCGGGCGCGGTTCGACGAGATGCTGCTGAACAACGCCAAGCGCAAGGGCGTGGTCGTGCGGGAGGGGTGCGCGGTCACCGATGTGGTGGAAGACGGCGAGCGGGTCACCGGTGCGCGGTACACCGATCCCGACGGCACCGAGCGGGAAGTGTCGGCGCGGTTCGTGATCGACGCGTCGGGCAACAAGAGCCGGCTCTACACCAAGGTCGGCGGTTCGCGGAACTATTCGGAGTTCTTCCGCAGCCTCGCGCTGTTCGGTTACTTCGAGGGTGGCAAGCGGCTGCCCGAGCCGGTCTCCGGGAACATCCTGAGTGTGGCCTTCGACAGCGGCTGGTTCTGGTACATCCCGCTGAGCGACACGCTGACCAGCGTCGGCGCGGTGGTGCGCCGGGAGGACGCCGAGAAGATCCAGGGTGACCGGGAGAAGGCCCTCAACACGCTGATCGCCGAGTGCCCGCTGATCTCGGAATACCTCGCGGACGCGACCCGGGTGACGACCGGCCGGTACGGGGAACTGCGCGTCCGCAAGGACTACTCCTACCAGCAGGAGACCTACTGGCGGCCGGGCATGATCCTGGTCGGCGACGCCGCGTGTTTCGTGGACCCGGTGTTCTCCTCCGGTGTGCACCTGGCGACCTACAGCGCGCTGCTCGCGGCCCGGTCGATCAACAGCGTCCTCGCCGGCGACCTGGACGAGAAGACCGCGCTGAACGAGTTCGAGCTGCGGTATCGCCGTGAGTACGGCGTGTTCTACGAGTTCCTCGTGTCCTTCTACCAGATGAACGTGAACGAGGAGTCGTACTTCTGGCAGGCCAAGAAGGTCACGCAGAACCAGAGCACCGACGTCGAGTCGTTCGTCGAGCTGATCGGCGGAGTGTCGTCCGGGGAGACCGCGCTGACGGCCGCCGACCGCATCGCCGCGCGCAGTGCCGAGTTCGCCGCGGCGGTGGACGAGATGGCGGGCGGGGACGGCGACAACATGGTGCCGATGTTCAAGTCGACGGTGGTCCAGCAGGCGATGCAGGAAGCGGGCCAGGTGCAGATGAAGGCGCTGCTCGGCGAGGACGCCGAACCCGAGCTGCCCCTGTTCCCCGGTGGCCTGGTGACCTCGCCCGAACGGATGAAGTGGCTGCCTCACCACCCTGCGTGA	MSVEDFDVVVAGGGPGGSTVATLVAMQGHRVLLLEKEVFPRYQIGESLLPATVHGVCRMLGISDELANAGFPIKRGGTFRWGARPEPWTFHFGISAKMAGSTSHAYQVERARFDEMLLNNAKRKGVVVREGCAVTDVVEDGERVTGARYTDPDGTEREVSARFVIDASGNKSRLYTKVGGSRNYSEFFRSLALFGYFEGGKRLPEPVSGNILSVAFDSGWFWYIPLSDTLTSVGAVVRREDAEKIQGDREKALNTLIAECPLISEYLADATRVTTGRYGELRVRKDYSYQQETYWRPGMILVGDAACFVDPVFSSGVHLATYSALLAARSINSVLAGDLDEKTALNEFELRYRREYGVFYEFLVSFYQMNVNEESYFWQAKKVTQNQSTDVESFVELIGGVSSGETALTAADRIAARSAEFAAAVDEMAGGDGDNMVPMFKSTVVQQAMQEAGQVQMKALLGEDAEPELPLFPGGLVTSPERMKWLPHHPA	MFDVIVVGGGPTGLMLAGELRLHGVRVLVLEKETEPTRQSRAQGLHVRSIEVMAQRGLLERFLERGHTVAVGGFFAGLATSWPERLDTAHSYVLAVPQVITEQLLAEHATALGAEIRRGRALVGLRQDEDGVTVDLADGEQLRARYVVGCDGGRSTVRKLLGVAFPGEPSRVETLLGEMEMTASQEELTSVMTEVRKTQQRFGAMPLGDGVFRVVVPAEGVAEDRTASPTLDEFKQQLRAHAGTDFGVHSPRWLSRFGDATRQAERYRVDRVFLAGDAAHIHPPTGGQGLNLGIQDAFNLGWKLAAEVDGWAPEGLLDTYHAERHPVATEVLDNTRAQIQLMSTEPGPQAVRRLMAELVEFENVNRYLIEKITAISVRYDVGEGHELLGRRMRDLALKHGRLYERMHEGRGLLLDQTGRLSVAGWEDRVDHVVEVSEELDVPAVLLRPDGHVVWAGEDQQELLTRMPAWFGAATAG	103.15	gnl|BL_ORD_ID|4833|hsp_num:0	5820			3	894	rifampin; rifaximin; rifapentine
BGC0000311.1|Balhimycin_15 # 40192 # 41382 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=14bp;gc_cont=0.730	BGC0000311.1|Balhimycin_15 	40192	41382	+	Loose	600	318.161	rgt1438	49.76	3002883	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin glycosyltransferase	ATGCGCGTGTTGATCTCGGGGTGCGGATCGCGCGGGGACACCGAACCGCTGATCGCCTTGGCGGTCCGGTTGCGGGAACTCGGTGTAGACGTCCGGATGTGCCTGCCGCCGGACTACGTGGAGCGGTGCGCCGAGGTCGGGGTGTCGATGGTGGCGGTCGGCCCGGCGATGCGCGCCGGGGCACGCGGGCCGGGAGAACCGCCGCCGGGAGCACCCGAAATCGTGTCCGAGGTGGTCGCGGACTGGTTCGACAAGGTGCCGGCGGCCGCCGAAGGGTGTGACGTGGTGGTGGCGACCGGCTTGCTGCCCGCCGCGGTCGTCGTGCGGTCGGTCGCCGAGAAGCTGGGCATCCCTTACCTCTACACCGTGCTGTCGCCGGACCACCTGCCGTCGGTGCTCAGCCAGGCGGAGCGCGACGAATACGACCAGGGCGCCGACCGGCTGTTCGGTGCGGTGGTCACCAGCGGGCGGGCCGCGATCGGCCTGCCGCCGGTGGCGAACCTCTTCACCTACGGCTACACCGAACAGCCCTGGCTGGGGGCGGACCAGATCCTCGCCCCGCCGCCACCGGGAGACTTGGACACCGTGCAGACCGGTGCGTGGATCCTGCCCGACGAACGGCCCCTTCCCGCGGAGCTGGAGACGTTCCTCGCGGCCGGGTCGCCGCCCGTGTACGTGGGTTTCGGCAGCTCGTCCGGACCCCGGACCGCCGGCGCCGCCAAGGCGGCCATCGAGGCGATCCGCGCCCGGGGCCACCGGGTCGTCCTCTCCCGCGGCTGGGCCGACCTGGCCGCGCCCGACGACTCGGCCGACTGCTTCACCGTCGGCGAAGTGAACCTCCAGGTGCTGTTCCGCCGGGTGGCCGCCGCCGTCCACCACGACAGCGCGGGCACGACACTCCTGGCCATCCGGGCAGGCACCCCCCAGATCGTCGTCCGCCGCGTGATAGACAACGTGGTGGAGCAGGCGTACCACGCCGACCGGGTGGCCGAACTGGGGGTCGGTGTGGCACTCGAAGGTCCGATCCCGGCCTCCGAGGCCATGTCGGACGCGCTCGAGACGGCGCTGGCACCGGAAACCCGCGCGCGAGCGGCGGAGGTGGCGGGCACGGTCCGCACCGACGGGACGACGGTGGCCGCGGAACTGCTGTTCGCCGCGGTCAGCCGGGAAAAGCCCGCCGTTCCCGCATGA	MRVLISGCGSRGDTEPLIALAVRLRELGVDVRMCLPPDYVERCAEVGVSMVAVGPAMRAGARGPGEPPPGAPEIVSEVVADWFDKVPAAAEGCDVVVATGLLPAAVVVRSVAEKLGIPYLYTVLSPDHLPSVLSQAERDEYDQGADRLFGAVVTSGRAAIGLPPVANLFTYGYTEQPWLGADQILAPPPPGDLDTVQTGAWILPDERPLPAELETFLAAGSPPVYVGFGSSSGPRTAGAAKAAIEAIRARGHRVVLSRGWADLAAPDDSADCFTVGEVNLQVLFRRVAAAVHHDSAGTTLLAIRAGTPQIVVRRVIDNVVEQAYHADRVAELGVGVALEGPIPASEAMSDALETALAPETRARAAEVAGTVRTDGTTVAAELLFAAVSREKPAVPA	MRMLLTTYGSRGDVEPLAGLAAGLRKLGVEARVCAPPDEEFAALPARAGVPLIPLGPPVRPVVAGERPPTPQDAFRLAAELVTARFDTLTEAAEGCQAVLATGLMPAGVRDVAEKLGIPYVFACFHIYGLPSRHFPPGARPGTPPAPDGTDHRELWEQDARSVNALYGDALNRHRTGIGLPPVRNVRDHVLTDRPWLAADPVLCPAEGMTEFDLVQTGPWFLPDERPLPAGLEEFLGAGAPPVYVGFGSMGAYAPEGIARVAVEACRAQGRRVVLARGWAGLTPDDGGADCFAVGEVNQQALFRRVAAVVHHGGAGTTTTAARAGAPQVVVPRIADQPYWAERVRDLGIGSAHPDPVVTFDSLSAALTTALAPEVRARARTVAGTIRTDGASVAARLLVETADRAGRPVSP	96.35	gnl|BL_ORD_ID|116|hsp_num:0	134			0	1212	rifampin; rifaximin; rifabutin; rifapentine
BGC0000311.1|Balhimycin_16 # 41447 # 42676 # 1 # ID=1_16;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=5bp;gc_cont=0.729	BGC0000311.1|Balhimycin_16 	41447	42676	+	Loose	600	388.267	rgt1438	57.53	3002883	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin glycosyltransferase	GTGAAGCGTGTGCTGTTGTCGACGCTCGGAAGCCGCGGAGACGTCGAACCACTGGTGGCCTTGGCGGTCCGGCTGCGCGACCTCGGCGCGGAGCCGCTGATGTGCGCACCGCCGGACTGCGCGGACCGGCTGGAAGAGGTCGGCGTGCCGCACGTGCCCGTCGGCCCGTCGGCGCGCGCGCCGATCCATCGGGAGAAGCCGTTGACGCCCGAGGACATGCGCCGGCTCATGGCCGAAGCGATCGCCATGCCGTTCGACCGGATACCGGCGGCCGCCGAGGGGTGTGCCGCAGTGGTGACGACCGGGCTGCTGGCCGCCGCGATCGGCGTGCGGTCGGTGGCCGAGAAGCTGGGCATCCCCTACTTCTACGCCTTCCACTGCCCGAGCTACGTGCCGTCACCGTACTATCCGCCGCCACCGCCCCTCGGCGAGCCGCCCGCCGAGGACGTGACCGACATCCGGGCGCTGTGGGAGCGGAACAACCGGAGCGCTTACCAGCGGTACGGGGGTCCGCTCAACAGCCACCGGGCCGCGATCGGCCTGCCTCCGGTGGAGGACATCTTCACCTTCGGCTACACCGATCACCCGTGGGTGGCGGCGGATTCGGTCCTGGCCCCGATGCAGCCGACCGACCTCGGTGCCGTGCAGACCGGCGCGTGGATCCTGCCCGACGAACGGCCGCTTTCCCCGGAGCTGGAAGCTTTCCTGGACACCGGCACCCCGCCGGTGTACCTCGGGTTCGGCAGCCTGCGCGCCCCGGCCGACGCCGTCCGGGTGTCCATCGACGCGATCCGGGCCCAAGGCCGCCGGGTAATCCTTTCCCGGGGCTGGGCCGACCTGGTCCTGCCCGACGACCGGGAAGACTGCTTCGCCACCGGCGAGGTGAACCAGCAGGTGCTGTTCGGCCGGGTGGCCGCCGTCATCCACCACGGCGGCGCGGGCACGACGCACGTGGCCATGCAGGCCGGGGCACCCCAGGTCCTGGTGCCCCAGATGGCGGACCAGCCGTACTACGCCGGCCGGGTGGCCGAGCTGGGGATCGGGGTGGCCCACGACGGTCCGGTCCCGACCTTCGACTCGCTGTCGGCCGCGCTCGTCACGGCGCTGGCCCCGGAAACCCGCGCACGAGCGGAGGCCGTGGCGCGCACGGCCGGTGCCGACGGGGCGGCGGTGGCCGCGAAACTGCTGCTCGACGCGGTCAGCCGGGAAAAGCCGGCTGTTCCCGCGTAA	MKRVLLSTLGSRGDVEPLVALAVRLRDLGAEPLMCAPPDCADRLEEVGVPHVPVGPSARAPIHREKPLTPEDMRRLMAEAIAMPFDRIPAAAEGCAAVVTTGLLAAAIGVRSVAEKLGIPYFYAFHCPSYVPSPYYPPPPPLGEPPAEDVTDIRALWERNNRSAYQRYGGPLNSHRAAIGLPPVEDIFTFGYTDHPWVAADSVLAPMQPTDLGAVQTGAWILPDERPLSPELEAFLDTGTPPVYLGFGSLRAPADAVRVSIDAIRAQGRRVILSRGWADLVLPDDREDCFATGEVNQQVLFGRVAAVIHHGGAGTTHVAMQAGAPQVLVPQMADQPYYAGRVAELGIGVAHDGPVPTFDSLSAALVTALAPETRARAEAVARTAGADGAAVAAKLLLDAVSREKPAVPA	MRMLLTTYGSRGDVEPLAGLAAGLRKLGVEARVCAPPDEEFAALPARAGVPLIPLGPPVRPVVAGERPPTPQDAFRLAAELVTARFDTLTEAAEGCQAVLATGLMPAGVRDVAEKLGIPYVFACFHIYGLPSRHFPPGARPGTPPAPDGTDHRELWEQDARSVNALYGDALNRHRTGIGLPPVRNVRDHVLTDRPWLAADPVLCPAEGMTEFDLVQTGPWFLPDERPLPAGLEEFLGAGAPPVYVGFGSMGAYAPEGIARVAVEACRAQGRRVVLARGWAGLTPDDGGADCFAVGEVNQQALFRRVAAVVHHGGAGTTTTAARAGAPQVVVPRIADQPYWAERVRDLGIGSAHPDPVVTFDSLSAALTTALAPEVRARARTVAGTIRTDGASVAARLLVETADRAGRPVSP	99.51	gnl|BL_ORD_ID|116|hsp_num:0	134			3	1212	rifampin; rifaximin; rifabutin; rifapentine
BGC0000311.1|Balhimycin_17 # 42758 # 44053 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=5bp;gc_cont=0.716	BGC0000311.1|Balhimycin_17 	42758	44053	+	Loose	600	332.413	rgt1438	50.74	3002883	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin glycosyltransferase	ATGCGCTCGGATAGCATTCCGCCTCATTATCGCAGGGGGACAGAACCGATCAAATTGGGGTGCGGGATGCGTGTGTTGCTGTCGACGGCGGGAAGCCGTGGAGACGTCGAACCGTTGCTGGCCTTGGCGGTCCGGTTGCAGGGACTCGGCGCGGAGGTGCTGATGTGCGCGTCGCCTGCTTCCGCGGAGCGGCTGGCCGAGGTCGGGGTGCCGCACGTGCCGGTCGGCCTGCAGCTGGACGGCATGTTGTTGCAGGAAGGAATGCCGCCGCCGTCGGCCGAGGACGAGCGCAGACTCGCGGCCATGGCGATCGACATGCAGTTCGACGCGGTCCCCGCGGCCGCCGAAGGGTGTGCCGCGGTCGTGGCGACCGGAGAGCTGGCCGCCGCGGCCGCCGTGCGGTCGGTGGCCGAGAAGCTGGGCATCCCGTACTTCTACGGCGCATACAGCCCGAACTACCTGGCGTCGCCGCACTATCCGCCGCCCGACGACGAGCGGACCACCCCGGGCGTGACCGACAACGGGGTGCTGTGGGCCGAGCGTGCCGAGCGTTTCGCCAAGCGGTACGGGGAAACGCTCAACAGCAGACGGGCGGCGATCGGCCTGCCCCCGGTGGCGGACGTCTTCGGCTACGGCTACACCGAGCAGCCCTGGCTGGCGGCGGACCCGGTCCTGGCCCCGCTGGATCCGGATCTCGACGCGGTGCAGACCGGCGCGTGGATCCTGCGTGACGATCGGCCGCTTTCCCCTGAGCTGGCGGCGTTTCTCGCTGCCGGGTCACCGCCGGTGTACGTGGGTTTCGGCAGCGCGTCCGGGCCGGGAATCGAGGACGCCGCGAAGGTGGCCATCGAGGCGATCCGGGCCCTCGGCCGCCGGGCGATCCTTTCCCGCGGCTGGGCCGATCTGGTCCTGCCCGACGACCGGGAGGACTGCTTCGCCGTCGACGAGGCGAATCTCCAGGTGCTGTTCGAGCAGTCGGCCGCCGTCGTCCACCACGGCAGCGCGGGCACCGAGCACCTGGCCACGCGGGCCGGCGTCCCCCAGATCGCGATACCCCGGCACACGGATCAGGCGTACTACGCCGGCCGGGTGGCCGAGCTGGGGGTCGGTGTGGCACTCGAAGGTCCGGTCCCGTCCTTCGCGGCGATGTCGGCGGAGCTCGCGACGGCCCTGGCCCCGGAAACCCGTGCGCGAGCGGCGGAGGTGGCGGGCACGGTCCGCACCGACGGGACGACGATGGCCGCGGAGCTGCTCTTCCAGGCGGCCGAACAGGGCAAACTGACCGTTCCCGCGTGA	MRSDSIPPHYRRGTEPIKLGCGMRVLLSTAGSRGDVEPLLALAVRLQGLGAEVLMCASPASAERLAEVGVPHVPVGLQLDGMLLQEGMPPPSAEDERRLAAMAIDMQFDAVPAAAEGCAAVVATGELAAAAAVRSVAEKLGIPYFYGAYSPNYLASPHYPPPDDERTTPGVTDNGVLWAERAERFAKRYGETLNSRRAAIGLPPVADVFGYGYTEQPWLAADPVLAPLDPDLDAVQTGAWILRDDRPLSPELAAFLAAGSPPVYVGFGSASGPGIEDAAKVAIEAIRALGRRAILSRGWADLVLPDDREDCFAVDEANLQVLFEQSAAVVHHGSAGTEHLATRAGVPQIAIPRHTDQAYYAGRVAELGVGVALEGPVPSFAAMSAELATALAPETRARAAEVAGTVRTDGTTMAAELLFQAAEQGKLTVPA	MRMLLTTYGSRGDVEPLAGLAAGLRKLGVEARVCAPPDEEFAALPARAGVPLIPLGPPVRPVVAGERPPTPQDAFRLAAELVTARFDTLTEAAEGCQAVLATGLMPAGVRDVAEKLGIPYVFACFHIYGLPSRHFPPGARPGTPPAPDGTDHRELWEQDARSVNALYGDALNRHRTGIGLPPVRNVRDHVLTDRPWLAADPVLCPAEGMTEFDLVQTGPWFLPDERPLPAGLEEFLGAGAPPVYVGFGSMGAYAPEGIARVAVEACRAQGRRVVLARGWAGLTPDDGGADCFAVGEVNQQALFRRVAAVVHHGGAGTTTTAARAGAPQVVVPRIADQPYWAERVRDLGIGSAHPDPVVTFDSLSAALTTALAPEVRARARTVAGTIRTDGASVAARLLVETADRAGRPVSP	104.87	gnl|BL_ORD_ID|116|hsp_num:0	134			0	1212	rifampin; rifaximin; rifabutin; rifapentine
BGC0000311.1|Balhimycin_18 # 44087 # 45313 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.659	BGC0000311.1|Balhimycin_18 	44087	45313	+	Loose	450	30.4166	mreA	26.8	3007050	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTCGACCACGTCCCAGTGCCGTATCTGTGACGGCACTGTCCACGAGTTCATCGACTTCGGACGCCAGCCGCTCTCGGACGCGTTCGTGGCTCCCGGCGCGGAAAAGGGTGAGTTCTTCTTCCGCCTTGCCACCGGCATCTGCGATTCCTGCACGATGGTGCAGCTGATGGAGGAAGTCCCGCGGGACCTGATGTTCCACGAGGCCTACCCCTACCTGTCGTCGGGTTCGGCCGTCATGCGCACGCACTTCCACGAGCTGGCCAAGCACCTGCTGGCCACGGAGCTGACCGGCGAGGACCCGTTCATCGTCGAGCTCGGCTGCAACGACGGCATCATGCTCAAGGCCGTGGCCGACGCGGGGGTGCGCCAGCTCGGCGTCGAACCCTCCGGCAGTGTCGCGGATCTGGCGGCAGCCAAGGGGATCCGCGTCCGCAAGGACTTCTTCGAAGAGGCGACGGCCGCCGACATCCGCGAGAACGACGGCCCCGCGGACGTGATCTACGCGGCCAACACACTGTGCCACATCCCTTACATGGACTCGATCCTGAAGGGCGTCACCAAGCTGCTCGGCCCGAACGGCGTGTTCGTCTTCGAGGACCCGTACCTCGGCGACATCGTGGAGCGCACGTCGTTCGACCAGATCTACGACGAGCATTTCTTCCTCTTCACGGCGCGCTCGGTCCAGGAGATGGCCCGGCGCAACGGCCTCGAGCTCGTGGACGTCGAGCGCATTCCGGTGCACGGCGGCGAGGTCCGCTACACCCTGGCCCTGGCCGGCGCTCGCAAGCCGTCCGAGGCCGTGGCGGAGCTCCTGGCCTGGGAGGCGGAGCGCAAGCTGGCGGAGTACGCCACGCTGGAACGTTTCGCCACCGACGTGAAGAAGATCAAGGAAGACCTGATCGCGCTGCTGACCAAGCTCCGTGCCGAAGGCAAGCGCGTCGTCGGCTACGGCGCGACGGCCAAGAGTGCCACGGTGACCAACTTCTGCGGCATCACCCCGGACCTGGTCGAGTTCATCTCGGACACGACACCGGCCAAGCAGGGCAAGCTCAGCCCGGGACAGCACATCCCGGTCCGCGAGTACGGGGAATTCGCCGGCAACCACCCGGACTACGCCCTGCTGTTCGCCTGGAACCACGCCGACGAGATCATGAACGTGGAACAGGCCTTTCGTGACGCCGGCGGTCAGTGGATCCTTTACGTGCCGAACGTGCACGTGAGCTGA	MSTTSQCRICDGTVHEFIDFGRQPLSDAFVAPGAEKGEFFFRLATGICDSCTMVQLMEEVPRDLMFHEAYPYLSSGSAVMRTHFHELAKHLLATELTGEDPFIVELGCNDGIMLKAVADAGVRQLGVEPSGSVADLAAAKGIRVRKDFFEEATAADIRENDGPADVIYAANTLCHIPYMDSILKGVTKLLGPNGVFVFEDPYLGDIVERTSFDQIYDEHFFLFTARSVQEMARRNGLELVDVERIPVHGGEVRYTLALAGARKPSEAVAELLAWEAERKLAEYATLERFATDVKKIKEDLIALLTKLRAEGKRVVGYGATAKSATVTNFCGITPDLVEFISDTTPAKQGKLSPGQHIPVREYGEFAGNHPDYALLFAWNHADEIMNVEQAFRDAGGQWILYVPNVHVS	MMKIHYINDYKDIQAKEDCVLVLGYFDGLHLGHKALFDKAKKIATEKNLKIVVLTFNETPRLTFARFQPELLLHLTSPEKRSEKFQEYGVDELYLMNFTSHFSKVSSDLFIKKYIYGLRAKAAVVGFDYKFGHNRTSGDYLARNFKGPVYIIDEISEGGEKISSTRIRQLITEGNVEKANQLLGYEFSTCGMVVHGDARGRTIGFPTANLAPINRTYLPADGVYISNVLINGKYYRAMTSIGKNITFGGTELRLEANIFDFDGDIYGETIEIFWLKRIREMVKFNGIDDLVKQLKKDKEIALNWKKDSQTL	131.19	gnl|BL_ORD_ID|4755|hsp_num:0	5749			612	864	
BGC0000311.1|Balhimycin_19 # 45409 # 46233 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.680	BGC0000311.1|Balhimycin_19 	45409	46233	+	Loose	500	28.1054	ErmH	44.44	3002823	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGCCTCAAGACCTCGACGCGGACCGGATTCTGGCGATATCCCCGCATTTGGACGACGCGGTTCTTTCCTTCGGTGCCGGCCTCGCCCGTGCGGCGCAGGCCGGCGCGAAGGTGACCGTTCACACGGTGTTCGCCGGGACCGCGGCGCCCCCTTATTCGCCGGCGGCGGAGCGGCTGCACGCGATCTGGGAGCTCTCACCGGATCAAGACGCGTCGCTCCGCCGCCGGGACGAAGACATCGCCGCGCTCGACCACCTGGGCGTCGACTACCGGCACGGCCGGTTCCTCGACGCCATCTACCGCAAGCTGCCGGACGGCCGATGGCTGGCCGACAACGTGCCGGGCCGCCAGAAGCTGGCCATCGGACGGCAATCGCCGCAGGGCGATCCGGAGCTGTTCTCCGCGGTCCGGGCGGACATCGAGTCGATCGTCGAAGAGTACGCCCCGGCGCTGATCCTGACCTGCGCGGCAGGCAACGGTCATGTCGACAACGAGATCGCGCGGGATGCCGCGCTGTTCGTCGCGTACGAGAAGGGCATCCGGGTTCGGCTGTGGGAAGACCTTCCGCACGCGATGTTCGCGGAGGGCGCCGCCGAACTGCCGGACGGATTCCGGCTGGGGCCGCCCGATTTCGGTTCCGTCGAACCGGAGGCACGGGCGCGGAAATTCGAAGCGCTGCGGCTCTACTCGTCGCAGATGCTGATGCTGCACGGGCCGGAAAAGGATTTCTTCGCTCAGCTGGACGGGCATGCCCGGAAGAGTGCACCGGGTGGTGGATACGGCGAAACGACCTGGCCGGTTGTCTCTCGCGAAGACAACGGCTGA	MPQDLDADRILAISPHLDDAVLSFGAGLARAAQAGAKVTVHTVFAGTAAPPYSPAAERLHAIWELSPDQDASLRRRDEDIAALDHLGVDYRHGRFLDAIYRKLPDGRWLADNVPGRQKLAIGRQSPQGDPELFSAVRADIESIVEEYAPALILTCAAGNGHVDNEIARDAALFVAYEKGIRVRLWEDLPHAMFAEGAAELPDGFRLGPPDFGSVEPEARARKFEALRLYSSQMLMLHGPEKDFFAQLDGHARKSAPGGGYGETTWPVVSREDNG	MAALLKRILRRRMAEKRSGRGRMAAARTTGAQSRKTAQRSGRSEADRRRRVHGQNFLVDRETVQRFVRFADPDPGEVVLEVGAGNGAITRELARLCRRVVAYEIDRHFADRLREATAEDPRIEVVAGDFLKTSQPKVPFSVVGNIPFGNTADIVDWCLNARRLRTTTLVTQLEYARKRTGGYRRWSRLTVATWPEVEWRMGERISRRWFRPVPAVDSAVLRLERRPVPLIPPGLMHDFRDLVETGFTGKGGSLDASLRRRFPARRVAAGFRRARLEQGVVVAYVTPGQWITLFEELHGR	91.64	gnl|BL_ORD_ID|1100|hsp_num:0	1193			228	309	erythromycin; lincomycin; pristinamycin IC; oleandomycin; carbomycin
BGC0000311.1|Balhimycin_20 # 46265 # 47119 # 1 # ID=1_20;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.698	BGC0000311.1|Balhimycin_20 	46265	47119	+	Loose	400	36.965	Erm(36)	39.39	3000605	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	GTGAGCGGTCAACTCGAGCGTGGTCCGGTGCGGACCACGCACGCCGACGTCCTGCTGGCCTCGGTGGGTGAGCGAGGCGTTCTGTGCGACTTCTACGACGAGGAGGGCTCGAACACCTATCGGGACCTGATCCAGGACGCGGACGGTACCCCGGAAGCGCGGGAGTTCGCCACTCGCGTCGGCCCGGTGCCCGGACCCGTGCTGGAGCTCGCGGCCGGCACGGGCCGGCTGACCTTCCCGTTCCTGGAGCTCGGCTGGGAGGTGACCGCCCTGGAACTGTCGGCCCCGGTGGTCGACGGCTTCCGGATGCGGCTGGCGGAAGCACCGGCGGACCTGCGGGACCGCTGCACAGTGGTTCAGGCGGACATGAGCGCTTTCTCGGTGGACCGGCGCTTCGGGGCAGCGGTCATCAGCTCGGGTTCGGTCAACGAACTGGACGAAGCCGGCCGGCAGGGCCTGTACGCGTCGGTTCGCGAGCACCTCGAGCCCGGCGGGAAGTTCCTGCTCAGCCTGGCCTTGTCGGAGGTCGCCGAGTCACAGCCGCCGGAGCGCCGGCAAGAGTTGCCAGGCCAGAGCGGCCGGCTGTACGTGTTGCACGTGAGTGTGCAGCCGGCGGAGGAGACCCAGGACATCACGATCTACCCCGCCGACGAAACAGCGGATCCCTTCGTCGTCTGCACGCATCGCCGCCGGCTCGTCCCGGCGGACCGGATAGTGCGGGAACTTCTTCGGGCCGGCTTCGACGTGATCGCGCGGACGCCGTTCGCGTCCGGTGCGTCCGGCCGGGCGGGCCATGAAGACATGTTGCTGGTGGAAGCGGTGAAGCAGGAGGGCGCTATCCCAGCCGCGCGGTGA	MSGQLERGPVRTTHADVLLASVGERGVLCDFYDEEGSNTYRDLIQDADGTPEAREFATRVGPVPGPVLELAAGTGRLTFPFLELGWEVTALELSAPVVDGFRMRLAEAPADLRDRCTVVQADMSAFSVDRRFGAAVISSGSVNELDEAGRQGLYASVREHLEPGGKFLLSLALSEVAESQPPERRQELPGQSGRLYVLHVSVQPAEETQDITIYPADETADPFVVCTHRRRLVPADRIVRELLRAGFDVIARTPFASGASGRAGHEDMLLVEAVKQEGAIPAAR	MPTYRGGRHEHGQNFLTDHTTIDRLSRLVGDSTGPIVEIGPGQGRLTRELQKLGRSLTAVEIDSRLADRLASASQFREQKHVTVVNADFLHWPLPTTPYVVVGNVPFHLTTAILRRLLHDGAWTQVVLLVQWEVARRRAGIGGSSMMTAQWWPWIDFSLHGRVPRSAFKPAPSVDGGLLEMTRRPDPLLSPDARESYRQFVHDVFTSRGRGIGEILANVSSSLGKRGALQLLKSEGIRSSSLPKDLSAEQWARLFTSASPTKSAKTGRNAHPAHSARRQGR	101.07	gnl|BL_ORD_ID|818|hsp_num:0	888			84	267	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0000311.1|Balhimycin_21 # 47100 # 48404 # -1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.676	BGC0000311.1|Balhimycin_21 	47100	48404	-	Loose	1050	27.335	lmrC	37.29	3002881	protein homolog model	n/a	n/a	lincosamide antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	ATGGAAATCCTAGTATTTATGGATTCCTTCGGTCTGTCCACCCCATTGAGCGTGGAAACCCTGCACGGATCGCTCACCGATCCGGCCATCTCGTCGATGAACTTGCTCAACGAGCTGATCGACGAATACCCGGTGGCTATTTCCATGGCGGCAGGCCGCCCGTACGAAGAATTCTTCGACATCCGCCTCATCCACGAGTACATCGACGCCTACTGCGACCACCTCCGCCGCGACCGGAAGCTCGACGAAGCGGGGGTCACCCGCACGCTCTTCCAGTACGGCACCACGAAAGGCGTCATCGCCGACCTCATCGCCCGCAACCTCGCCGAGGACGAGAACATCGACGCCGCCCCGGAATCCGTGGTGGTCACCGTGGGCGCCCAGGAGGCGATGTTCCTGGTGCTTCGCACGCTGCGGGCGACCGAACACGACGTGCTGCTCGCCCCCGCCCCCACCTACGTCGGCCTGACGGGGGCGGCGCTGCTCACCGACACGCCCGTCTGGCCGGTGCAGTCGACCGAGAACGGCATCGACCCGGACGACCTGGTCCTGCAGCTGAAGCGGGCCGACGAACAGGGCAAGCGGGTCCGGGCCTGTTACGTGACACCGAACTTCGCCAACCCGACCGGGACCAGCATGGACCTGGCCGCCCGGCACCGGCTCCTCGAGGTCGCCGAGGCCAACGGCATCCTGCTCCTGGAGGACAACGCGTACGGGCTCTTCGGCGCCGAACGCCTCCCCACCCTGAAAGCCCTCGACCGGTCGGGGACCGTGGTCTACATCGGCTCCTTCGCCAAGACCGGCATGCCCGGTGCCCGGGTCGGCTTCACCGTGGCGGACCAGCGAATGGCCGGGGGCGGCCTGCTCGCCGACCAGCTCTCCAAGCTCAAGGGCATGCTCACGGTGAACACGTCCCCGATAGCCCAGTCGGTGATCGCCGGGAAGCTGCTCCTCAACGACTTCAGCCTGACCAAGGCCAACGCGCGCGAGATCGCGGTCTACCAGCGCAACCTGCGGCTCGTGCTGGGCGAGCTCGAGCGACGGCTCGGCGGGCGCGCCGGGGTCCGCTGGAACACGCCGACCGGTGGGTTCTTCGTCACCGTCACCGTCCCCTTCACCGTCGACGACGACCTGCTCGCCCTCGCCGCCCGCGACCACGGCGTGCTGTTCACCCCGATGCACCACTTCTACGGCGGCAAGGGCGGGTTCAACCAGCTGCGGCTGTCGATCAGCCTGCTCACCCCGGAACTGATCGAAGAGGGCGTCGCCCGGCTCGCCGCGCTCATCACCGCGCGGCTGGGATAG	MEILVFMDSFGLSTPLSVETLHGSLTDPAISSMNLLNELIDEYPVAISMAAGRPYEEFFDIRLIHEYIDAYCDHLRRDRKLDEAGVTRTLFQYGTTKGVIADLIARNLAEDENIDAAPESVVVTVGAQEAMFLVLRTLRATEHDVLLAPAPTYVGLTGAALLTDTPVWPVQSTENGIDPDDLVLQLKRADEQGKRVRACYVTPNFANPTGTSMDLAARHRLLEVAEANGILLLEDNAYGLFGAERLPTLKALDRSGTVVYIGSFAKTGMPGARVGFTVADQRMAGGGLLADQLSKLKGMLTVNTSPIAQSVIAGKLLLNDFSLTKANAREIAVYQRNLRLVLGELERRLGGRAGVRWNTPTGGFFVTVTVPFTVDDDLLALAARDHGVLFTPMHHFYGGKGGFNQLRLSISLLTPELIEEGVARLAALITARLG	MADASIVCTNLSFSWPDETPVFDGLSFALGAGRCGLVGPNGAGKSTLLRLAVGELTPTAGSITAQGHVGYLPQSLPLIDGTVDEALEIASIRAALHAIESGDVDEAHFTTVGDHWDIEERTTIVLDRLGLGDVSLDRPLRSLSGGQVLAIGLAAQLLKRPDVLILDEPTNNLDLAARQRLYQVVEEWKGALLVVSHDRELLDRVDTIAELQASELRLYGGNFTAYTEAVELEQENVQRAVRGAEQELRRHKREAQAAQERAQRRASNAKRNKASSGVPRIHAGALQRQAQESAGRAASVHQDRVSQAKAKLDEASQGMREEARLAITLPQTSVPAGRTVLTCHEANVRYGERTLFTGSGVDLGIRGPERIALLGPNGSGKSTLLKLIAGELEPSSGTVTAPTDRVSYLSQRLDLLDLDASVLDNLRRFAPHLQDGEVRYRLAQFLFRGDRVHRTAGWLSGGERLRATLACVLSTDPAPQLLLLDEPTNNLDLNSAAQLENALNAFQGAFVVVSHDQAFLRAIGVSRWLRLADGTLEEIAEADDAWPHRDK	78.91	gnl|BL_ORD_ID|900|hsp_num:0	974			498	666	lincomycin; clindamycin; celesticetin
BGC0000311.1|Balhimycin_22 # 48610 # 49464 # 1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.731	BGC0000311.1|Balhimycin_22 	48610	49464	+	Loose	600	50.8322	EstT	27.73	3007459	protein homolog model	n/a	n/a	macrolide antibiotic; glycylcycline; tetracycline antibiotic	antibiotic inactivation	macrolide esterase	ATGCTGATGACGACTGAGCACGGGATCCGGCTGTCGTACCACGACCAGGGCCGTGGTGCGCCGGTTCTGCTGCTGACCGGCACCGGGGCGCCGAGCTCGGTGTGGGACCTGCACCAGGTGCCCGCGCTCCGCGCCGCCGGGTTCCGGGTGATCACCATGGACAACCGCGGGATCCCGCCCAGCGACGACGGCGCGGACGGGTTCACCGTCGACGACCTCGTCGCGGACGTGGCCGCGCTGCTCGACCACCTCGACGCGTCGCCGTGCCGCGTCGTCGGCACGTCGATGGGCTCGTACATCGCGCAGGAGCTGGCGCTGGCCCGCCCGGAACTGGTGGACGCCGTCGTGCTGATGGCGGCCTGCGGCCGGAGCAGTCTCGTCCAGCGCGTGCTCGCGGAGGCCGAGGCGGACCTGATCGGACGGGGGACCGAGCTGCCGCCGGGGTACCGCGCCGCCGTTCGCGCGATGCACAACCTGGGGCCCGCGACGCTCGCCGACGACGACCTCGCTGCCGACTGGCTCGACCTGTTCGCGGCGTCGGAGAACTGGGGGCCGGGCGTCCGGGCGCAGCTGCTGCTGAGCGCGTTGCCCGACCGTCGCGAGGCCTACCGGGCGATCAAGGTGCCCTGCCACGTCGTTTCGTTCGAGCACGACCTCGTGGCGCCGCCGTCCGCCGGGCAGGAGCTGGCCGCCGTGATCCCCGGCGCCACGCACCGCACGATCCCGGGGTGCGGGCACTTCGGCTACCTGGAGAAGCCGGAAGCGGTGAACCGCGAGCTGCTCCGGTTCCTCCGCACGGAATCCGGCGTGGCTGTGACATCCGGGGCTTCGCCCCGGACCCCCGAAGAACTGTGA	MLMTTEHGIRLSYHDQGRGAPVLLLTGTGAPSSVWDLHQVPALRAAGFRVITMDNRGIPPSDDGADGFTVDDLVADVAALLDHLDASPCRVVGTSMGSYIAQELALARPELVDAVVLMAACGRSSLVQRVLAEAEADLIGRGTELPPGYRAAVRAMHNLGPATLADDDLAADWLDLFAASENWGPGVRAQLLLSALPDRREAYRAIKVPCHVVSFEHDLVAPPSAGQELAAVIPGATHRTIPGCGHFGYLEKPEAVNRELLRFLRTESGVAVTSGASPRTPEEL	MKKKLLWILILGLIIISCKQRKTEMKEKIIKTNGIELCTESFGNKKNPAILLVAGATVSMLYWDTEFCQQLSEKGFFVIRYDNRDVGKSTNYEPGSTPYDIVDLTNDAISILDGYKIDKAHFVGISLGGLISQIASIKFADRVNSLTLMSSGPWGDSDPTIPEMDTSILDFHSKAGTVNWTNEDSVVNYLIQGAELMSGKKQFDKQRSEKLIRAEFNRANNYISMFNHAASQGGGGEEYWNRLNEIKQPTLIIHGTDDKIWHYKNAGFLLEKIKGSNLITLEGTGHELHVDDWKSIIDGIEKHIND	92.81	gnl|BL_ORD_ID|4956|hsp_num:0	5948			96	453	tigecycline
BGC0000311.1|Balhimycin_23 # 49530 # 51275 # 1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.747	BGC0000311.1|Balhimycin_23 	49530	51275	+	Loose	1000	133.65	almE	26.43	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGACCGGCGCGATCGTGCCCCCGTCCACGGCACCCGCCCTGTTCGAGGCGGCCGCCGCCGCGGTGCCGGACCGGCCGGCCGTGGCGATGGGGACCACCACGCTGACCTACGCCGAGCTGAATACCCAGGCCAACCGGCTCGCGCGCCGGCTCGTGGCGCACGGCGTGGGCCCGGAACGGCTGGTCGCACTGGCGATGCCGCGGTCGATCGAGTTCGCCGTCGCGATGCTGGCCGTGCACAAGGCCGGCGGTGCGTACGTGCCGATCGACCCGGACTATCCCGCGGAACGCCGGCAGCACATGCTGGCCGGTGCGGCGGCGCAGTGCCTGCTGTGCCTGCCCGGGCAGGACGTCGCCGGCGCTCCGGTCGTGCTGAGCGTGGCGCTGGCGGAGCCGGGCCGTCCCGAGCCGGACCTGGACGACTCCGACCGGCTCGCCCCGCTGCTGCCCAGCCACCCCGCGTACGTCATCTTCACCTCGGGCTCGACCGGGCAGCCGAAGGGCGTCGTGGTCACGCACCGGGGAATCCCGAACCTGGCCGCCGACTACGTGCACCGCCAGAACCTGCTGCCCGACAGCCGGTTGCTGGCTTTCGCGTCCCCCAGCTTCGACGCCGCCGTCGCCGAGTTCTGGCCGATCTGGCTGGCCGGTGCCTGCCTGGTGCTGGCGCCCGCGCCGGACCTGATCCCCGGGGAGCCGCTCGCCCGGCTGGTCCGGGACCGGCACATCACCCACGTGACGCTGCCGCCGTCCGCCCTGGCCCCGCTGGAAGAAGCCGGCGGCCTGCCGCCGGGGCTGACCCTCCTGGTCGCCGGCGAGGCGGGCCCGGCTCCGGTCGCGAAGCGCTGGGCCGCCGGCCGCGTCATGATCAACGCGTACGGCCCCACCGAAGCCACGGTCGCGGTGACCGCGAGCGACCCGCTGACCGGCGAAGACACGCCGCCGATCGGCAGGCCGATCACCGGTGTCCACACCTACGTCCTGGACGACCGGCTGGTCCCCGTCCCGGACGGGACCGTGGGGGAGCTGTACATGACCGGCCCGGGCCTCGCCCGCGGTTACCTGCACCGGCCGGCCGCGACCGCGGAACGGTTCCTGCCGGACCCGTTCGGCGGTCCGGGGCAGCGCATGTACCGCACGGGTGACCGGGTGCGGGCGCGCCCGGACGGTCAGCTCGTCTTCGTCGGCCGGGCCGACGACCAGCTGAAGGTGCGTGGTCACCGGATCGAGCCGGCGGAGGTCGAATCCGCGCTGCTCGCGGTGGACGGGGTGGCCCAGGCGGTGGTGACCGAACACGACAACCGGCTCGTGGCGTACGTGGTCGGCGCCGGGGGCGCGCGGGTGCCCGCCGAAGACCTCCTGCCGCCGCTGAGGAAGCAGCTGCCCGCCTACCTGGTCCCCGACGTGGTCGTCGGCCTGCCGCACCTGCCGACCACCCCGAACGGCAAGGTCGACCGGGCCGCGCTGCCCGCGCCCGAGGCGGAGGACACCGGGCGCGCGATCTCCGGGCGGGCGCCGAGCACGCCCACGGAAATCCACCTGGCCGCCTTGTTCGCGGAAGTGCTCGGTGTCAGCAGCGTCGGCGTGGAGGACAGCTTCTTCGAGGTCGGCGGCCACTCGCTGCTCGCCACCCGGCTGGTTTCCCGCATCCGCGAAAGCCTGCGGGTCCGGCTGCGGGTGCAGGCCTTCTTCGACGCGCCGACCGTGGCCGAACTCGCCAAGGTGCTCGACGCCGCCCTGACGTGA	MTGAIVPPSTAPALFEAAAAAVPDRPAVAMGTTTLTYAELNTQANRLARRLVAHGVGPERLVALAMPRSIEFAVAMLAVHKAGGAYVPIDPDYPAERRQHMLAGAAAQCLLCLPGQDVAGAPVVLSVALAEPGRPEPDLDDSDRLAPLLPSHPAYVIFTSGSTGQPKGVVVTHRGIPNLAADYVHRQNLLPDSRLLAFASPSFDAAVAEFWPIWLAGACLVLAPAPDLIPGEPLARLVRDRHITHVTLPPSALAPLEEAGGLPPGLTLLVAGEAGPAPVAKRWAAGRVMINAYGPTEATVAVTASDPLTGEDTPPIGRPITGVHTYVLDDRLVPVPDGTVGELYMTGPGLARGYLHRPAATAERFLPDPFGGPGQRMYRTGDRVRARPDGQLVFVGRADDQLKVRGHRIEPAEVESALLAVDGVAQAVVTEHDNRLVAYVVGAGGARVPAEDLLPPLRKQLPAYLVPDVVVGLPHLPTTPNGKVDRAALPAPEAEDTGRAISGRAPSTPTEIHLAALFAEVLGVSSVGVEDSFFEVGGHSLLATRLVSRIRESLRVRLRVQAFFDAPTVAELAKVLDAALT	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	104.50	gnl|BL_ORD_ID|4935|hsp_num:0	5928			111	1653	colistin A; colistin B
BGC0000311.1|Balhimycin_24 # 51289 # 52479 # 1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.715	BGC0000311.1|Balhimycin_24 	51289	52479	+	Loose	500	26.5646	TEM-76	26.51	3000942	protein homolog model	n/a	n/a	monobactam; cephalosporin; penam; penem	antibiotic inactivation	TEM beta-lactamase	ATGCAGACGACGAACGCCGTCGACCTCGGCAACCCCGACCTGTACACGACCCTGGAACGGCACGCCCGCTGGCGCGAGCTCGCGGCGGAAGACGCGATGGTGTGGAGTGACCCGGGCAGTTCCCCCTCCGGCTTCTGGTCGGTGTTCTCGCACCGGGCGTGCGCCGCGGTCCTCGCGCCGTCGGCGCCGCTCACCTCCGAATACGGGATGATGATCGGGTTCGACCGCGACCACCCGGACAACTCCGGCGGCCGGATGATGGTGGTCTCCGAACACGAGCAGCACCGCAAGCTGCGCAAGCTCGTCGGGCCGCTGCTGTCCCGGGCGGCCGCGCGCAAGCTGGCCGAGCGGGTGCGGATCGAGGTCGGCGACGTGCTCGGCCGGGTCCTCGACGGCGAGGTCTGCGACGCGGCCACGGCGATCGGCCCCCGCATCCCCGCCGCGGTCGTGTGCGAGATCCTCGGCGTGCCCGCCGAGGACGAAGACATGCTCATCGACCTGACCAACCACGCCTTCGGCGGCGAGGACGAGCTGTTCGACGGGATGACCCCGCGGCAGGCGCACACCGAGATCCTCGTCTACTTCGACGAACTGATCACCGCGCGCCGCAAGGAACCCGGCGACGACCTCGTCAGCACGCTGGTGACCGACGACGACCTCACGATCGACGACGTGCTGCTCAACTGCGACAACGTGCTCATCGGCGGCAACGAGACCACGCGGCACGCGATCACCGGCGCGGTGCACGCGCTGGCGACGGTGCCCGGCCTGCTGACGGCGCTGCGGGACGGGAGCGCGGACGTCGACACCGTCGTGGAAGAGGTGCTGCGCTGGACCTCGCCCGCGATGCACGTGCTCCGGGTGACGACCGCCGACGTCACGATCAACGGCCGCGACCTGCCGTCCGGCACCCCGGTGGTGGCGTGGCTGCCCGCGGCGAACCGGGACCCCGCCGAGTTCGACGACCCGGACACCTTCCTGCCCGGGCGGAAACCCAACCGGCACATCACCTTCGGCCACGGCATGCACCACTGCCTCGGGTCCGCGCTCGCGCGGATCGAGCTGTCGGTCGTGCTGCGGGTGCTGGCCGAGCGGGTGTCCCGGGTGGACCTGGAACGGGAGCCGGCCTGGTTGCGGGCGATCGTCGTGCAGGGGTACCGGGAACTCCCGGTGCGGTTCACCGGGCGCTGA	MQTTNAVDLGNPDLYTTLERHARWRELAAEDAMVWSDPGSSPSGFWSVFSHRACAAVLAPSAPLTSEYGMMIGFDRDHPDNSGGRMMVVSEHEQHRKLRKLVGPLLSRAAARKLAERVRIEVGDVLGRVLDGEVCDAATAIGPRIPAAVVCEILGVPAEDEDMLIDLTNHAFGGEDELFDGMTPRQAHTEILVYFDELITARRKEPGDDLVSTLVTDDDLTIDDVLLNCDNVLIGGNETTRHAITGAVHALATVPGLLTALRDGSADVDTVVEEVLRWTSPAMHVLRVTTADVTINGRDLPSGTPVVAWLPAANRDPAEFDDPDTFLPGRKPNRHITFGHGMHHCLGSALARIELSVVLRVLAERVSRVDLEREPAWLRAIVVQGYRELPVRFTGR	MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMGDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW	138.46	gnl|BL_ORD_ID|1802|hsp_num:0	1951			219	468	ampicillin
BGC0000311.1|Balhimycin_25 # 52645 # 53715 # 1 # ID=1_25;partial=00;start_type=TTG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.690	BGC0000311.1|Balhimycin_25 	52645	53715	+	Loose	700	25.409	OCH-5	35.0	3002518	protein homolog model	n/a	n/a	monobactam; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	OCH beta-lactamase	TTGACTTCCGATTCGACTGTCCAGAATTTCGAGATCGACTACGTCGAAATGTATGTGGAAAACCTCGAGGCGGCCACGTTCACCTGGGTCGACAAGTATGCTTTCGCCGTCGCCGGTACCGACCGGTCGGCGGACCACCGGAGCGTCACGCTGCGGCAGGGCCCGATCAAGCTGGTCCTCACCGAACCGACGTCGGACCGGCACCCGGCGGCCGCCTACCTCCAGTCGCACGGCGACGGCGTGGCCGACATCGCGCTGCGCACGCCGGACGTGACCGCCGCTTTCGAAGCCGCGGTGCGGGGCGGGGCCGCCGCCGTGCGCGAACCGGTGCGGCTCGCCGGCGGGCCGATCGTCACGGCCACCATCGGCGGGTTCGGCGACGTCGTGCACACCCTGATCCAGAGCGGCGAAGCCACCGCGGCCGCGCCGGAGACCACCGGCCAGGGCGGGGGAGACGTGAACCTGCTCGGGCTCGACCACTTCGCGGTCTGCCTGAACTCGGGTGACCTCGGTCCCACGGTGGCGTTCTACGAGCGGGCCTTCGGGTTCCGGCAGATCTTCGAGGAGCACATCGTGGTCGGCAGGCAGGCGATGAACTCCACCGTGGTGCAGAGCGCGTCGGGGGAGGTCACCCTCACCCTGATCGAGCCCGACAGCAACGCCGACCCCGGCCAGATCGACGAGTTCCTCAAGGCCCACCAGGGAGCCGGCGTCCAGCACATCGCCTTCAACGCCGACGACGCGGTCCGCGCGGTCCGGGCGCTGTCCGGCCGCGGGGTGGAGTTCCTGAAGACTCCGGGGACCTATTACGACATGCTCGGCGAGCGGATCACGCTGGAGACGCACACGCTGGACGACCTGCGGTCGACGAACGTGCTCGCCGACGAGGACCACGGCGGCCAGCTGTTCCAGATCTTCGCCGCTTCCACCCACCCGCGTCACACCATCTTCTTCGAGATCATCGAGCGGCAGGGCGCGGGAACCTTCGGCAGCTCCAACATCAAGGCCCTGTACGAGGCCGTGGAGCTGGAGCGGACCGGGCAGAGCGAGTTCGGCGCCGCCCGGCGATGA	MTSDSTVQNFEIDYVEMYVENLEAATFTWVDKYAFAVAGTDRSADHRSVTLRQGPIKLVLTEPTSDRHPAAAYLQSHGDGVADIALRTPDVTAAFEAAVRGGAAAVREPVRLAGGPIVTATIGGFGDVVHTLIQSGEATAAAPETTGQGGGDVNLLGLDHFAVCLNSGDLGPTVAFYERAFGFRQIFEEHIVVGRQAMNSTVVQSASGEVTLTLIEPDSNADPGQIDEFLKAHQGAGVQHIAFNADDAVRAVRALSGRGVEFLKTPGTYYDMLGERITLETHTLDDLRSTNVLADEDHGGQLFQIFAASTHPRHTIFFEIIERQGAGTFGSSNIKALYEAVELERTGQSEFGAARR	MRKSTTLLIGFLTTAAIIPNNGALAASKANDGDLRRIVDETVRPLMAEQKIPGMAVAITIDGKSHFFGYGVASKESGQKVTEDTIFEIGSVSKTFTAMLGGYGLATGAFSLSDPATKWAPELAGSSFDKITMLDLGTYTPGGLPLQFPDAVTDDSSMLAYFKKWRPDYPAGTQHRYSNPSIGLFGYLAARSMDKPFDVLMEQKLLPAFGLKNTFINVPESQMKNYAYGYSKANKPIRVSGGTLDAQAYGIKTTALDLARFVELNIDSSSLEPDFQKAVAATHTGYYHVDANNQGLGWEFYNYPTALKTLLAGNSSDMALKSHKIEKFDTPRQPSADVLINKTGSTNGFGAYAAFIPAKKIGIVVLANRNYPIDERVKAAYRILQALDNKQ	91.28	gnl|BL_ORD_ID|1121|hsp_num:0	1220			285	405	
BGC0000311.1|Balhimycin_26 # 53712 # 54788 # 1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.743	BGC0000311.1|Balhimycin_26 	53712	54788	+	Loose	800	26.5646	tetA(P)	32.35	3000180	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACGTACGTTTCCCTGGGCGACCTCGAACGTGCCGCTCGCGACGTCCTCCCCGGCGAGATCTGGGACTTCCTCGCCGGGGGGAGCGGCGCCGAGGCATCGCTGACGGCCAACCGCACCGCGCTCGACCGGGTTTTCGTGGTTCCCCGGATGCTGTGCGACCTGACCGGCAGCACCACCGAGGCCGAGCTCCTGGGCCGGCGCGCCGCGCTCCCGATGGCGGTCGCGCCGGTCGCGTACCAGCGGTTGTTCCACCCCGAGGGCGAGCTGGCGGCCGCTCGCGCGGCTCGCGACGCCGGCGTGCCGTACACCATCTGCACCTTGAGCAGCGTCCCGCTCGAGGAGGTCGCGGCCGTCGGCGGCCGGCCGTGGTTCCAGCTGTACTGGCTGCGTGACGAGAAGCGGTCGCTGGAGCTCGTGCGCCGCGCGGAAGACGCCGGGTGCGAAGCGATCGTGTTCACCGTGGACGTGCCGTGGATGGGACGGCGGTGGCGGGACATGCGCAACGGCTTCGCGTTGCCGGAATCGGTGACAGCGGCCAACTTCGACGCCGGATCGGCCGCGCACCGCCGCACGCGCGGGGCCTCGGCCGTGGCCGACCACACCGCGCGCGAGTTCGCCCCCGCCACCTGGGAGTCGGTGGCGACGGTCCGCGCGCACACGGACCTGCCGGTGGTGCTCAAGGGCATCCTCGCCGCCGAGGACGCCCGCCGTGCCGTCGAGGCCGGGGCCGACGGGATCGTGGTGTCCAACCACGGAGGTCGTCAGTTGGACGGCGCGGTGCCCGGGATCGAGGTGCTGGGCGAGATCGCCGCCGAGGTCTCCGGCCGCTGCGAAGTGCTGCTGGACGGCGGAATCCGGACCGGCGGGGACATCCTCAAGGCGGCCGCGCTGGGCGCGTCGGGCGTGCTGGTCGGGCGGCCCGTGATGTGGGGGCTGGCCGCGGCGGGCCAGGAGGGCGTCCGGCAGGTGTTCGAACTGCTCGCCGCCGAACTCCGGAACGCGCTGGGCCTGGCGGGCTGTGACTCGGTGAGCGCGGCCGGCCGGCTGGGCACGAGGGTCCCCCGCTACGGCTGA	MTYVSLGDLERAARDVLPGEIWDFLAGGSGAEASLTANRTALDRVFVVPRMLCDLTGSTTEAELLGRRAALPMAVAPVAYQRLFHPEGELAAARAARDAGVPYTICTLSSVPLEEVAAVGGRPWFQLYWLRDEKRSLELVRRAEDAGCEAIVFTVDVPWMGRRWRDMRNGFALPESVTAANFDAGSAAHRRTRGASAVADHTAREFAPATWESVATVRAHTDLPVVLKGILAAEDARRAVEAGADGIVVSNHGGRQLDGAVPGIEVLGEIAAEVSGRCEVLLDGGIRTGGDILKAAALGASGVLVGRPVMWGLAAAGQEGVRQVFELLAAELRNALGLAGCDSVSAAGRLGTRVPRYG	MVNKLSAYKTYLLFSAITAMCFSLVATVMMVYHIEIVHLNPLQLILVGTTLELACFIFEIPTAIVADVYSRKLSIVIGGVLTGVGFILEGSISSFVFVLVAQIVWGLGSTFISGSLEAWIAEEEKNKDLDEIYIKGAQAGQIGAFIGIVLSTVIANFSVRLPIIVSGVLFIILALFLWLYMPENNFKPSAPGDLNTFKKMVYTFKSGLKFVKSKSIIMILLAVTLFYGLSSEGYDRLSNAHFLQDTTLPKLGNLSSVTWFGIFGILGMILSFIVMHFMAKNLKNEDNRKNGKLLLCINILYISSMLIFALTRNFSLMLIAYLATNTFRIINKPIFSAWLNGHIDDNSRATVLSINGQMNSLGQILGGPIIGIIATNISVSIGIVCTSLLVTPVLVLYIVAMIIDKKVDDRVGGIDYEENN	85.24	gnl|BL_ORD_ID|467|hsp_num:0	508			141	342	tetracycline
BGC0000311.1|Balhimycin_27 # 54879 # 56237 # 1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.701	BGC0000311.1|Balhimycin_27 	54879	56237	+	Loose	1080	58.151	rosB	25.53	3003049	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCTGCACACCTTTGCCGCGGCGGTCGCGCCGGTCGCACCGATCGCCGCGCACAGTCTCCTGGTCTTCCTGCTGCAGATCGGCTTGCTGCTCCTGCTCGCCGTCGTGCTCGGCCGGCTGGCCGGCCGGTTCGGGATGCCCGCGGTCGTCGGTGAGCTGTTCGTCGGGGTGATCCTCGGTCCGTCGCTGCTGGGCTGGGCGGCGCCGGGCCTGCACAGCTGGCTGTTCCCGGCCGTCGCCGAGCAGTACCACCTGCTCGACGCCGTCGGCCAGGTCGGCGTCCTGCTGCTGGTCGGCCTCACCGGCGTGCAGATGGACATGGGGCTGGCCCGCAAGCGCGGCCTCACCGCGGCCGGGGTCAGCATCGGCGGCCTGGTCCTTCCGCTCGGCCTGGGGATCGGCGCGGGTTACCTGCTGCCGAAGGTGCTCGTTCCGGAGGGCACCGACGTCACCGTCTTCGCGATGTTCCTCGGCGTGGCCCTGTGCGTCAGCGCCATCCCGGTCATCGCCAAGACCCTCATCGACATGAAACTGCTGCACCGCAACATCGGGCAGCTCACGCTCACCGCCGGCATGGTCGACGACGTGTTCGGCTGGTTCATGCTGTCCGTCGTCAGCGCGATGGCGGTCAACGCGGTCTCCGCCGGCACCGTGCTCACTTCGCTGGCCTACCTGGTCGCCATCCTCGCCTTCTGTTTCACCCTCGGCCGTCCGCTGGCCCGGGGTGTGCTCCGCGTCGCGGCCAAGTCCGACGGTCCCGGGCTCACCGTCGCCACCGTCGTCGTCCTGATCTTCCTCGCCGCGGCCGGTACGCAGGCGCTCGGCCTGGAGGCGGTCTTCGGCGCCTTCCTCTGCGGCATCCTGCTCGGGACGGCGGGCAAGGTGGATCCGGCCAAGCTCGCCCCCCTGCGCACGGTCGTCCTGTCGGGACTCGCCCCCCTCTTCTTCGCCACGGCCGGGTTGCGGATGGACCTCACCGCGCTGACCCACCCGGTGGTCCTGCTCACCGGTCTGGTGGTGCTCGCCCTGGCCATCGCCGGCAAGTTCGCCGGCGCGTTCGCCGGCGCGCGGCTGAGCGGGTTGAACAAGTGGGAAGGGCTGGCGCTCGGCGCCGGGCTGAACGCGCGGGGAGTCATCCAGGTCGTGGTGGCCATGGTCGGCCTGCGGCTGGGTATCCTCAGCGTGGAGGTCTACACGATCATCATCCTCGTCGCGATCGTCACTTCCCTGATGGCGTCGCCGATCCTGCGGTTCGCGATGTCCAGAGTGGAGCAGACCGCCGAAGAACAGGTTCGCGAGAACGAACACCGGGCGTGGAACACGCACCCGGCGGCGAACCCGCAGGAGCAAAGTCTCTAG	MLHTFAAAVAPVAPIAAHSLLVFLLQIGLLLLLAVVLGRLAGRFGMPAVVGELFVGVILGPSLLGWAAPGLHSWLFPAVAEQYHLLDAVGQVGVLLLVGLTGVQMDMGLARKRGLTAAGVSIGGLVLPLGLGIGAGYLLPKVLVPEGTDVTVFAMFLGVALCVSAIPVIAKTLIDMKLLHRNIGQLTLTAGMVDDVFGWFMLSVVSAMAVNAVSAGTVLTSLAYLVAILAFCFTLGRPLARGVLRVAAKSDGPGLTVATVVVLIFLAAAGTQALGLEAVFGAFLCGILLGTAGKVDPAKLAPLRTVVLSGLAPLFFATAGLRMDLTALTHPVVLLTGLVVLALAIAGKFAGAFAGARLSGLNKWEGLALGAGLNARGVIQVVVAMVGLRLGILSVEVYTIIILVAIVTSLMASPILRFAMSRVEQTAEEQVRENEHRAWNTHPAANPQEQSL	MHHSTPLITTIVGGLVLAFLLGSLAHRLRSSPLVGYLAAGVLAGPFTPGFVADTSLAPELAEIGVILLMFGVGLHFSLKDLLAVKAIAIPGAVAQIAVATLLGMGLSHLLGWDLMTGFVFGLCLSTASTVVLLRALEERQLIDSQRGQIAIGRSIVEDLAMVLTLVLLPAFAGVMGNETTSLSQLFTELAITIGKVIAFITLMIVVGRRLVPWILAKTASTGSRELFTLAVLVLALGIAYGAVGLFDVSFALGAFFAGMVLNESELSHRAAQDTLPLRDAFAVLFFVSVGMLFDPMILLREPLAVLASLAIIIFGKSAAAFILVRMFGHSNVYSTHHFCPWRKSVNLPFILAGLGISLGLMSEHGRNLVLAGAILSIMLNPLLFTLLDRYLAKNETMEDLILEEAVEEEKQIPGRFVQSCTVSRLWSGGSLLGAKLHAEGIPLVVIENSRPRVEALREQGINAVLGNAASADIMSLARLDCALVIILTIPNGYEAGEIVASARIKRPDLEIIARAHYDDEVVYISVRGANQVVMGEREIANSMLNMLKIETLTEEDKRPLCPI	80.28	gnl|BL_ORD_ID|466|hsp_num:0	507			42	1212	polymyxin B; polymyxin B1; polymyxin B2; polymyxin B3; polymyxin B4
BGC0000311.1|Balhimycin_30 # 58211 # 59320 # 1 # ID=1_30;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=11bp;gc_cont=0.678	BGC0000311.1|Balhimycin_30 	58211	59320	+	Loose	500	30.8018	mphJ	36.96	3004544	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	ATGACCACGCGTGTATGGGACTACCAGGCCGAATACCGGAACGAGCGGCTCGACCTGCTGGACGCGGTCGAGACGGTCTTCGACTCGGGGCAGCTCGTGCTCGGGGCGAGCGTGCGTGGCTTCGAGGCGGAATTCGCCGCGTACCACGGGGTCGGGCACTGCGTTGGCCTCGACAACGGGACGAACGCGATCAAGCTCGGCCTGCAGGCGCTGGGTGTCGGGCCGGGCGACGAGGTGATCACGGTGTCCAACACCGCCGCCCCGACCGTGGTCGCCATCGACGGCACCGGCGCCACGCCGGTCTTCGTCGACGTCCGCGAGGACGACTTCCTGATGGACACCGGCCAGGTCGCGGCCGCGATCACCGAGCGCACCAAGTGCCTGCTGCCCGTGCACCTATACGGACAGTGCGTGGACATGGCTCCGCTGAAGGACCTCGCCGCGAAGCATGGACTGTCCATTTTGGAGGACTGTGCCCAGGCGCACGGGGCCCGGCAGAACGGAACGGTCGCGGGCTCGACCGGTGACGCGGCCGCGTTCTCCTTCTACCCGACCAAGGTGCTCGGGGCGTACGGCGACGGCGGCGCGACCATCACCTCCGACGAATCCGTGGACCGGCGGCTGCGGCGGCTGCGCTACTACGGCATGGACAAGCAGTACTACACGCTGGAAACGCCGGCCCACAACAGCCGGCTGGACGAGGTCCAGGCCGAGATCCTGCGGCGCAAGCTCAAGCGGCTCGACACCTACGTCGCCGCCCGCCAGGCCATCGCCCAGCGCTACGTCGACGGACTGGGCGACACGGAGCTGAAGCTGCCGCGGACCGTCCCCGGCAACGAGCACGTGTACTACGTGTACGTCGTGCGCCACCCGCGACGTGACGACATCATCGAGCGCCTCAAGGCGTACGACATCCACTTGAACATCAGCTATCCGTGGCCGGTGCACACCATGACCGGTTTCGCCCACCTCGGCTACGCGACCGGCGCGTTCCCGGTCACCGAAAAACTGGCCGGCGAGATCTTCTCGCTGCCGATGTACCCCGCGCTTTCCGCCGACCTGCAGGACAAGGTCATCCATGCGGTGCGCGAGGTGGTGTCCACCCTCTGA	MTTRVWDYQAEYRNERLDLLDAVETVFDSGQLVLGASVRGFEAEFAAYHGVGHCVGLDNGTNAIKLGLQALGVGPGDEVITVSNTAAPTVVAIDGTGATPVFVDVREDDFLMDTGQVAAAITERTKCLLPVHLYGQCVDMAPLKDLAAKHGLSILEDCAQAHGARQNGTVAGSTGDAAAFSFYPTKVLGAYGDGGATITSDESVDRRLRRLRYYGMDKQYYTLETPAHNSRLDEVQAEILRRKLKRLDTYVAARQAIAQRYVDGLGDTELKLPRTVPGNEHVYYVYVVRHPRRDDIIERLKAYDIHLNISYPWPVHTMTGFAHLGYATGAFPVTEKLAGEIFSLPMYPALSADLQDKVIHAVREVVSTL	MSKNNVEHMLALAKNNGILVDPTTVKVNESGLDFLAIFASTIDGIPWVLRQPRRDDVVETARYEKRVLDLVAKHLRVEVPDWQVHTSEFIAYPILGGTPMATINMETKNYDWYLNPESLPELCIQTWAEALVELHGIHHDLARDAGIRVKQPSYARASLREKMNEIKRVFGVSGALWDRWQKWLADETFWPAHSALVHGDLHPGHILVAENGKVTGLLDWTEAEVSDPAIDFTVVYLLFGDTGLADFIQRYEKAGGRVWSRMHEHIVEMTAAYPVTLATFALKSGLEEFKIMARQALGVDENGKEITS	119.81	gnl|BL_ORD_ID|2691|hsp_num:0	3220			138	276	erythromycin; telithromycin; tylosin
BGC0000311.1|Balhimycin_31 # 59344 # 59961 # 1 # ID=1_31;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.701	BGC0000311.1|Balhimycin_31 	59344	59961	+	Loose	275	25.0238	Streptomyces rimosus otr(A)	29.63	3002891	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	GTGCAAGCACGCAAACTCGCCGTCGACGGCGCGATCGAGTTCACCCCCCGGGTCTTCCCCGACGACCGGGGCCTGTTCGTCTCGCCGTTCCAGGAAGAGGCCTTCGCCGAGGCCCGCGGCGGCCCGCTGTTCCGGGTGGCGCAGACGAACCACAGCATGTCCAAGCGCGGCGTGGTGCGTGGCATCCACTACACGATGACGCCACCGGGCACGGCCAAGTACGTCTACTGTGCCCGCGGCAAGGCGTTGGACATCGTGGTCGACATCCGGGTCGGCTCGCCGACGTTCGGCCGGTGGGACGCGGTCCTGCTGGACCAGCGGGACCACCGGGCGATGTACTTCCCGGTGGGGGTCGGCCACGCGTTCGTGGCCCTCGAGGACGACACCGCCATGTGGTACCTGCTCTCCACGGCCTACGTGGCGCGGAACGAGCTCGCCCTCTCGGTCCTGGATCCCGCGCTGGGCCTGCCCATCGACGCCGACGTCGACCCGATCCTGTCCGAACGGGACCAGGTGGCCGTCACGCTCGCCGAGGCGGGACGGCAGGGGTTGCTGCCGGACTACGCCACCTGCCTGGAGCTCGACCGGCAGCTGTCCGAAGTCTCCCTTTCCGCCTGA	MQARKLAVDGAIEFTPRVFPDDRGLFVSPFQEEAFAEARGGPLFRVAQTNHSMSKRGVVRGIHYTMTPPGTAKYVYCARGKALDIVVDIRVGSPTFGRWDAVLLDQRDHRAMYFPVGVGHAFVALEDDTAMWYLLSTAYVARNELALSVLDPALGLPIDADVDPILSERDQVAVTLAEAGRQGLLPDYATCLELDRQLSEVSLSA	MNKLNLGILAHVDAGKTSLTERLLHRTGVIDEVGSVDAGTTTTDSMELERQRGITIRSAVATFVLDDLKVNLIDTPGHSDFISEVERALGVLDGAVLVVSAVEGVQPQTRILMRTLRRLGIPTLVFVNKIDRGGARPDGVLREIRDRLTPAAVALSAVADAGTPRARAIALGPDTDPDFAVRVGELLADHDDAFLTAYLDEEHVLTEKEYAEELAAQTARGLVHPVYFGSALTGEGLDHLVHGIRELLPSVHASQDAPLRATVFKVDRGARGEAVAYLRLVSGTLGTRDSVTLHRVDHTGRVTEHAGRITALRVFEHGSATSETRATAGDIAQAWGLKDVRVGDRAGHLDGPPPRNFFAPPSLETVIRPERPEEAGRLHAALRMLDEQDPSIDLRQDEENAAGAVVRLYGEVQKEILGSTLAESFGVRVRFDPTRTVCIEKPVGTGEALIELDTRTHNYFWGAPWVCASDRPSPARAITFRLAVELGSLPLAFHKAIEETVHTTLRHGLYGWQVTDCAVTLTRTGVRSPVSAADDFRKANARLVLMDALGRAGTEVHEPVSSFELEVPAARLSPVLAKLAELGATPGVPTAEGDVFRLEGTMPTSLVHDFNQRVPGLTQGEGVFLAEHRGYRPAVGQPPVRPRPEGPNPLNRDEYILHVLKRV	30.92	gnl|BL_ORD_ID|4807|hsp_num:0	1273			732	894	oxytetracycline
BGC0000311.1|Balhimycin_33 # 61291 # 61947 # 1 # ID=1_33;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.761	BGC0000311.1|Balhimycin_33 	61291	61947	+	Loose	700	24.2534	vanK gene in vanI cluster	38.24	3003727	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanK	ATGGTGAACGGTGAACTGGTGCTCCGGCTCGACGGCACCCGGCCCCTGTCGGCCGCGTCGGTCGAGGAACTGGACGCCCTCTGCGATCGCGTGGAAGACCACCGGGAACCCGGCCCGGTCACCGTCCACGTCACGGGTGTCCCGGCCGCCGGCTGGACGGCGGAGGTGACGGTCGGCCTGGTCTCCAAGTGGGAACGGGTGGTGCGCCGGTTCGAGCGGCTCGGCAGGCTCACCATCGCCGTGGCGGCGGGTGACTGCGCCGGAACGGCACTGGACGTCCTCCTCGCGGCCGACGTCCGGATCGCCGCGCCGGGCACCCGGCTGCTGCTCGCCCGGGCCGGCGGCGCGCCGTGGCCCGGGATGACCGTGCACCGGCTCACCCGGCAGGCCGGGGCGGCCGGCATCCGGCGGGCGGTGCTGCTCGGCGCCCCGATCGAGGCCGGTCGCGCGCTGGCCCTGAACCTGGTCGACGAGGTCTCGGAGGACCCGGCGGCCGCGCTGGCGGAGCTCGCCGGGACGGCCGGTGCCGTGGACGGCAAGGAGCTGGCGATCCGCCGTCAGCTGGTCTTCGAAGCCGGCTCGACCGCCTTCGAGGACGCACTCGGCGCCCACCTGGCCGCGGCGGACCGGGCCCTGCGCAGGGAAACCGCGTCGTGA	MVNGELVLRLDGTRPLSAASVEELDALCDRVEDHREPGPVTVHVTGVPAAGWTAEVTVGLVSKWERVVRRFERLGRLTIAVAAGDCAGTALDVLLAADVRIAAPGTRLLLARAGGAPWPGMTVHRLTRQAGAAGIRRAVLLGAPIEAGRALALNLVDEVSEDPAAALAELAGTAGAVDGKELAIRRQLVFEAGSTAFEDALGAHLAAADRALRRETAS	MLNVDKISEETYYAFISQADLGNFMQYPSWAKVKTEWTSDLLGWFTPDNKLAGCGLILYRKMPCLNRYLAYCPRGPLIDWQSPNLREWFEPLVAYLRSKQVFSIKIDPPVVQAKWSAPTIKTFLGQAREQGSKGKVLRDLPPDEDYTTVQQVQQQLRQMGWRKQRGDTGFAATQPQYVYRLPLEGRSLEEVFAGFHTNWRRNVKKAERLGVKVRVGTEQDLPAFYELLKVTSERDHFKVRSFSYFSNLYRSLKAEAADRIALYLAEDEEELLAATLAVHSNAHSWYLYGASSNVKREKAPNHAIQWRMIQDAYQLKAYTYDFRGISPTLDESDPLFGLLRFKLGFGGEACEMISAWDYPLQPLLYRAFQLYLKRR	58.13	gnl|BL_ORD_ID|4747|hsp_num:0	2245			528	630	vancomycin; teicoplanin
BGC0000311.1|Balhimycin_34 # 61944 # 63248 # 1 # ID=1_34;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.738	BGC0000311.1|Balhimycin_34 	61944	63248	+	Loose	2200	26.1794	rpoB2	40.74	3000501	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	GTGACGGCCGCACCCCCGACGTCTCCGCCGGGGCCGCGGCTCGACCGCCCGGCCCTGGCGGAGGCAGCCGGCCGCGTCGACGACCTGCTCGCCGAACTGCCGCCGCCGTCCGCCCGGACCCCCGGGCAACGCGAGGCCGCGTCTTCGGCGCTGGACGGGATCCGGGCGATGCGCGCGGACTACGTCGGGGCGCACGCCGAAGCGATCTACGACGAACTCACCGACGGCCGGTCCCGGTCCCTGCGCATCGACGAGCTCGTCCGGGCCGCCGCCCGGGCCTTTCCCGGCCTGGTGCCCACGGACGAGCAGATGGCGGCCGAGCGCGCGCGGCCGCAGGCGGAGAAGGACGGGCGGGAGATCGACCAGGGCATCTTCCTGCGCGGGATCCTGCGGGCGGAGCGGGCCGGCCCGCACCTGCTCGACGCCATGCTCCAGCCCACCCCGAGGGCGCTGAAGCTGCTCCCGGGATTCACCGAGTCCGGTGTCGTGCAGATGGAGGCGGTCCGGCTGGAACGCCGGGACGGCGTCGCGTACCTGACCCTGTGCCGGGACGACTGCCTCAACGCCGAGGACGCCCAGCAGGTCGACGACATGGAGACCGCGGTCGACCTGGCGCTGCTCGACCCGGCCGTCCGGGTGGGGCTGCTGCGCGGCGGGGAGATGAGCCATCCCCGCTACCGGGGGCGCCGCGTGTTCTGCGCCGGCATCAACCTCAAGAAGCTGAGCTCGGGCGGCATCCCGCTGGTCGATTTCCTGCTGCGGCGGGAGCTGGGGTACATCCACAAGATCGTGCGCGGCGTGGTCACCGAAGGTTCGTGGCATTCGCGGCTGACCGACAAGCCGTGGATCGCGGCCGTCGACTCCTTCGCCATCGGCGGCGGGGCCCAGCTGCTCCTCGTCTTCGACCACGTGCTGGCCGCGTCCGACGCCTACTTCAGCCTGCCCGCGGCGAAGGAGGGGATCATCCCCGGCGCGTCGAACTTCCGGCTCTCCCGGTTCGCCGGGCCCCGCGTGGCCCGGCAGGTGATCCTCGGCGGCCGCCGGATCCGGGCGGACGAGCCGGATGCCCGACTGCTCGTCGACGAGGTCGTCCCGCCGGCGGAGCTGGACGCGGCGATCGACGCCGCGCTGGCCCGCCTGGACGGGGAGGCGGTGCTGGCCAACCGGCGCATGCTGAACCTGGCCGAGGAACCGCCGGACGAATTCCGCCGGTACATGGCCGAGTTCGCCCTGCAGCAGGCGCTGCGGATCTACGGCGAAGACGTGATCGGCAAGGTCGGCCGGTTCGCGGCGGGCTCGTCGTGA	MTAAPPTSPPGPRLDRPALAEAAGRVDDLLAELPPPSARTPGQREAASSALDGIRAMRADYVGAHAEAIYDELTDGRSRSLRIDELVRAAARAFPGLVPTDEQMAAERARPQAEKDGREIDQGIFLRGILRAERAGPHLLDAMLQPTPRALKLLPGFTESGVVQMEAVRLERRDGVAYLTLCRDDCLNAEDAQQVDDMETAVDLALLDPAVRVGLLRGGEMSHPRYRGRRVFCAGINLKKLSSGGIPLVDFLLRRELGYIHKIVRGVVTEGSWHSRLTDKPWIAAVDSFAIGGGAQLLLVFDHVLAASDAYFSLPAAKEGIIPGASNFRLSRFAGPRVARQVILGGRRIRADEPDARLLVDEVVPPAELDAAIDAALARLDGEAVLANRRMLNLAEEPPDEFRRYMAEFALQQALRIYGEDVIGKVGRFAAGSS	MLEGRIVTVSSRTESPLAAPGVPGAPRRLSFARIREPLAVPGLLDIQTESFGWLIGAPDWCARAAARGTEPVAGLAEVLAEISPIEDFAGTMSLTLSDPRFEEVKASVEECKDKDLTYAAPWFVTAEFVNNNTGEIKSQTVFMGDFPMMTAHGTFVVNGTERVVVSQLVRSPGVYFDHAIDKGSEKDVHSARVIPSRGAWLEFDVDKRDTLGVRIDRKRRQPVTVLLKALGWSAERIAERFGFAPLIMASLAKDNVAGTDDALLEIHRKLRPGEPPTKESAQNLLANLFFTEKRYDLARVGRYKIDKKLGLRAPGAPRVLTEDDIAATIEYLVRLHAGERTMIAPGGVEVPVEVDDIDHFGNRRVRTVGELIQNQIRVGLSRMERVVRERMTTQDVEAITPQSLMNIRPVVAAMKEFFGTSQLSQFMDQRNPLASLTNKRRLSALGPGGLSRERAGLEVRDVHYSHYGRMCPIETPEGPNIGLMGYLSVYARVNPFGFVETPYRRVVDGRVTDEVDYLTADEEDRHVVAQANEPLDAEGRFLAARIPVRRKNSEVELVDSAAVDYMDVSPRQMVSVATAMIPFLEHDDANRALMGANMQRQAVPLIRSEAPIVGTGMELRAAVDAGDVVVNEKAGVVEEVSADYVTVMADDGTRKSYRMRKFNRSNQGTCSNQRPIVDEGQRVEAGQVLADGPCTENGEMALGKNLLVAIMPWEGHNYEDAIILSQRLVEQDVLTSIHIEEHEIDARDTKLGAEEITRDIPNVSDEVLADLDERGIVRIGAEVRDGDILVGKVTPKGETELTPEERLLRAIFGEKAREVRDTSLKVPHGESGKVIGIRVFSREDDDDLPPGVNELVRVYVAQKRKIQDGDKLAGRHGNKGVIGKILPTEDMPFLPDGTPVDIILNTHGVPRRMNIGQILETHLGWIGKAGWKVEGNPEWAKDLPEEMWEAPADSNIATPVFDGAREEELTGLLGSTLPNRDGERMVDDNGKAVLFDGRSGEPFPYPVAVGYMYILKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMECWAMQAYGAAYTLQELLTIKSDDVVGRVKVYEAIVKGDNIPEPGVPESFKVLLKELQALCLNVEVLSAGAAVELAHGVDDDHERTAANLGINLSRAESITETELSG	37.35	gnl|BL_ORD_ID|2431|hsp_num:0	2831			3186	3267	rifampin; rifaximin; rifabutin; rifapentine
BGC0000311.1|Balhimycin_35 # 63245 # 64054 # 1 # ID=1_35;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.717	BGC0000311.1|Balhimycin_35 	63245	64054	+	Loose	300	27.335	AAC(3)-VIIIa	37.5	3002542	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	GTGAGCGGCGACCGGGTGCGGTACGAGAAGAAGGACCACGTCGCCTACGTGACGCTGGACCGGCCCGGCGTGCTGAACGCCATGGACCGGCGGACGCACGAGGAGCTCGCCGGAATCTGGGACGACGCCGAGGCCGACGACGAAGTCCGGGTGGTGGTGCTGACCGGCGCCGGGAACCGCGCGTTCTCCGTCGGCCAGGACCTCAAGGAACGCGCCCGGCTGAACGAAGCGGGTGCGCGGGCCACGACGTTCGGCAGCCGGGGCCAGCCGGGGCATCCCCGGCTGACCGACCGGTTCACCCTGTCCAAGCCGGTGGTCGCCCGGGTGCACGGCTACGCGCTGGGCGGTGGCTTCGAGCTGGTGCTCGCCTGCGACATCGTCATCGCCTCCGACGATTCGGTGTTCGCCCTGCCGGAGGTCCGCCTCGGCCTGATCCCCGGGGCGGGCGGGGTGTTCCGGCTGCCGCGGCAGCTGCCGCAGAAGGTGGCGATGGGCTACCTGCTGACCGGCCGCCGGATGGACGCGGCGACGGCGCTGCGGTACGGATTGGTCAACGAGGTCGTGCCACCGGAGGAACTGGACCGGTGCGTCGCCGAATGGACGGACAGCCTCGTGCGCGCCGCTCCGCTTTCGGTTCGCGCGATCAAGGAGGCCGCGCTACGGTCGCTCGACCTCCCCCTGGAGGAGGCGTTCACCGCTTCCTACACCTGGGAAGAGCGCCGTCGGCGGAGCGAAGACGCGATCGAGGGTCCCCGGGCCTTCGCCGCGAAACGGGATCCGGTCTGGACCGGGGAATACCGGCCGGGTTGA	MSGDRVRYEKKDHVAYVTLDRPGVLNAMDRRTHEELAGIWDDAEADDEVRVVVLTGAGNRAFSVGQDLKERARLNEAGARATTFGSRGQPGHPRLTDRFTLSKPVVARVHGYALGGGFELVLACDIVIASDDSVFALPEVRLGLIPGAGGVFRLPRQLPQKVAMGYLLTGRRMDAATALRYGLVNEVVPPEELDRCVAEWTDSLVRAAPLSVRAIKEAALRSLDLPLEEAFTASYTWEERRRRSEDAIEGPRAFAAKRDPVWTGEYRPG	MDEKELIERAGGPVTRGRLVRDLEALGVGAGDTVMVHTRMSAIGYVVGGPQTVIDAVRDAVGADGTLMAYCGWNDAPPYDLAEWPPAWREAARAEWPAYDPLLSEADRGNGRVPEALRHQPGAVRSRHPDASFVAVGPAAHPLMDDHPWDDPHGPDSPLARLAGAGGRVLLLGAPLDTLTLLHHAEARAEAPGKRFVAYEQPVTVGGRRVWRRFRDVDTSRGVPYGRVVPEGVVPFTVIAQDMLAAGIGRTGRVAAAPVHLFEAADVVRFGVEWIESRMGGAAGGA	94.06	gnl|BL_ORD_ID|461|hsp_num:0	501			444	585	neomycin
BGC0000311.1|Balhimycin_37 # 65378 # 66667 # 1 # ID=1_37;partial=01;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.751	BGC0000311.1|Balhimycin_37 	65378	66667	+	Loose	1000	52.7582	almE	22.03	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGGAGGAAATCCGGACAGAGTTCATCCGACCGCTGCTGACATCGTTGTCCGCGCACGCCGCGGACCGCCCCGCCTACTCCGACGACCGGCGAACGCTGACCTACGGCGGGCTGGCCCACGCCGCCGCGGAGCTCGCCGCCGGGCTCGGGGTGGCCCGGGGCGACCGCGTGCTGGTGCACGTCGGCAGCCGGGTCGAGTTCGCCGTCGCCCTGCTGGCGGTGCTGCGGGCGGCGGCCGTGGGAGTCCCGGTGAGCGTGCGCTCGACCGACGCCGAACTCGCCCACCTGGCGGCCGATTCGGGGGCGACGCTCCTGGTCACGGAGGCGCGGCACGCCGCCGCGGCCGAACGGCTGCGCCGCGACCGGCCCGGTCTGCGGGTTCTCTTCGTCGACGATCCGCCGCCCGCGCGGGTGGGCGAGCCGCGCGACGACCTCGGACTGGACGAGCCGGCTTGGCTGCTCTACACCTCCGGCACCACCGGCCGGCCCAAGGGCGTCCTGCTCTCGCAGCGCGCGATGCTGTGGTCGACGGCCGCGTACTACGTCCCCATGCTCGGGCTCGACGCCGAAGACACCGTGCTGTGGCCGTTGCCGACGCACCACGCGTACGCCCTGTCGCTGGCGTTCGTCACCACGATCGCGCTGGGGGCGCACACCCGGCTGGCCGACGGGTGCACGCCGGACCTGCTCGCCCGGTACCCCGGCAGTGTGCTCGCCGGTGTTCCCGCGCTCTACCTCCGGCTCCGCCAGGAGTCCGGCGGTCCCCTCGCCGCGCCGCGGCTGTGCCTGAGCGGCGGCGCGCCGTGCACGCCGGCGACCCGGGCCGCGGTCCGGGACCTGTTCGGGCTCCCGGTGGCCGACGGCTACGGGAGCACCGAGACGGGCGGGAAGGTCGCCGCCGAGCTTCCCGGTGAAGCGGGCCTGGTCCCGGTGCCCGGCTTGGAGATCCGGATCGACGCGGGGGAGGTGCTCGTCCGCGGTCCCGGGCTGATGCTGGGCTACCACGGGCGAACCGAATCACCGCTGCGGGACGGCTGGTACCGCACGGGCGACGCCGGCCGGTTCGAGGGCGGCCGGCTCGTGCTCGAGGGCCGCGTGGACGACGTGATCGTCTGCGGTGGCCAGAACGTCCACCCTGCCGAAATCGAGGCGGTGCTCGAAGAGTCGCCTTCGGTGCGGGACGTCCTCGTGCTCGGCCGTCCCGACGACGTCCTGGGCGAGGTGCCGGTGGCGTTCGTGGTCGCCGGGCCCGGCGGCTTCGACGCCGAGGAGCTGCGTGGCCGGTGTCTA	MEEIRTEFIRPLLTSLSAHAADRPAYSDDRRTLTYGGLAHAAAELAAGLGVARGDRVLVHVGSRVEFAVALLAVLRAAAVGVPVSVRSTDAELAHLAADSGATLLVTEARHAAAAERLRRDRPGLRVLFVDDPPPARVGEPRDDLGLDEPAWLLYTSGTTGRPKGVLLSQRAMLWSTAAYYVPMLGLDAEDTVLWPLPTHHAYALSLAFVTTIALGAHTRLADGCTPDLLARYPGSVLAGVPALYLRLRQESGGPLAAPRLCLSGGAPCTPATRAAVRDLFGLPVADGYGSTETGGKVAAELPGEAGLVPVPGLEIRIDAGEVLVRGPGLMLGYHGRTESPLRDGWYRTGDAGRFEGGRLVLEGRVDDVIVCGGQNVHPAEIEAVLEESPSVRDVLVLGRPDDVLGEVPVAFVVAGPGGFDAEELRGRCL	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	77.34	gnl|BL_ORD_ID|4935|hsp_num:0	5928			108	1446	colistin A; colistin B
